<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>

<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31707455</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-8798</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Archives of virology</Title>
                <ISOAbbreviation>Arch. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Molecular, antigenic, and pathogenic characterization of H5N8 highly pathogenic avian influenza viruses isolated in the Democratic Republic of Congo in 2017.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-019-04456-x</ELocationID>
            <Abstract>
                <AbstractText>In May 2017, high mortality of chickens and Muscovy ducks due to the H5N8 highly pathogenic avian influenza virus (HPAIV) was reported in the Democratic Republic of Congo (DR Congo). In this study, we assessed the molecular, antigenic, and pathogenic features in poultry of the H5N8 HPAIV from the 2017 Congolese outbreaks. Phylogenetic analysis of the eight viral gene segments revealed that all 12 DR Congo isolates clustered in clade 2.3.4.4B together with other H5N8 HPAIVs isolated in Africa and Eurasia, suggesting a possible common origin of these viruses. Antigenically, a slight difference was observed between the Congolese isolates and a representative virus from group C in the same clade. After intranasal inoculation with a representative DR Congo virus, high pathogenicity was observed in chickens and Muscovy ducks but not in Pekin ducks. Viral replication was higher in chickens than in Muscovy duck and Pekin duck organs; however, neurotropism was pronounced in Muscovy ducks. Our data confirmed the high pathogenicity of the DR Congo virus in chickens and Muscovy ducks, as observed in the field. National awareness and strengthening surveillance in the region are needed to better control HPAIVs.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Twabela</LastName>
                    <ForeName>Augustin T</ForeName>
                    <Initials>AT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, North 18, West 9, Kita-ku, Sapporo, Hokkaido, 060-0818, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Central Veterinary Laboratory of Kinshasa, Kinshasa I, Gombe, Democratic Republic of Congo.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Okamatsu</LastName>
                    <ForeName>Masatoshi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, North 18, West 9, Kita-ku, Sapporo, Hokkaido, 060-0818, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tshilenge</LastName>
                    <ForeName>Georges Mbuyi</ForeName>
                    <Initials>GM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Veterinary Laboratory of Kinshasa, Kinshasa I, Gombe, Democratic Republic of Congo.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mpiana</LastName>
                    <ForeName>Serge</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Veterinary Laboratory of Kinshasa, Kinshasa I, Gombe, Democratic Republic of Congo.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Masumu</LastName>
                    <ForeName>Justin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Veterinary Laboratory of Kinshasa, Kinshasa I, Gombe, Democratic Republic of Congo.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nguyen</LastName>
                    <ForeName>Lam Thanh</ForeName>
                    <Initials>LT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, North 18, West 9, Kita-ku, Sapporo, Hokkaido, 060-0818, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsuno</LastName>
                    <ForeName>Keita</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, North 18, West 9, Kita-ku, Sapporo, Hokkaido, 060-0818, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Hokkaido, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Monne</LastName>
                    <ForeName>Isabella</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Istituto Zooprofilattico Sperimentale Delle Venezie, Legnaro, PD, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zecchin</LastName>
                    <ForeName>Bianca</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Istituto Zooprofilattico Sperimentale Delle Venezie, Legnaro, PD, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sakoda</LastName>
                    <ForeName>Yoshihiro</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7021-1688</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, North 18, West 9, Kita-ku, Sapporo, Hokkaido, 060-0818, Japan. sakoda@vetmed.hokudai.ac.jp.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Hokkaido, Japan. sakoda@vetmed.hokudai.ac.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>JP18Fm0108008</GrantID>
                    <Agency>Japan Agency for Medical Research and Development</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Austria</Country>
            <MedlineTA>Arch Virol</MedlineTA>
            <NlmUniqueID>7506870</NlmUniqueID>
            <ISSNLinking>0304-8608</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31707455</ArticleId>
            <ArticleId IdType="doi">10.1007/s00705-019-04456-x</ArticleId>
            <ArticleId IdType="pii">10.1007/s00705-019-04456-x</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31706162</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0341</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>539</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Virology</Title>
                <ISOAbbreviation>Virology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mutations of the segment-specific nucleotides at the 3' end of influenza virus NS segment control viral replication.</ArticleTitle>
            <Pagination>
                <MedlinePgn>104-113</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0042-6822(19)30304-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2019.10.015</ELocationID>
            <Abstract>
                <AbstractText>The vRNAs of influenza A viruses contain 12 and 13 nucleotide-long sequences at their 3' and 5' termini respectively that are highly conserved and constitute the vRNA promoter. These sequences and the next three segment-specific nucleotides show inverted partial complementarity and are followed by several unpaired nucleotides of poorly characterized function at the 3' end. We have performed systematic point-mutations at the segment-specific nucleotides 15-18 of the 3'-end of a NS-like vRNA segment. All NS-like vRNAs containing mutations at position 15, and some at positions 16-18 showed reduced transcription/replication efficiency in a transfection/infection system. In addition, the replication of recombinant viruses containing mutations at position 15 was impaired both in single and multi-cycle experiments. This reduction was the consequence of a decreased expression of the NS segment. The data indicate that NS1 plays a role in the transcription/replication of its own segment, which elicits a global defect on virus replication.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rodriguez</LastName>
                    <ForeName>Paloma</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centro Nacional de Biotecnología, C.S.I.C. Darwin 3, Cantoblanco, 28049, Madrid, Spain; CIBER de Enfermedades Respiratorias CIBERES, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marcos-Villar</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centro Nacional de Biotecnología, C.S.I.C. Darwin 3, Cantoblanco, 28049, Madrid, Spain; CIBER de Enfermedades Respiratorias CIBERES, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zamarreño</LastName>
                    <ForeName>Noelia</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centro Nacional de Biotecnología, C.S.I.C. Darwin 3, Cantoblanco, 28049, Madrid, Spain; CIBER de Enfermedades Respiratorias CIBERES, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yángüez</LastName>
                    <ForeName>Emilio</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centro Nacional de Biotecnología, C.S.I.C. Darwin 3, Cantoblanco, 28049, Madrid, Spain; CIBER de Enfermedades Respiratorias CIBERES, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nieto</LastName>
                    <ForeName>Amelia</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centro Nacional de Biotecnología, C.S.I.C. Darwin 3, Cantoblanco, 28049, Madrid, Spain; CIBER de Enfermedades Respiratorias CIBERES, Spain. Electronic address: anieto@cnb.csic.es.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Virology</MedlineTA>
            <NlmUniqueID>0110674</NlmUniqueID>
            <ISSNLinking>0042-6822</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Gene expression</Keyword>
            <Keyword MajorTopicYN="N">Influenza virus</Keyword>
            <Keyword MajorTopicYN="N">NS segment</Keyword>
            <Keyword MajorTopicYN="N">Segment-specific nucleotides</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31706162</ArticleId>
            <ArticleId IdType="pii">S0042-6822(19)30304-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.virol.2019.10.015</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31702775</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2049-632X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pathogens and disease</Title>
                <ISOAbbreviation>Pathog Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Key amino acid residues of neuraminidase involved in influenza A virus entry.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">ftz063</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/femspd/ftz063</ELocationID>
            <Abstract>
                <AbstractText>Generally, influenza virus neuraminidase (NA) plays a critical role in the release stage of influenza virus. Recently, it has been found that NA may promote influenza virus to access the target cells. However, the mechanism remain unclear. Here, we reported that peramivir indeed possessed anti-influenza A virus (IAV) activity in the stage of viral entry. Importantly, we verified the critical residues of influenza NA involved in the viral entry. As a result, peramivir as an efficient NA inhibitor could suppress the initiation of IAV infection. Furthermore, mutational analysis showed NA might be associated with viral entry via amino acids residues R118, E119, D151, R152, W178, I222, E227, E276, R292 and R371. Our results demonstrated neuraminidase must contain the key amino acid residues can involve in IAV entry.</AbstractText>
                <CopyrightInformation>© FEMS 2019.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Fangzhao</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Teng</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Jiagui</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Yingna</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Shuwen</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Pathog Dis</MedlineTA>
            <NlmUniqueID>101595366</NlmUniqueID>
            <ISSNLinking>2049-632X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Influenza A virus</Keyword>
            <Keyword MajorTopicYN="N">neuraminidase</Keyword>
            <Keyword MajorTopicYN="N">neuraminidase active site</Keyword>
            <Keyword MajorTopicYN="N">peramivir</Keyword>
            <Keyword MajorTopicYN="N">viral entry</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31702775</ArticleId>
            <ArticleId IdType="pii">5614974</ArticleId>
            <ArticleId IdType="doi">10.1093/femspd/ftz063</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31702542</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1465-2099</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of general virology</Title>
                <ISOAbbreviation>J. Gen. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1099/jgv.0.001348</ELocationID>
            <Abstract>
                <AbstractText>Serological assays with modern influenza A/H3N2 viruses have become problematic due to the progressive reduction in the ability of viruses of this subtype to bind and agglutinate red blood cells (RBCs). This is due to reduced ability of the viral haemagglutinin (HA) glycoprotein to bind to the sialic acid-containing receptors presented by these cells. Additionally, as a result of reduced HA-mediated binding in cell culture, modern A/H3N2 viruses often acquire compensatory mutations during propagation that enable binding of cellular receptors through their neuraminidase (NA) surface protein. Viruses that have acquired this NA-mediated binding agglutinate RBCs through their NA, confusing the results of serological assays designed to assess HA antigenicity. Here we confirm with a large dataset that the acquisition of mutations that confer NA binding of RBCs is a culture artefact, and demonstrate that modern A/H3N2 isolates with acquired NA-binding mutations revert to a clinical-like NA sequence after a single passage in human airway epithelial (HAE) cells.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Brown</LastName>
                    <ForeName>Jonathan C</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Disease, Imperial College, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Biological Standards and Control, Potters Bar, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barclay</LastName>
                    <ForeName>Wendy S</ForeName>
                    <Initials>WS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Disease, Imperial College, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galiano</LastName>
                    <ForeName>Monica</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Present address: WHO Collaborating Centre for Reference and Research on Influenza, Francis Crick Institute, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Harvey</LastName>
                    <ForeName>Ruth</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Present address: WHO Collaborating Centre for Reference and Research on Influenza, Francis Crick Institute, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Biological Standards and Control, Potters Bar, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Gen Virol</MedlineTA>
            <NlmUniqueID>0077340</NlmUniqueID>
            <ISSNLinking>0022-1317</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">H3N2</Keyword>
            <Keyword MajorTopicYN="N">haemagglutination</Keyword>
            <Keyword MajorTopicYN="N">influenza</Keyword>
            <Keyword MajorTopicYN="N">neuraminidase</Keyword>
            <Keyword MajorTopicYN="N">serology</Keyword>
            <Keyword MajorTopicYN="N">vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31702542</ArticleId>
            <ArticleId IdType="doi">10.1099/jgv.0.001348</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31700085</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Changes of urine metabolite profiles are induced by inactivated influenza vaccine inoculations in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>16249</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-52686-5</ELocationID>
            <Abstract>
                <AbstractText>The safety evaluation of vaccines is critical to avoid the development of side effects in humans. To increase the sensitivity of detection for toxicity tests, it is important to capture not only pathological changes but also physiological changes. <sup>1</sup>H nuclear magnetic resonance (NMR) spectroscopy analysis of biofluids produces profiles that show characteristic responses to changes in physiological status. In this study, mouse urine metabolomics analysis with <sup>1</sup>H NMR was performed using different influenza vaccines of varying toxicity to assess the usefulness of <sup>1</sup>H NMR in evaluating vaccine toxicity. Two types of influenza vaccines were used as model vaccines: a toxicity reference vaccine (RE) and a hemagglutinin split vaccine. According to the blood biochemical analyses, the plasma alanine transaminase levels were increased in RE-treated mice. Changes in metabolite levels between mice administered different types of influenza vaccines were observed in the <sup>1</sup>H NMR spectra of urine, and a tendency toward dosage-dependent responses for some spectra was observed. Hierarchical clustering analyses and principal component analyses showed that the changes in various urine metabolite levels allowed for the classification of different types of vaccines. Among them, two liver-derived metabolites were shown to largely contribute to the formation of the cluster. These results demonstrate the possibility that urine metabolomics analysis could provide information about vaccine-induced toxicity and physiological changes.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sasaki</LastName>
                    <ForeName>Eita</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo, 208-0011, Japan. esasaki@nih.go.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kusunoki</LastName>
                    <ForeName>Hideki</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo, 208-0011, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Momose</LastName>
                    <ForeName>Haruka</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo, 208-0011, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Furuhata</LastName>
                    <ForeName>Keiko</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo, 208-0011, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hosoda</LastName>
                    <ForeName>Kazuo</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Science, Graduate School of Science and Technology, Gunma University, 1-5-1 Tenjin-cho, Kiryu, Gunma, 376-8515, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wakamatsu</LastName>
                    <ForeName>Kaori</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1412-5691</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Science, Graduate School of Science and Technology, Gunma University, 1-5-1 Tenjin-cho, Kiryu, Gunma, 376-8515, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mizukami</LastName>
                    <ForeName>Takuo</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6105-6049</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo, 208-0011, Japan. tmiz@nih.go.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamaguchi</LastName>
                    <ForeName>Isao</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo, 208-0011, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>JP18ak0101071</GrantID>
                    <Agency>Japan Agency for Medical Research and Development (AMED)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>JP19fk0108051</GrantID>
                    <Agency>Japan Agency for Medical Research and Development (AMED)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>JP19fk0108051</GrantID>
                    <Agency>Japan Agency for Medical Research and Development (AMED)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>JP19fk0108051</GrantID>
                    <Agency>Japan Agency for Medical Research and Development (AMED)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31700085</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-019-52686-5</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-019-52686-5</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696947</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-9071</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medical virology</Title>
                <ISOAbbreviation>J. Med. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evaluation of high-throughput digital lateral flow immunoassays for the detection of influenza A/B viruses from clinical swab samples.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.25626</ELocationID>
            <Abstract>
                <AbstractText>We evaluated the performance of new high-throughput digital lateral flow immunoassays (LFIAs) detecting influenza antigens, and compared them with those of the widely used digital LFIA and the rapid nucleic acid amplification test (NAAT). We tested 199 clinical nasopharyngeal (nasal) swab samples using three LFIA tests (BD Veritor Plus, STANDARD F Influenza A/B FIA, and ichroma TRIAS) and the rapid NAAT (ID NOW Influenza A &amp; B2). Agreements and clinical performances (sensitivity and specificity) were evaluated based on the results of RT-PCR and verification panel. The agreement of each test with RT-PCR was moderate to almost perfect. The sensitivity of ID NOW was significantly higher than that of LFIAs (P=0.0005, 0.0044, and 0.0026 for influenza A and P=0.0044, 0.0026, and 0.0044 for influenza B, respectively). The specificities were not significantly different between the four tests (P&gt;0.05). However, the reference panel suggests that ichroma TRIAS test is more sensitive than the other two LFIA tests. All three LFIA assays performed similarly with no false positives against influenza A. For influenza B, ichroma TRIAS had 2/166 false positives whereas there were no false positives for the other two LFIA tests. Influenza antigen digital LFIAs have advantages in terms of workflow when simultaneous tests are required. Rapid NAAT has higher sensitivity, while new antigen LFIAs are efficient and high-throughput. It is recommended that users select appropriate methods and algorithms according to the number of specimens and laboratory conditions in each clinical laboratory. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yoo</LastName>
                    <ForeName>Soo Jin</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, Sanggye Paik Hospital, Inje University, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shim</LastName>
                    <ForeName>Hee Sook</ForeName>
                    <Initials>HS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoon</LastName>
                    <ForeName>Sumi</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moon</LastName>
                    <ForeName>Hee-Won</ForeName>
                    <Initials>HW</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9509-6073</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Med Virol</MedlineTA>
            <NlmUniqueID>7705876</NlmUniqueID>
            <ISSNLinking>0146-6615</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Influenza virus</Keyword>
            <Keyword MajorTopicYN="N">Lateral flow immunoassay</Keyword>
            <Keyword MajorTopicYN="N">Nucleic acid amplification tests</Keyword>
            <Keyword MajorTopicYN="N">Rapid influenza diagnostic test</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696947</ArticleId>
            <ArticleId IdType="doi">10.1002/jmv.25626</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696308</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-8798</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Archives of virology</Title>
                <ISOAbbreviation>Arch. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Displacement of the Gent/1999 human-like swine H1N2 influenza A virus lineage by novel H1N2 reassortants in Germany.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-019-04457-w</ELocationID>
            <Abstract>
                <AbstractText>A swine influenza survey was conducted between 2003 and 2015 in Germany. During this period, 8122 snout swabs or other respiratory specimens from pigs of 5178 herds, mainly from Germany, were investigated for the presence of swine influenza A virus (S-IAV). In total, 1310 S-IAV isolates were collected. Of this collection, the complete genome of 267 H1N2 S-IAV isolates was sequenced and phylogenetically analyzed. The data demonstrate the incursion of human-like swine H1N2 viruses (Gent/1999-like) in 2000 and prevalent circulation until 2010. From 2008 onward, a sustained and broad change of the genetic constellation of the swine H1N2 subtype commenced. The Gent/1999-like swine H1N2 viruses ceased and several new swine H1N2 reassortants emerged and became prevalent in Germany. Of these, the upsurge of the Diepholz/2008-like, Emmelsbuell/2009-like and Papenburg/2010-like viruses is notable. The data reveal the importance of reassortment events in S-IAV evolution. The strong circulation of S-IAV of different lineages in the swine population throughout the year underlines that pigs are important reservoir hosts.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zell</LastName>
                    <ForeName>Roland</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8317-2152</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Experimental Virology, Institute for Medical Microbiology, Jena University Hospital, Friedrich Schiller University Jena, 07745, Jena, Germany. roland.zell@med.uni-jena.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Groth</LastName>
                    <ForeName>Marco</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>CF DNA Sequencing, Leibniz Institute on Aging, Fritz Lipmann Institute, 07745, Jena, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krumbholz</LastName>
                    <ForeName>Andi</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Experimental Virology, Institute for Medical Microbiology, Jena University Hospital, Friedrich Schiller University Jena, 07745, Jena, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Infection Medicine, Kiel University and University Medical Center Schleswig-Holstein, 24105, Kiel, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lange</LastName>
                    <ForeName>Jeannette</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Experimental Virology, Institute for Medical Microbiology, Jena University Hospital, Friedrich Schiller University Jena, 07745, Jena, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Paul-Ehrlich-Institut, 63225, Langen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Philipps</LastName>
                    <ForeName>Anja</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Experimental Virology, Institute for Medical Microbiology, Jena University Hospital, Friedrich Schiller University Jena, 07745, Jena, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Thermo Fisher Scientific GENEART GmbH, 93059, Regensburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dürrwald</LastName>
                    <ForeName>Ralf</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Experimental Virology, Institute for Medical Microbiology, Jena University Hospital, Friedrich Schiller University Jena, 07745, Jena, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Robert Koch Institute, 13353, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>01KI7142</GrantID>
                    <Agency>Bundesministerium für Bildung und Forschung</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>01KI07143</GrantID>
                    <Agency>Bundesministerium für Bildung und Forschung</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>01KI1006J</GrantID>
                    <Agency>Bundesministerium für Bildung und Forschung</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>#259949</GrantID>
                    <Agency>European Union FP7-Influenza-2010 ESNIP3</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Austria</Country>
            <MedlineTA>Arch Virol</MedlineTA>
            <NlmUniqueID>7506870</NlmUniqueID>
            <ISSNLinking>0304-8608</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696308</ArticleId>
            <ArticleId IdType="doi">10.1007/s00705-019-04457-w</ArticleId>
            <ArticleId IdType="pii">10.1007/s00705-019-04457-w</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31694956</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Elucidating the interactions between influenza virus polymerase and host factor ANP32A.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">JVI.01353-19</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01353-19</ELocationID>
            <Abstract>
                <AbstractText>The avian origin influenza A viral polymerase is restricted in human cells. This restriction has been associated with species differences in host factor ANP32A. Avian ANP32A supports the activity of an avian origin polymerase. However, the avian origin polymerase is incompatible with human ANP32A. Avian ANP32A proteins harbour an additional 33 amino acids compared to human ANP32A proteins, which are crucial for their ability to support the avian origin influenza polymerase. Here, we elucidate the interactions between ANP32A proteins and the influenza A viral polymerase using split luciferase complementation assays, co-immunoprecipitation and <i>in situ</i> split Venus interaction assays. We show greater interaction between chicken ANP32A and the viral polymerase compared to human ANP32A and visualise these interactions <i>in situ</i> in the cell nucleus. We demonstrate that the 33 amino acids of chicken ANP32A and the PB2 627 domain of viral polymerase complex both contribute to this enhanced interaction. Finally, we show how these interactions are affected by the presence of viral RNA and the processivity of the polymerase, giving insights into the way that ANP32A might act during virus infection.<b>Importance</b> Successful zoonotic transmission of influenza A virus into humans can lead to pandemics in an immunologically naïve population. Host encoded ANP32A proteins are required to support influenza A polymerase activity, and species differences in ANP32A can restrict host range of influenza. Understanding how ANP32A proteins support the viral polymerase and how differences in ANP32A affect the ability of the polymerase to co-opt these proteins will enhance our understanding of viral replication and species restriction as well as suggesting targeted antiviral approaches to treat influenza infection.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Mistry et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mistry</LastName>
                    <ForeName>Bhakti</ForeName>
                    <Initials>B</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5455-0479</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Molecular Virology, Imperial College London, St Mary's Campus, London, W2 1PG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Long</LastName>
                    <ForeName>Jason S</ForeName>
                    <Initials>JS</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0251-6487</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Molecular Virology, Imperial College London, St Mary's Campus, London, W2 1PG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schreyer</LastName>
                    <ForeName>Jocelyn</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Molecular Virology, Imperial College London, St Mary's Campus, London, W2 1PG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Staller</LastName>
                    <ForeName>Ecco</ForeName>
                    <Initials>E</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8443-5559</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Molecular Virology, Imperial College London, St Mary's Campus, London, W2 1PG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sanchez-David</LastName>
                    <ForeName>Raul-Yusef</ForeName>
                    <Initials>RY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Molecular Virology, Imperial College London, St Mary's Campus, London, W2 1PG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barclay</LastName>
                    <ForeName>Wendy S</ForeName>
                    <Initials>WS</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3948-0895</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Molecular Virology, Imperial College London, St Mary's Campus, London, W2 1PG, UK w.barclay@imperial.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31694956</ArticleId>
            <ArticleId IdType="pii">JVI.01353-19</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01353-19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31694949</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The G protein-coupled receptor FFAR2 promotes internalization during influenza A virus entry.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">JVI.01707-19</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01707-19</ELocationID>
            <Abstract>
                <AbstractText>Influenza A virus (IAV) co-opts numerous host factors to complete its replication cycle. Here, we identified free fatty acid receptor 2 (FFAR2) as a cofactor for IAV entry into host cells. We found that downregulation of FFAR2 or Ffar2 expression significantly reduced the replication of IAV in A549 or RAW 264.7 cells. The treatment of A549 cells with FFAR2 siRNA or the FFAR2 pathway agonists 4-CMTB and compound 58 [Cmp 58; (S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-phenylthiazol-2-yl)butanamide], dramatically inhibited the nuclear accumulation of viral NP protein at early timepoints post infection, indicating that FFAR2 functions in the early stage of IAV replication cycle. FFAR2 downregulation had no effect on the expression of sialic acid (SA) receptors on the cell membrane, the attachment of IAV to the SA receptors, or the activity of the viral ribonucleoprotein (RNP) complex. Rather, the amount of internalized IAVs was significantly reduced in FFAR2 knocked-down, 4-CMTB-, or Cmp 58-treated A549 cells. Further studies showed that FFAR2 associated with β-arrestin1 and that β-arrestin1 interacted with the β2-subunit of the AP-2 complex (AP2B1), the essential adaptor of the clathrin-mediated endocytosis pathway. Notably, siRNA knockdown of either β-arrestin1 or AP2B1 dramatically impaired IAV replication, and AP2B1 knockdown or treatment with Barbadin, an inhibitor targeting the β-arrestin1/AP2B1 complex, remarkably decreased the amount of internalized IAVs. Moreover, we found that FFAR2 interacted with three GPCR kinases (i.e., GRK2, GRK5, and GRK6) whose downregulation inhibited IAV replication. Together, our findings demonstrate that the FFAR2 signaling cascade is important for the efficient endocytosis of IAV into host cells.<b>IMPORTANCE</b> To complete its replication cycle, IAV hijacks the host endocytosis machinery to invade cells. However, the underlying mechanisms of how IAV is internalized into host cells remain poorly understood, emphasizing the need to elucidate the role of host factors in IAV entry into cells. In this study, we identified FFAR2 as an important host factor for the efficient replication of both low pathogenic and highly pathogenic IAV. We revealed that FFAR2 facilitates the internalization of IAV into target cells during the early stage of infection. Upon further characterization of the role of FFAR2-associated proteins in virus replication, we found that the FFAR2-β-arrestin1-AP2B1 signaling cascade is important for the efficient endocytosis of IAV. Our findings thus further our understanding of the biological details of IAV entry into host cells and establish FFAR2 as a potential target for antiviral drug development.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Wang et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Guangwen</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jinliang</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kong</LastName>
                    <ForeName>Fandi</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Qibing</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Ya</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Shanyu</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Yuhui</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liang</LastName>
                    <ForeName>Libin</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Junping</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Nan</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Yuzhen</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Wenjun</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Deng</LastName>
                    <ForeName>Guohua</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Pucheng</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Liling</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeng</LastName>
                    <ForeName>Xianying</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Guobin</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bu</LastName>
                    <ForeName>Zhigao</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Hualan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Chengjun</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China lichengjun@caas.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31694949</ArticleId>
            <ArticleId IdType="pii">JVI.01707-19</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01707-19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31694942</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>HA stability regulates H1N1 influenza virus replication and pathogenicity in mice by modulating type I interferon responses in dendritic cells.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">JVI.01423-19</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01423-19</ELocationID>
            <Abstract>
                <AbstractText>Hemagglutinin (HA) stability, or the pH at which HA is activated to cause membrane fusion, has been associated with the replication, pathogenicity, transmissibility, and interspecies adaptation of influenza A viruses. Here, we investigated mechanisms by which a destabilizing HA mutation, Y17H (activation pH 6.0), attenuates virus replication and pathogenicity in DBA/2 mice, compared to wild-type (WT; activation pH 5.5). Extracellular lung pH was measured to be near neutral (pH 6.9-7.5). WT and Y17H viruses had similar environmental stability at pH 7.0; thus, extracellular inactivation was unlikely to attenuate Y17H virus. The Y17H virus had accelerated replication kinetics in MDCK, A549, and Raw264.7 cells when inoculated at an MOI of 3 PFU/cell. The destabilizing mutation also increased early infectivity and type I interferon (IFN) responses in mouse bone marrow-derived dendritic cells (DCs). In contrast, the HA-Y17H mutation reduced replication in murine airway mNEC and mTEC cultures and attenuated virus replication, virus spread, severity of infection, and cellular infiltration in the lungs of mice. Normalizing virus infection and weight loss in mice by inoculating them with Y17H virus at a dose 500-fold higher than that of WT virus revealed that the destabilized mutant virus triggered the upregulation of more host genes and increased type I IFN responses and cytokine expression in DBA/2 mouse lungs. Overall, HA destabilization decreased virulence in mice by boosting early infection in DCs, resulting in greater activation of antiviral responses, including type I IFN. These studies reveal HA stability may regulate pathogenicity by modulating IFN responses.<b>Importance</b> Diverse influenza A viruses circulate in wild aquatic birds, occasionally infecting farm animals. Rarely, an avian- or swine-origin influenza virus adapts to humans and starts a pandemic. Seasonal and many universal influenza vaccines target the HA surface protein, which is a key component of pandemic influenza. Understanding HA properties needed for replication and pathogenicity in mammals may guide response efforts to control influenza. Some antiviral drugs and broadly reactive influenza vaccines that target the HA protein have suffered resistance due to destabilizing HA mutations that do not compromise replicative fitness in cell culture. Here, we show that despite not compromising fitness in standard cell cultures, a destabilizing H1N1 HA stalk mutation greatly diminishes viral replication and pathogenicity in vivo by modulating type I IFN responses. This encourages targeting the HA stalk with antiviral drugs and vaccines as well as reevaluating previous candidates that were susceptible to destabilizing resistance mutations.</AbstractText>
                <CopyrightInformation>Copyright © 2019 American Society for Microbiology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Russier</LastName>
                    <ForeName>Marion</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Guohua</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Briard</LastName>
                    <ForeName>Benoit</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meliopoulos</LastName>
                    <ForeName>Victoria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cherry</LastName>
                    <ForeName>Sean</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kanneganti</LastName>
                    <ForeName>Thirumala-Devi</ForeName>
                    <Initials>TD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schultz-Cherry</LastName>
                    <ForeName>Stacey</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Immunology &amp; Biochemistry, College of Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vogel</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Russell</LastName>
                    <ForeName>Charles J</ForeName>
                    <Initials>CJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Department of Immunology, Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105-3678 charles.russell@stjude.org.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Immunology &amp; Biochemistry, College of Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee 38163.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31694942</ArticleId>
            <ArticleId IdType="pii">JVI.01423-19</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01423-19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31692637</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2214-2509</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>18</Volume>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>IDCases</Title>
                <ISOAbbreviation>IDCases</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Adult influenza A (H3N2) with reduced susceptibility to baloxavir or peramivir cured after switching anti-influenza agents.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e00650</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.idcr.2019.e00650</ELocationID>
            <Abstract>
                <AbstractText>We describe two adults with A/H3N2 influenza with (patient 1), and without (patient 2) polymerase acidic (PA) subunit I38 T substitution during the same season. Patient 1 had a reduced clinical response to baloxavir, a cap-dependent endonuclease inhibitor (CEI), but was cured by peramivir, a neuraminidase inhibitor. Baloxavir was clinically effective for patient 2, for whom peramivir had been ineffective. Susceptibility to baloxavir can be decreased by a PA unit mutation, but response to treatment can be increased by switching and/or combination with a neuraminidase inhibitor, even though CEI are clinically effective against influenza in adults.</AbstractText>
                <CopyrightInformation>© 2019 The Authors.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Seki</LastName>
                    <ForeName>Masafumi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sakai-Tagawa</LastName>
                    <ForeName>Yuko</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yasuhara</LastName>
                    <ForeName>Atsuhiro</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Watanabe</LastName>
                    <ForeName>Yuji</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Clinical Microbiology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>IDCases</MedlineTA>
            <NlmUniqueID>101634540</NlmUniqueID>
            <ISSNLinking>2214-2509</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Baloxavir</Keyword>
            <Keyword MajorTopicYN="N">Peramivir</Keyword>
            <Keyword MajorTopicYN="N">Polymerase</Keyword>
            <Keyword MajorTopicYN="N">Polymerase acidic subunit</Keyword>
            <Keyword MajorTopicYN="N">Viral infection</Keyword>
        </KeywordList>
        <CoiStatement>None.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31692637</ArticleId>
            <ArticleId IdType="doi">10.1016/j.idcr.2019.e00650</ArticleId>
            <ArticleId IdType="pii">S2214-2509(19)30289-6</ArticleId>
            <ArticleId IdType="pii">e00650</ArticleId>
            <ArticleId IdType="pmc">PMC6804930</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Front Microbiol. 2018 Dec 06;9:3026</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30574137</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17278083</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Euro Surveill. 2019 Jan;24(3):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30670142</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2019 Nov;25(11):2108-2111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31436527</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Intern Med. 2007;46(13):953-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17603232</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect. 2011 Oct;63(4):300-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21839113</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Euro Surveill. 2019 Mar;24(12):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30914078</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2000 Jan 26;283(4):499-505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10659876</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2018 Sep 6;379(10):913-923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30184455</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Med. 2010 Nov 02;7(11):e1000362</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21072246</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Infect Dis. 2019 Apr;32(2):176-186</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30724789</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2018 Mar 5;217(6):887-896</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29186472</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31690232</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1742-5662</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>16</Volume>
                    <Issue>160</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>29</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the Royal Society, Interface</Title>
                <ISOAbbreviation>J R Soc Interface</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Frustration and fidelity in influenza genome assembly.</ArticleTitle>
            <Pagination>
                <MedlinePgn>20190411</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1098/rsif.2019.0411</ELocationID>
            <Abstract>
                <AbstractText>The genome of the influenza virus consists of eight distinct single-stranded RNA segments, each encoding proteins essential for the viral life cycle. When the virus infects a host cell, these segments must be replicated and packaged into new budding virions. The viral genome is assembled with remarkably high fidelity: experiments reveal that most virions contain precisely one copy of each of the eight RNA segments. Cell-biological studies suggest that genome assembly is mediated by specific reversible and irreversible interactions between the RNA segments and their associated proteins. However, the precise inter-segment interaction network remains unresolved. Here, we computationally predict that tree-like irreversible interaction networks guarantee high-fidelity genome assembly, while cyclic interaction networks lead to futile or frustrated off-pathway products. We test our prediction against multiple experimental datasets. We find that tree-like networks capture the nearest-neighbour statistics of RNA segments in packaged virions, as observed by electron tomography. Just eight tree-like networks (of a possible 262 144) optimally capture both the nearest-neighbour data and independently measured RNA-RNA binding and co-localization propensities. These eight do not include the previously proposed hub-and-spoke and linear networks. Rather, each predicted network combines hub-like and linear features, consistent with evolutionary models of interaction gain and loss.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Farheen</LastName>
                    <ForeName>Nida</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Indian Institute of Science Education and Research, Pune 411008, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thattai</LastName>
                    <ForeName>Mukund</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Simons Centre for the Study of Living Machines, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore 560065, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J R Soc Interface</MedlineTA>
            <NlmUniqueID>101217269</NlmUniqueID>
            <ISSNLinking>1742-5662</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">influenza</Keyword>
            <Keyword MajorTopicYN="N">network evolution</Keyword>
            <Keyword MajorTopicYN="N">segmented virus</Keyword>
            <Keyword MajorTopicYN="N">self-assembly</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31690232</ArticleId>
            <ArticleId IdType="doi">10.1098/rsif.2019.0411</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31689309</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the &quot;von Magnus effect&quot;.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0224317</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0224317</ELocationID>
            <Abstract>
                <AbstractText>Continuous cell culture-based influenza vaccine production could significantly reduce footprint and manufacturing costs compared to current batch processing. However, yields of influenza virus in continuous mode can be affected by oscillations in virus titers caused by periodic accumulation of defective interfering particles. The generation of such particles has also been observed previously in cascades of continuous stirred tank reactors (CSTRs) and is known as the &quot;von Magnus effect&quot;. To improve virus yields and to avoid these oscillations, we have developed a novel continuous tubular bioreactor system for influenza A virus production. It was built using a 500 mL CSTR for cell growth linked to a 105 m long tubular plug-flow bioreactor (PFBR). Virus propagation took place only in the PFBR with a nominal residence time of 20 h and a production capacity of 0.2 mL/min. The bioreactor was first tested with suspension MDCK cells at different multiplicities of infection (MOI), and then with suspension avian AGE1.CR.pIX cells at a fixed nominal MOI of 0.02. Maximum hemagglutinin (HA) titers of 2.4 and 1.6 log10(HA units/100 μL) for suspension MDCK cells and AGE1.CR.pIX cells, respectively, were obtained. Flow cytometric analysis demonstrated that 100% infected cells with batch-like HA titers can be obtained at a MOI of at least 0.1. Stable HA and TCID50 titers over 18 days of production were confirmed using the AGE1.CR.pIX cell line, and PCR analysis demonstrated stable production of full-length genome. The contamination level of segments with deletions (potentially defective interfering particles), already present in the virus seed, was low and did not increase. Control experiments using batch and semi-continuous cultures confirmed these findings. A comparison showed that influenza virus production can be achieved with the tubular bioreactor system in about half the time with a space-time-yield up to two times higher than for typical batch cultures. In summary, a novel continuous tubular bioreactor system for cell culture-based influenza virus production was developed. One main advantage, an essentially single-passage amplification of viruses, should enable efficient production of vaccines as well as vectors for gene and cancer therapy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tapia</LastName>
                    <ForeName>Felipe</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8470-2047</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wohlfarth</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sandig</LastName>
                    <ForeName>Volker</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>ProBioGen AG, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jordan</LastName>
                    <ForeName>Ingo</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>ProBioGen AG, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Genzel</LastName>
                    <ForeName>Yvonne</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reichl</LastName>
                    <ForeName>Udo</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Chair for Bioprocess Engineering, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>I have read the journal’s policy and the authors of this manuscript have the following competing interests: This work was part of the doctoral project of FT and was funded by the Max Planck Institute (MPI). FT, YG and UR are employed by the MPI. FT, YG and UR are authors on patent application WO/2017/190790 entitled “Plug-flow bioreactor, system containing the same, and method for production of virus” which covers the tubular bioreactor described in this work. The AGE1.CR.pIX cell line is a proprietary product of ProBioGen AG, who authorized its use in this project. IJ and VS are employed by ProBioGen AG. IJ and VS are authors on patents WO/2005/042728 and WO/2007/054516 covering the AGE1.CR.pIX cell line. No additional funding was provided by ProBioGen AG to the work described in this manuscript. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31689309</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0224317</ArticleId>
            <ArticleId IdType="pii">PONE-D-19-11824</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31687874</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2164-554X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human vaccines &amp; immunotherapeutics</Title>
                <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Knowledge and acceptance of influenza and pertussis vaccinations among pregnant women of low socioeconomic status in Turkey.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2019.1689082</ELocationID>
            <Abstract>
                <AbstractText>Pregnant women and infants are at relatively high risk for influenza- and pertussis-related morbidity and mortality. Vaccination is the most important prevention strategy for both diseases. We evaluated knowledge and acceptance of influenza and pertussis vaccinations among pregnant women. We performed a cross-sectional survey of 465 pregnant women receiving prenatal care at the obstetric outpatient clinic in a tertiary medical center in Turkey between November 2015 and May 2016. We used a questionnaire investigating the knowledge of pertussis and influenza to evaluate potential influences on the acceptance or rejection of pertussis or influenza vaccinations. The acceptance rates of pertussis and influenza vaccinations were 11.2% and 19.8%, respectively. Maternal age, education level, employment status, number of gestations, and gestational age did not affect the rate of acceptance of these vaccinations. On the other hand, pregnant women who had a history of vaccination during their adolescence and in previous pregnancies were significantly more likely to accept pertussis vaccination. Knowledge about the risks of pertussis and influenza diseases for pregnant women and their children has a significant effect on vaccination acceptance. Even in low socioeconomic status groups, a recommendation for vaccinations by the primary obstetrician was significantly predictive of acceptance of both pertussis and influenza vaccination. This study revealed that the acceptance rates of pertussis and influenza vaccination among pregnant women are very low in Turkey. Healthcare worker recommendations and increased awareness about pertussis and influenza morbidity and mortality in pregnant women and infants are essential to improve the rates of vaccination acceptance during pregnancy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yakut</LastName>
                    <ForeName>Nurhayat</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Marmara University Medical Faculty, Division of Pediatric Infectious Diseases, Department of Pediatrics, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soysal</LastName>
                    <ForeName>Sunullah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Marmara University Medical Faculty, Department of Obstetrics and Gynecology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soysal</LastName>
                    <ForeName>Ahmet</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Atasehir Memorial Hospital, Clinics of Pediatrics, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bakir</LastName>
                    <ForeName>Mustafa</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Marmara University Medical Faculty, Division of Pediatric Infectious Diseases, Department of Pediatrics, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Vaccin Immunother</MedlineTA>
            <NlmUniqueID>101572652</NlmUniqueID>
            <ISSNLinking>2164-5515</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Pregnant women</Keyword>
            <Keyword MajorTopicYN="N">acceptance</Keyword>
            <Keyword MajorTopicYN="N">influenza</Keyword>
            <Keyword MajorTopicYN="N">knowledge</Keyword>
            <Keyword MajorTopicYN="N">pertussis</Keyword>
            <Keyword MajorTopicYN="N">vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31687874</ArticleId>
            <ArticleId IdType="doi">10.1080/21645515.2019.1689082</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31687431</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2352-3409</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>27</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Data in brief</Title>
                <ISOAbbreviation>Data Brief</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Statistical modelling of data showing pandemic H1N1 2009 swine influenza a virus infection kinetics in vaccinated pigs.</ArticleTitle>
            <Pagination>
                <MedlinePgn>104576</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dib.2019.104576</ELocationID>
            <Abstract>
                <AbstractText>A swine influenza A pandemic 2009 H1N1 (pH1N1) virus was used in a pig challenge model to investigate the efficacy of whole inactivated vaccines homologous or heterologous to the challenge virus as well as a commercial vaccine. Nasal shedding of viral RNA was monitored daily by real-time, quantitative RT-PCR (RRT-qPCR) as detailed (1). Here we report the statistical modelling of the viral RNA shedding kinetics.</AbstractText>
                <CopyrightInformation>Crown Copyright © 2019 Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Canini</LastName>
                    <ForeName>Laetitia</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Edinburgh, University of Edinburgh, Charlotte Auerbach Road, Edinburgh, EH9 3FL, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Everett</LastName>
                    <ForeName>Helen E</ForeName>
                    <Initials>HE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Department, Animal and Plant Health Agency (APHA-Weybridge), New Haw, Addlestone, KT15 3NB, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aramouni</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford, OX3 7DQ, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Coward</LastName>
                    <ForeName>Vivien</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Department, Animal and Plant Health Agency (APHA-Weybridge), New Haw, Addlestone, KT15 3NB, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramsay</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Department, Animal and Plant Health Agency (APHA-Weybridge), New Haw, Addlestone, KT15 3NB, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kelly</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Department, Animal and Plant Health Agency (APHA-Weybridge), New Haw, Addlestone, KT15 3NB, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morgan</LastName>
                    <ForeName>Sophie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Pirbright Institute, Ash Road, Pirbright, Woking, GU24 0NF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tchilian</LastName>
                    <ForeName>Elma</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Pirbright Institute, Ash Road, Pirbright, Woking, GU24 0NF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gilbert</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford, OX3 7DQ, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Charleston</LastName>
                    <ForeName>Bryan</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Pirbright Institute, Ash Road, Pirbright, Woking, GU24 0NF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brown</LastName>
                    <ForeName>Ian H</ForeName>
                    <Initials>IH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Department, Animal and Plant Health Agency (APHA-Weybridge), New Haw, Addlestone, KT15 3NB, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brookes</LastName>
                    <ForeName>Sharon M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Department, Animal and Plant Health Agency (APHA-Weybridge), New Haw, Addlestone, KT15 3NB, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Woolhouse</LastName>
                    <ForeName>Mark E J</ForeName>
                    <Initials>MEJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Edinburgh, University of Edinburgh, Charlotte Auerbach Road, Edinburgh, EH9 3FL, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Data Brief</MedlineTA>
            <NlmUniqueID>101654995</NlmUniqueID>
            <ISSNLinking>2352-3409</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Pandemic 2009 swine influenza a virus</Keyword>
            <Keyword MajorTopicYN="N">Statistical modelling RRT-qPCR</Keyword>
            <Keyword MajorTopicYN="N">Viral kinetics</Keyword>
            <Keyword MajorTopicYN="N">Whole inactivated vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31687431</ArticleId>
            <ArticleId IdType="doi">10.1016/j.dib.2019.104576</ArticleId>
            <ArticleId IdType="pii">S2352-3409(19)30931-X</ArticleId>
            <ArticleId IdType="pii">104576</ArticleId>
            <ArticleId IdType="pmc">PMC6820103</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Med Res Methodol. 2013 Apr 25;13:60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23617810</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2019 Apr 17;37(17):2288-2293</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30914224</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31687130</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">0368-0762</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>72</Volume>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Irish veterinary journal</Title>
                <ISOAbbreviation>Ir Vet J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Seroprevalence of influenza D virus in selected sample groups of Irish cattle, sheep and pigs.</ArticleTitle>
            <Pagination>
                <MedlinePgn>11</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13620-019-0150-8</ELocationID>
            <Abstract>
                <AbstractText>Influenza D virus (IDV) is a new member of the Orthomyxoviridae family. It was first reported in swine in 2011 and isolated from bovine samples received for routine respiratory disease diagnosis in Ireland during 2014-2016. The goal of this study was to determine the seroprevalence in selected populations of IDV in cattle, pigs and sheep. Results showed a high prevalence of IDV in cattle sampled at slaughter (94.6%) or for diagnostic reasons (64.9%), whereas prevelance in samples taken for diagnostic reasons from sheep (4.5%) and pigs (5.8%) was much lower. This study suggests that IDV is widespread in Irish cattle.</AbstractText>
                <CopyrightInformation>© The Author(s). 2019.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>O'Donovan</LastName>
                    <ForeName>Tom</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">0000-0003-3234-1945</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Central Veterinary Research Laboratory, Celbridge, Co. Kildare Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donohoe</LastName>
                    <ForeName>Leah</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Veterinary Research Laboratory, Celbridge, Co. Kildare Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ducatez</LastName>
                    <ForeName>Mariette F</ForeName>
                    <Initials>MF</Initials>
                    <AffiliationInfo>
                        <Affiliation>INRA UMR 1225 IHAP-ENVT, 31076 Toulouse, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meyer</LastName>
                    <ForeName>Gilles</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>INRA UMR 1225 IHAP-ENVT, 31076 Toulouse, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ryan</LastName>
                    <ForeName>Eoin</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>3Ruminant Animal Health Division, Department of Agriculture, Food and the Marine, Celbridge, Ireland.</Affiliation>
                        <Identifier Source="ISNI">0000 0004 0488 662X</Identifier>
                        <Identifier Source="GRID">grid.433528.b</Identifier>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Ir Vet J</MedlineTA>
            <NlmUniqueID>0100762</NlmUniqueID>
            <ISSNLinking>0368-0762</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cattle</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Respiratory</Keyword>
            <Keyword MajorTopicYN="N">Surveillance</Keyword>
            <Keyword MajorTopicYN="N">Virus</Keyword>
        </KeywordList>
        <CoiStatement>Competing interestsThe authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31687130</ArticleId>
            <ArticleId IdType="doi">10.1186/s13620-019-0150-8</ArticleId>
            <ArticleId IdType="pii">150</ArticleId>
            <ArticleId IdType="pmc">PMC6820949</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2013 Feb;9(2):e1003176</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23408893</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 Sep 15;7(1):11660</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28916759</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2006 Apr 21;312(5772):384-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16627734</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2006 May 1;193(9):1229-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16586359</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2018 Feb;24(2):389-391</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29350168</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2016 Feb;22(2):352-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26812282</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 May;89(10):5340-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25740998</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2014 Oct;95(Pt 10):2127-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24989173</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2017 Aug 12;390(10095):697-708</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28302313</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2015 Feb;21(2):368-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25628038</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2015 Dec;486:28-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26386554</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2018 Jul;24(7):1388-1389</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29912692</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31685871</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>04</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>15899</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-52258-7</ELocationID>
            <Abstract>
                <AbstractText>The influenza epidemic is a huge burden to public health. Current influenza vaccines provide limited protection against new variants due to frequent mutation of the virus. The continual emergence of novel variants necessitates the method rapidly monitoring influenza virus infection in experimental systems. Although several replication-competent reporter viruses carrying fluorescent proteins or small luciferase have been generated in previous studies, visualizing influenza virus infection via such strategy requires reverse genetic modification for each viral strain which is usually time-consuming and inconvenient. Here, we created a novel influenza A nucleoprotein (NP) dependent reporter gene transcription activation module using NP-specific nanobodies. Our results demonstrated the modular design allowed reporter genes (mNeonGreen fluorescent protein and Gaussia luciferase) specifically expressing to detect intracellular NP protein, and therefore acts as a universal biosensor to monitor infection of various influenza A subtypes in living cells. The new system may provide a powerful tool to analyze influenza A infections at the cellular level to facilitate new antiviral drug discovery. Moreover, this approach may easily extend to develop live-cell biosensors for other viruses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cao</LastName>
                    <ForeName>Jiali</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhong</LastName>
                    <ForeName>Nicole</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Concordia International School Shanghai, 345 Huangyang Road Pudong, Shanghai, 201206, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Guosong</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Mingfeng</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Baohui</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fu</LastName>
                    <ForeName>Baorong</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yingbin</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Tianying</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2477-329X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yali</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Kunyu</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Xiamen International Travel Healthcare Center, Xiamen, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yixin</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China. yxchen2008@xmu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yuan</LastName>
                    <ForeName>Quan</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China. yuanquan@xmu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xia</LastName>
                    <ForeName>Ningshao</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0179-5266</Identifier>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>31670934</GrantID>
                    <Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81871651</GrantID>
                    <Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81672023</GrantID>
                    <Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31685871</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-019-52258-7</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-019-52258-7</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31685296</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(19)31460-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2019.10.071</ELocationID>
            <Abstract>
                <AbstractText>2018/19 was the first season of introduction of a newly licensed adjuvanted influenza vaccine (aTIV) for adults aged 65 years and over and the sixth season in the roll-out of a childhood influenza vaccination programme with a quadrivalent live attenuated influenza vaccine (LAIV). The season saw mainly A(H1N1)pdm09 and latterly A(H3N2) circulation. End-of-season adjusted vaccine effectiveness (aVE) estimates against laboratory confirmed influenza infection in primary care were calculated using the test negative case control method adjusting for key confounders. End-of-season aVE was 44.3% (95% CI: 26.8, 57.7) against all laboratory-confirmed influenza; 45.7% (95% CI: 26.0, 60.1) against influenza A(H1N1)pdm09 and 35.1% (95% CI: -3.7,59.3) against A(H3N2). Overall aVE was 49.9% (95%CI: -13.7, 77.9) for all those ≥ 65 years of age and 62.0% (95% CI: 3.4, 85.0) for those who received aTIV. Overall aVE for 2-17 year olds receiving LAIV was 48.6% (95% CI: -4.4, 74.7). The paper provides evidence of overall significant influenza VE in 2018/19, most notably against influenza A(H1N1)pdm09, however, as seen in 2017/18, there was reduced, non-significant VE against A(H3N2). aTIV provided significant protection for those 65 years of age and over.</AbstractText>
                <CopyrightInformation>Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pebody</LastName>
                    <ForeName>Richard G</ForeName>
                    <Initials>RG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom. Electronic address: Richard.Pebody@phe.gov.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Whitaker</LastName>
                    <ForeName>Heather</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ellis</LastName>
                    <ForeName>Joanna</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrews</LastName>
                    <ForeName>Nick</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marques</LastName>
                    <ForeName>Diogo F P</ForeName>
                    <Initials>DFP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Protection Scotland, Glasgow, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cottrell</LastName>
                    <ForeName>Simon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Wales, Cardiff, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reynolds</LastName>
                    <ForeName>Arlene J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Protection Scotland, Glasgow, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gunson</LastName>
                    <ForeName>Rory</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>West of Scotland Specialist Virology Centre, Glasgow, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thompson</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galiano</LastName>
                    <ForeName>Monica</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lackenby</LastName>
                    <ForeName>Angie</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Robertson</LastName>
                    <ForeName>Chris</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Strathclyde, Glasgow, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Doherty</LastName>
                    <ForeName>Mark G</ForeName>
                    <Initials>MG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Agency Northern Ireland, Belfast, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Owens</LastName>
                    <ForeName>Katie</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yonova</LastName>
                    <ForeName>Ivelina</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Surrey Guildford, United Kingdom; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shepherd</LastName>
                    <ForeName>Samantha J</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>West of Scotland Specialist Virology Centre, Glasgow, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moore</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Wales, Cardiff, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johnston</LastName>
                    <ForeName>Jillian</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Agency Northern Ireland, Belfast, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donati</LastName>
                    <ForeName>Matthew</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, Bristol, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McMenamin</LastName>
                    <ForeName>Jim</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Protection Scotland, Glasgow, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lusignan</LastName>
                    <ForeName>Simon de</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zambon</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Effectiveness</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Primary care</Keyword>
            <Keyword MajorTopicYN="N">Vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31685296</ArticleId>
            <ArticleId IdType="pii">S0264-410X(19)31460-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2019.10.071</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31683010</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1567-7257</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</Title>
                <ISOAbbreviation>Infect. Genet. Evol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A novel reassortant clade 2.3.4.4 highly pathogenic avian influenza H5N6 virus identified in South Korea in 2018.</ArticleTitle>
            <Pagination>
                <MedlinePgn>104056</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1567-1348(19)30282-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.meegid.2019.104056</ELocationID>
            <Abstract>
                <AbstractText>Since 2017, clade 2.3.4.4b H5N6 highly pathogenic avian influenza viruses (HPAIVs) have been detected over a broad geographic region, including Eurasia. These viruses have evolved through reassortment with Eurasian low pathogenic avian influenza viruses (LPAIVs), resulting in multiple genotypes. Here, we sequenced the full-length genome of 15 H5N6 HPAIVs collected from wild birds and poultry farms in South Korea from January to March 2018. A comparative phylogenetic analysis was then conducted. Three distinct genotypes were identified in South Korea during 2017/2018, including a novel reassortant genotype, H214. The novel reassortant H5N6 viruses isolated in this study possessed PB2, PA, and NP gene segments of Eurasian LPAIV on a genetic backbone of the H35-like genotype, which was identified in Korea and the Netherlands during 2017. Bayesian molecular clock analysis suggested that the novel reassortant viruses were generated most likely during the fall migration/wintering season of migratory waterfowl in 2017. Considering the continued emergence and spread of clade 2.3.4.4 HPAIV, enhanced surveillance of wild waterfowl is needed for early detection of HPAIV incursions.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Baek</LastName>
                    <ForeName>Yoon-Gi</ForeName>
                    <Initials>YG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Research &amp; Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Yu-Na</ForeName>
                    <Initials>YN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Research &amp; Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Dong-Hun</ForeName>
                    <Initials>DH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology and Veterinary Science, The University of Connecticut, 61 North Eagleville Road, Unit-3089, Storrs, CT 06269, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheon</LastName>
                    <ForeName>Sun-Ha</ForeName>
                    <Initials>SH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Research &amp; Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kye</LastName>
                    <ForeName>Soo-Jeong</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Research &amp; Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Yu-Ri</ForeName>
                    <Initials>YR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Research &amp; Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Si</LastName>
                    <ForeName>Young-Jae</ForeName>
                    <Initials>YJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Research &amp; Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Myoung-Heon</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Research &amp; Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Youn-Jeong</ForeName>
                    <Initials>YJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Research &amp; Diagnostic Division, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea. Electronic address: leeyj700@korea.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Infect Genet Evol</MedlineTA>
            <NlmUniqueID>101084138</NlmUniqueID>
            <ISSNLinking>1567-1348</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">2.3.4.4b H5N6</Keyword>
            <Keyword MajorTopicYN="N">HPAIV</Keyword>
            <Keyword MajorTopicYN="N">Novel genotype</Keyword>
            <Keyword MajorTopicYN="N">Novel reassortant</Keyword>
            <Keyword MajorTopicYN="N">Phylogenetic analysis</Keyword>
            <Keyword MajorTopicYN="N">tMRCA</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31683010</ArticleId>
            <ArticleId IdType="pii">S1567-1348(19)30282-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.meegid.2019.104056</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31675983</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1297-9716</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>50</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Veterinary research</Title>
                <ISOAbbreviation>Vet. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pathobiology and innate immune responses of gallinaceous poultry to clade 2.3.4.4A H5Nx highly pathogenic avian influenza virus infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>89</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13567-019-0704-5</ELocationID>
            <Abstract>
                <AbstractText>In the 2014-2015 Eurasian lineage clade 2.3.4.4A H5 highly pathogenic avian influenza (HPAI) outbreak in the U.S., backyard flocks with minor gallinaceous poultry and large commercial poultry (chickens and turkeys) operations were affected. The pathogenesis of the first H5N8 and reassortant H5N2 clade 2.3.4.4A HPAI U.S. isolates was investigated in six gallinaceous species: chickens, Japanese quail, Bobwhite quail, Pearl guinea fowl, Chukar partridges, and Ring-necked pheasants. Both viruses caused 80-100% mortality in all species, except for H5N2 virus that caused 60% mortality in chickens. The surviving challenged birds remained uninfected based on lack of clinical disease and lack of seroconversion. Among the infected birds, chickens and Japanese quail in early clinical stages (asymptomatic and listless) lacked histopathologic findings. In contrast, birds of all species in later clinical stages (moribund and dead) had histopathologic lesions and systemic virus replication consistent with HPAI virus infection in gallinaceous poultry. These birds had widespread multifocal areas of necrosis, sometimes with heterophilic or lymphoplasmacytic inflammatory infiltrate, and viral antigen in parenchymal cells of most tissues. In general, lesions and antigen distribution were similar regardless of virus and species. However, endotheliotropism was the most striking difference among species, with only Pearl guinea fowl showing widespread replication of both viruses in endothelial cells of most tissues. The expression of IFN-γ and IL-10 in Japanese quail, and IL-6 in chickens, were up-regulated in later clinical stages compared to asymptomatic birds.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bertran</LastName>
                    <ForeName>Kateri</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, 30605, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la Universitat Autònoma de Barcelona, 08193, Bellaterra, Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pantin-Jackwood</LastName>
                    <ForeName>Mary J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, 30605, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Criado</LastName>
                    <ForeName>Miria F</ForeName>
                    <Initials>MF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, 30605, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Dong-Hun</ForeName>
                    <Initials>DH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, 30605, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology &amp; Veterinary Science, University of Connecticut, Storrs, CT, 06269, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Balzli</LastName>
                    <ForeName>Charles L</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, 30605, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Battelle National Biodefense Institute, National Biodefense Analysis and Countermeasures Center, 8300 Research PI, Fort Detrick, MD, 21702, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spackman</LastName>
                    <ForeName>Erica</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, 30605, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suarez</LastName>
                    <ForeName>David L</ForeName>
                    <Initials>DL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, 30605, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swayne</LastName>
                    <ForeName>David E</ForeName>
                    <Initials>DE</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7472-1992</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, 30605, USA. david.swayne@usda.gov.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>6612-32000-066-00D</GrantID>
                    <Agency>Agricultural Research Service</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>HHSN272201400008C</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>60-6040-6-005</GrantID>
                    <Agency>ARS/APHIS</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>58-6040-7-012FN</GrantID>
                    <Agency>DELTA-FLU</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Vet Res</MedlineTA>
            <NlmUniqueID>9309551</NlmUniqueID>
            <ISSNLinking>0928-4249</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31675983</ArticleId>
            <ArticleId IdType="doi">10.1186/s13567-019-0704-5</ArticleId>
            <ArticleId IdType="pii">10.1186/s13567-019-0704-5</ArticleId>
            <ArticleId IdType="pmc">PMC6824115</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 May;88(10):5381-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24574407</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2007 Jul 26;25(30):5637-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17126960</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2016;182:116-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26711037</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Virol. 2009 Jan;44(1):39-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18977691</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2017 Oct 13;91(21):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28794040</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 1999 Sep 11;354(9182):916-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10489954</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Dis. 2008 Sep;52(3):455-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18939635</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Res. 2011 Feb 07;42:24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21314907</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Med Genomics. 2017 Dec 21;10(Suppl 4):70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29322931</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Res. 2014;45:85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25163545</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2003 Mar;77(5):3148-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12584339</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Jul 09;8(7):e68375</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23874602</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Interferon Cytokine Res. 2011 Apr;31(4):393-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21194349</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Immunol. 2011 Aug;23(4):481-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21840185</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Dis. 2003;47(3 Suppl):1114-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14575124</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Infect Dis. 2016 Jul;16(7):e108-e118</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27211899</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2016 Jul;494:190-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27110710</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Microbiol. 2002 Sep;40(9):3256-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12202562</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2015 Sep;96(9):2511-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25986634</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Pathol. 2010 Sep;47(5):893-914</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20682805</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Res. 2013 Mar 28;44:23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23537387</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Res. 2014 Nov 28;45:118</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25431115</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2007 Apr;81(8):4044-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17267493</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Pathol. 2012 Dec;41(6):519-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23237364</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2010 Dec 20;408(2):167-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20947115</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Pathol. 2006 Jun;35(3):250-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16753617</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Rev Sci Tech. 2009 Apr;28(1):113-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19618622</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Vet Sci. 2009 Mar;10(1):53-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19255524</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2015 May;21(5):886-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25898265</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2016 Aug;495:161-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27236304</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Pathol. 2016 Dec;45(6):630-639</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27215697</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Zoonoses Public Health. 2018 May;65(3):312-321</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28905526</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2013 Jul 26;165(1-2):177-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23597652</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Res. 2011 Oct 07;42:106</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21982125</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Microbiol. 2014 Dec 02;5:653</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25520707</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Vet Sci. 2017 Aug 31;18(S1):269-280</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28859267</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lab Invest. 2007 Apr;87(4):383-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17297435</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2000 Oct;74(20):9372-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11000205</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Poult Sci. 2012 Oct;91(10):2496-501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22991533</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2016 Jul;22(7):1283-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27314845</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2016 Apr 12;11(4):e0153671</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27071061</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2013 May 25;381(9880):1815</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23664058</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Dis. 2015 Jun;59(2):344-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26473689</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Immunol Immunopathol. 2011 Jun 15;141(3-4):221-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21458080</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Korean J Pathol. 2014 Feb;48(1):36-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24627693</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbes Infect. 2015 Jan;17(1):48-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25284683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Pathol. 2001 Mar;38(2):149-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11280371</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Virol. 1987;93(1-2):81-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3813892</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Pathol. 2014;43(1):9-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24467281</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Methods Mol Biol. 2008;436:53-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18370041</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2003 May 25;310(1):8-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12788625</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Pathol. 2008 Dec;37(6):555-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19023755</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Dis. 2007 Mar;51(1 Suppl):242-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17494560</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1993 Mar;193(1):503-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8438586</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Microbes Infect. 2017 Mar 8;6(3):e12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28270655</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Vet Med Sci. 2013 May 2;75(4):451-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23182866</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Pathol. 2013 Aug;42(4):347-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23782222</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Pathol. 2016;45(2):208-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26814367</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Genes. 2019 Aug;55(4):502-512</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31089865</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Avian Dis. 2010 Mar;54(1 Suppl):555-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20521693</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31679542</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1469-4409</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>147</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>04</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Epidemiology and infection</Title>
                <ISOAbbreviation>Epidemiol. Infect.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>High expression levels of influenza virus receptors in airway of the HBV-transgenic mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e297</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268819001833</ELocationID>
            <Abstract>
                <AbstractText>In the human population, influenza A viruses are associated with acute respiratory illness and are responsible for millions of deaths annually. Avian and human influenza viruses typically have a different α2-3- and α2-6-linked sialic acid (SA) binding preference. Only a few amino acid changes in the haemagglutinin on the surface of avian influenza viruses (AIV) can cause a switch from avian to human receptor specificity, and the individuals with pathognostic chronic diseases might be more susceptible to AIV due to the decreased expression level of terminal α2-3-linked SA in their saliva. Here, using lectin and virus histochemical staining, we observed the higher expression levels of α2-3/6-linked SA influenza virus receptors in the airway of HBV-transgenic mice compared with that of control mice due to the significant decrease in control mice during ageing, which imply that this is also a risk factor for individuals with pathognostic chronic diseases susceptible to influenza viruses. Our findings will help understand the impact on influenza virus pathogenesis and transmission.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Jiajun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an 710069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Hao</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell Engineering Research Centre and Department of Cell Biology, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jia</LastName>
                    <ForeName>Liyuan</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an 710069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lan</LastName>
                    <ForeName>Xianchun</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an 710069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Yuhui</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an 710069, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>College of Medicine, Xi'an International University, Xi'an 710077, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bian</LastName>
                    <ForeName>Huijie</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell Engineering Research Centre and Department of Cell Biology, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Zheng</ForeName>
                    <Initials>Z</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1839-3450</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Functional Glycomics, College of Life Sciences, Northwest University, Xi'an 710069, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Epidemiol Infect</MedlineTA>
            <NlmUniqueID>8703737</NlmUniqueID>
            <ISSNLinking>0950-2688</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">airway</Keyword>
            <Keyword MajorTopicYN="N">influenza A virus</Keyword>
            <Keyword MajorTopicYN="N">liver disease</Keyword>
            <Keyword MajorTopicYN="N">receptors</Keyword>
            <Keyword MajorTopicYN="N">α2-3/6-linked sialic acids</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31679542</ArticleId>
            <ArticleId IdType="doi">10.1017/S0950268819001833</ArticleId>
            <ArticleId IdType="pii">S0950268819001833</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31677416</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-2661</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>127</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Research in veterinary science</Title>
                <ISOAbbreviation>Res. Vet. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Limited impact of influenza A virus vaccination of piglets in an enzootic infected sow herd.</ArticleTitle>
            <Pagination>
                <MedlinePgn>47-56</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0034-5288(19)30810-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rvsc.2019.10.015</ELocationID>
            <Abstract>
                <AbstractText>Recent studies have questioned the effect of maternal derived antibodies (MDAs) to protect piglets against infection with influenza A virus (IAV). The lack of protection against IAV infections provided by MDAs has encouraged alternative vaccination strategies targeting young piglets in an attempt to stimulate an early antibody response. There is a lack of studies documenting the efficacy of piglet vaccination. In the present study, we monitored a group of vaccinated and non-vaccinated piglets in a Danish sow herd that initiated piglet vaccination with ¼ dose of an inactivated swine influenza vaccine at the time of castration (day 3-4). A total of 160 piglets from 11 sows were included and either vaccinated with 0.5 mL inactivated swine influenza vaccine or sham-vaccinated. From week 0 until week 6, all included piglets were clinically examined and nasal swapped once per week and weighed at weeks 0, 3 and 6. Blood samples were collected from sows at week 0 and from piglets at week 3. Vaccination of piglets had limited effect on clinical signs, body weight, antibody development and viral shedding, within the first 6 weeks of life. At least 50% of all pigs of each treatment group tested positive for IAV at week 2, and very early onset of IAV shedding was observed. In total, 18 pigs were IAV positive in nasal swabs for more than one consecutive sampling time indicating prolonged shedding and 14 pigs were IAV positive with negative samplings in between indicating re-infection with the same IAV strain.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ryt-Hansen</LastName>
                    <ForeName>Pia</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Veterinary Institute, Technical University of Denmark, Kemitorvet Building 204, DK-2800 Kongens Lyngby, Denmark. Electronic address: pryt@vet.dtu.dk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Larsen</LastName>
                    <ForeName>Inge</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dpt. of Veterinary and Animal Sciences Grønnegårdsvej 2, University of Copenhagen, DK-1870 Frederiksberg C, Denmark. Electronic address: inge@sund.ku.dk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kristensen</LastName>
                    <ForeName>Charlotte Sonne</ForeName>
                    <Initials>CS</Initials>
                    <AffiliationInfo>
                        <Affiliation>SEGES Danish Pig Research Center, Vinkelvej 11, DK-8620 Kjellerup, Denmark. Electronic address: csk@seges.dk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krog</LastName>
                    <ForeName>Jesper Schak</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Veterinary Institute, Technical University of Denmark, Kemitorvet Building 204, DK-2800 Kongens Lyngby, Denmark. Electronic address: JSKR@ssi.dk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Larsen</LastName>
                    <ForeName>Lars Erik</ForeName>
                    <Initials>LE</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Veterinary Institute, Technical University of Denmark, Kemitorvet Building 204, DK-2800 Kongens Lyngby, Denmark; Dpt. of Veterinary and Animal Sciences Grønnegårdsvej 2, University of Copenhagen, DK-1870 Frederiksberg C, Denmark. Electronic address: lael@sund.ku.dk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Res Vet Sci</MedlineTA>
            <NlmUniqueID>0401300</NlmUniqueID>
            <ISSNLinking>0034-5288</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Influenza a virus</Keyword>
            <Keyword MajorTopicYN="N">Influenza vaccination</Keyword>
            <Keyword MajorTopicYN="N">Piglet vaccination</Keyword>
            <Keyword MajorTopicYN="N">Recurrent shedding</Keyword>
            <Keyword MajorTopicYN="N">Reinfection</Keyword>
            <Keyword MajorTopicYN="N">Swine influenza</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31677416</ArticleId>
            <ArticleId IdType="pii">S0034-5288(19)30810-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.rvsc.2019.10.015</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31669761</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0720</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>141</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</Title>
                <ISOAbbreviation>Eur J Pharm Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.</ArticleTitle>
            <Pagination>
                <MedlinePgn>105124</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-0987(19)30397-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejps.2019.105124</ELocationID>
            <Abstract>
                <AbstractText>Influenza virus infections are a persistent threat to human health due to seasonal outbreaks and sporadic pandemics. Amantadine and rimantadine are FDA-approved influenza antiviral drugs and work by inhibiting the viral M2 proton channel. However, the therapeutic potential for the antiviral amantadine/rimantadine was curtailed by the emergence of drug-resistant mutations in its target protein M2. In this study, we identified four amantadine-resistant M2 mutants among avian and human influenza A H5N1 strains circulating between 2002 and 2019: the single S31N and V27A mutants, and the S31N/L26I and S31N/V27A double mutants. Herein, utilizing two-electrode voltage clamp (TEVC) assays, we screened a panel of structurally diverse M2 inhibitors against these single and double mutant channels. Three compounds 6, 7, and 15 were found to significantly block all three M2 mutants: M2-S31N, M2-S31N/L26I, and M2-S31N/V27A. Using recombinant viruses generated from reverse genetics, we further showed that these compounds also inhibited the replication of recombinant viruses harboring either the single S31N or double S31N/L26I and S31N/V27A mutants. This work represents the first example in developing antivirals by targeting the drug-resistant double mutants of M2 proton channels.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Musharrafieh</LastName>
                    <ForeName>Rami</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721 USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Chunlong</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721 USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721 USA. Electronic address: junwang@pharmacy.arizona.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Eur J Pharm Sci</MedlineTA>
            <NlmUniqueID>9317982</NlmUniqueID>
            <ISSNLinking>0928-0987</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Amantadine</Keyword>
            <Keyword MajorTopicYN="N">Antiviral</Keyword>
            <Keyword MajorTopicYN="N">Drug resistance</Keyword>
            <Keyword MajorTopicYN="N">Influenza virus</Keyword>
            <Keyword MajorTopicYN="N">M2</Keyword>
            <Keyword MajorTopicYN="N">Proton channel</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31669761</ArticleId>
            <ArticleId IdType="pii">S0928-0987(19)30397-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ejps.2019.105124</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31669062</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Protective efficacy of vaccines of the Korea national antigen bank against the homologous H5Nx clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(19)31417-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2019.10.044</ELocationID>
            <Abstract>
                <AbstractText>The occurrence of severe outbreaks of highly pathogenic avian influenza in Korea led to establishment of a national antigen bank for emergency preparedness. Here, we developed five vaccines for this bank (clade 2.3.2.1C, clade 2.3.4.4A, B, C, and D) by reverse genetics, inactivated them with formalin, and evaluated the protective efficacy and potency of serial dilutions against lethal homologous challenge in specific-pathogen-free chickens. After vaccination with one dose, each vaccine resulted in 100% survival, with no clinical symptoms, or lack of detectable virus shedding, and high levels of pre-challenge protective immunity (8.4-10.2 log<sub>2</sub>). After vaccination with one-tenth of the full dose, protection was similar to that with the full dose. After vaccination with one-hundredth of the initial dose, survival was 20-80%, and all vaccines showed virus shedding. Four vaccines (excluding clade 2.3.2.1C) had satisfactory potency. In antibody-persistence tests, all vaccines maintained long-lasting protective immunity. Our results suggest that inactivated reverse-genetics vaccines genetically matched to outbreak viruses provide adequate protection after a single vaccination.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Yong-Myung</ForeName>
                    <Initials>YM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>Hyun-Kyu</ForeName>
                    <Initials>HK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Hyun-Mi</ForeName>
                    <Initials>HM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Myoung-Heon</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>To</LastName>
                    <ForeName>Thanh Long</ForeName>
                    <Initials>TL</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Center for Veterinary Diagnostics, No. 11, 78th Lane, GiaiPhong Road, Dong Da, Hanoi, Viet Nam.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Hyun-Mi</ForeName>
                    <Initials>HM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea. Electronic address: greenkang@korea.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antigen bank</Keyword>
            <Keyword MajorTopicYN="N">Chicken</Keyword>
            <Keyword MajorTopicYN="N">Highly pathogenic avian influenza</Keyword>
            <Keyword MajorTopicYN="N">Inactivation</Keyword>
            <Keyword MajorTopicYN="N">Vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31669062</ArticleId>
            <ArticleId IdType="pii">S0264-410X(19)31417-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2019.10.044</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31668495</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-0067</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jul</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Epidemics</Title>
                <ISOAbbreviation>Epidemics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Analyzing influenza outbreaks in Russia using an age-structured dynamic transmission model.</ArticleTitle>
            <Pagination>
                <MedlinePgn>100358</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1755-4365(18)30143-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.epidem.2019.100358</ELocationID>
            <Abstract>
                <AbstractText>In this study, we addressed the ability of a minimalistic SEIR model to satisfactorily describe influenza outbreak dynamics in Russian settings. For that purpose, we calibrated an age-specific influenza dynamics model to Russian acute respiratory infection (ARI) incidence data over 2009-2016 and assessed the variability of proportion of non-immune individuals in the population depending on the regarded city, the non-epidemic indicence baseline, the contact structure considered and the used calibration method. The experiments demonstrated the importance of distinguishing characteristics of different age groups, such as contact intensities and background immunity levels. It was also found that the current model calibration process, which relies mostly on ARI incidence, demonstrates notable variation of output parameter values. Employing additional sources of data, such as strain-specific influenza incidence and external assessments on underreporting levels in different age groups, might enhance the plausibility of parameter values obtained by model calibration, along with reducing the assessment variation.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Leonenko</LastName>
                    <ForeName>Vasiliy</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>ITMO University, Saint Petersburg, Russian Federation. Electronic address: vnleonenko@yandex.ru.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bobashev</LastName>
                    <ForeName>Georgiy</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Epidemics</MedlineTA>
            <NlmUniqueID>101484711</NlmUniqueID>
            <ISSNLinking>1878-0067</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Background immunity</Keyword>
            <Keyword MajorTopicYN="N">Incidence data</Keyword>
            <Keyword MajorTopicYN="N">Mathematical modeling</Keyword>
            <Keyword MajorTopicYN="N">Seasonal influenza</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31668495</ArticleId>
            <ArticleId IdType="pii">S1755-4365(18)30143-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.epidem.2019.100358</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31666492</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1884-2836</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>31</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Japanese journal of infectious diseases</Title>
                <ISOAbbreviation>Jpn. J. Infect. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic characterization of a schoolgirl infection with novel reassortant H5N6 avian influenza virus.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.7883/yoken.JJID.2019.101</ELocationID>
            <Abstract>
                <AbstractText>A 10-year-old schoolgirl was laboratory confirmed infection with H5N6 subtype highly pathogenic avian influenza (HPAI) virus in Suzhou city in November, 2018 (JSSZ01). Hemagglutinin (HA) gene of this H5N6 virus belonged to 2.3.4.4 H5 clade and the HA linkage peptide of JSSZ01 strain was RERRRKR↓GLF with multiple basic amino acids. Q226L and G228S mutations were not observed, but S128P, S137A, T160A substitutions in receptor binding sites (RBS) were discovered. Resistance mutation D198N in neuraminidase (NA) protein was also identified in this strain. Besides, 11 amino acids (59-69AAs) deletion was identified in NA stalk region. Most genes of JSSZ01 exhibited the highest identity with previous H5N6 viruses, but its PA segment sequence was highly similar to previous avian H3 viruses (Accession Number: EPI596567 or EPI590058), indicating that JSSZ01 may be generated by gene reassortment.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Zefeng</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Center for Disease Prevention and Control.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ya</LastName>
                    <ForeName>Xuerong</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Center for Disease Prevention and Control.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Di</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Center for Disease Prevention and Control.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Cheng</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Center for Disease Prevention and Control.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Qiang</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Center for Disease Prevention and Control.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xia</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Suzhou Center for Disease Prevention and Control.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>Jpn J Infect Dis</MedlineTA>
            <NlmUniqueID>100893704</NlmUniqueID>
            <ISSNLinking>1344-6304</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Avian Influenza virus</Keyword>
            <Keyword MajorTopicYN="N">Hemagglutinin (HA)</Keyword>
            <Keyword MajorTopicYN="N">Mutation</Keyword>
            <Keyword MajorTopicYN="N">Neuraminidase (NA)</Keyword>
            <Keyword MajorTopicYN="N">Reassortment</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31666492</ArticleId>
            <ArticleId IdType="doi">10.7883/yoken.JJID.2019.101</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31666364</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-660X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical microbiology</Title>
                <ISOAbbreviation>J. Clin. Microbiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Metagenomic Nanopore sequencing of influenza virus direct from clinical respiratory samples.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">JCM.00963-19</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.00963-19</ELocationID>
            <Abstract>
                <AbstractText>Influenza is a major global public health threat as a result of its highly pathogenic variants, large zoonotic reservoir, and pandemic potential. Metagenomic viral sequencing offers the potential for a diagnostic test for influenza which also provides insights on transmission, evolution and drug resistance, and simultaneously detects other viruses. We therefore set out to apply Oxford Nanopore Technology to metagenomic sequencing of respiratory samples. We generated influenza reads down to a limit of detection of 10<sup>2</sup>-10<sup>3</sup> genome copies/ml in pooled samples, observing a strong relationship between the viral titre and the proportion of influenza reads (p = 4.7x10<sup>-5</sup>). Applying our methods to clinical throat swabs, we generated influenza reads for 27/27 samples with high-to-mid viral titres (Cycle threshold (Ct) values &lt;30) and 6/13 samples with low viral titres (Ct values 30-40). No false positive reads were generated from 10 influenza-negative samples. Thus Nanopore sequencing operated with 83% sensitivity (95% CI 67-93%) and 100% specificity (95% CI 69-100%) compared to the current diagnostic standard. Coverage of full length virus was dependent on sample composition, being negatively influenced by increased host and bacterial reads. However, at high influenza titres, we were able to reconstruct &gt;99% complete sequence for all eight gene segments. We also detected a Human Coronavirus co-infection in one clinical sample. While further optimisation is required to improve sensitivity, this approach shows promise for the Nanopore platform to be used in the diagnosis and genetic analysis of influenza and other respiratory viruses.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Lewandowski et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lewandowski</LastName>
                    <ForeName>Kuiama</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, National infection Service, Porton Down, Salisbury, SP4 0JG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Yifei</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pullan</LastName>
                    <ForeName>Steven T</ForeName>
                    <Initials>ST</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, National infection Service, Porton Down, Salisbury, SP4 0JG, UK steven.pullan@phe.gov.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lumley</LastName>
                    <ForeName>Sheila F</ForeName>
                    <Initials>SF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Foster</LastName>
                    <ForeName>Dona</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Oxford NIHR BRC, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sanderson</LastName>
                    <ForeName>Nicholas</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Oxford NIHR BRC, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vaughan</LastName>
                    <ForeName>Alison</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Oxford NIHR BRC, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morgan</LastName>
                    <ForeName>Marcus</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bright</LastName>
                    <ForeName>Nicole</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kavanagh</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vipond</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, National infection Service, Porton Down, Salisbury, SP4 0JG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carroll</LastName>
                    <ForeName>Miles</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, National infection Service, Porton Down, Salisbury, SP4 0JG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marriott</LastName>
                    <ForeName>Anthony C</ForeName>
                    <Initials>AC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, National infection Service, Porton Down, Salisbury, SP4 0JG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gooch</LastName>
                    <ForeName>Karen E</ForeName>
                    <Initials>KE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, National infection Service, Porton Down, Salisbury, SP4 0JG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andersson</LastName>
                    <ForeName>Monique</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeffery</LastName>
                    <ForeName>Katie</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peto</LastName>
                    <ForeName>Timothy E A</ForeName>
                    <Initials>TEA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Oxford NIHR BRC, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Crook</LastName>
                    <ForeName>Derrick W</ForeName>
                    <Initials>DW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Oxford NIHR BRC, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walker</LastName>
                    <ForeName>A Sarah</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matthews</LastName>
                    <ForeName>Philippa C</ForeName>
                    <Initials>PC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, South Parks Road, Oxford OX1 3SY, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Oxford NIHR BRC, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Clin Microbiol</MedlineTA>
            <NlmUniqueID>7505564</NlmUniqueID>
            <ISSNLinking>0095-1137</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31666364</ArticleId>
            <ArticleId IdType="pii">JCM.00963-19</ArticleId>
            <ArticleId IdType="doi">10.1128/JCM.00963-19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31666126</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1297-9716</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>50</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Veterinary research</Title>
                <ISOAbbreviation>Vet. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Host-range shift of H3N8 canine influenza virus: a phylodynamic analysis of its origin and adaptation from equine to canine host.</ArticleTitle>
            <Pagination>
                <MedlinePgn>87</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13567-019-0707-2</ELocationID>
            <Abstract>
                <AbstractText>Prior to the emergence of H3N8 canine influenza virus (CIV) and the latest avian-origin H3N2 CIV, there was no evidence of a circulating canine-specific influenza virus. Molecular and epidemiological evidence suggest that H3N8 CIV emerged from H3N8 equine influenza virus (EIV). This host-range shift of EIV from equine to canine hosts and its subsequent establishment as an enzootic CIV is unique because this host-range shift was from one mammalian host to another. To further understand this host-range shift, we conducted a comprehensive phylodynamic analysis using all the available whole-genome sequences of H3N8 CIV. We found that (1) the emergence of H3N8 CIV from H3N8 EIV occurred in approximately 2002; (2) this interspecies transmission was by a reassortant virus of the circulating Florida-1 clade H3N8 EIV; (3) once in the canine species, H3N8 CIV spread efficiently and remained an enzootic virus; (4) H3N8 CIV evolved and diverged into multiple clades or sublineages, with intra and inter-lineage reassortment. Our results provide a framework to understand the molecular basis of host-range shifts of influenza viruses and that dogs are potential &quot;mixing vessels&quot; for the establishment of novel influenza viruses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Wanting</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ministry of Education Joint International Research Laboratory of Animal Health and Food Safety, Engineering Laboratory of Animal Immunity of Jiangsu Province, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Gairu</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ministry of Education Joint International Research Laboratory of Animal Health and Food Safety, Engineering Laboratory of Animal Immunity of Jiangsu Province, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Ruyi</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ministry of Education Joint International Research Laboratory of Animal Health and Food Safety, Engineering Laboratory of Animal Immunity of Jiangsu Province, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Weifeng</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Taishan Medical College, Taian, 271000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Kemang</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ministry of Education Joint International Research Laboratory of Animal Health and Food Safety, Engineering Laboratory of Animal Immunity of Jiangsu Province, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Shilei</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ministry of Education Joint International Research Laboratory of Animal Health and Food Safety, Engineering Laboratory of Animal Immunity of Jiangsu Province, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lai</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4995-3251</Identifier>
                    <AffiliationInfo>
                        <Affiliation>College of Natural, Applied, and Health Sciences, Kentucky State University, Frankfort, KY, USA. alexander.lai@kysu.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Shuo</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ministry of Education Joint International Research Laboratory of Animal Health and Food Safety, Engineering Laboratory of Animal Immunity of Jiangsu Province, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China. shuosu@njau.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2017YFD0500101</GrantID>
                    <Agency>China</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Vet Res</MedlineTA>
            <NlmUniqueID>9309551</NlmUniqueID>
            <ISSNLinking>0928-4249</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31666126</ArticleId>
            <ArticleId IdType="doi">10.1186/s13567-019-0707-2</ArticleId>
            <ArticleId IdType="pii">10.1186/s13567-019-0707-2</ArticleId>
            <ArticleId IdType="pmc">PMC6822366</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 1996 Apr;77 ( Pt 4):661-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8627254</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1994 Nov 1;204(2):673-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7941336</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Rec. 2008 Sep 27;163(13):378</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19031639</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Dec 16;8(12):e82486</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24358190</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2008 Jun;14(6):902-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18507900</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Virol. 2009;154(5):887-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19396578</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2014 Apr 10;508(7495):254-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24531761</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2014 May 1;30(9):1312-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24451623</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Evol Appl. 2017 Oct 24;11(4):534-546</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29636804</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Rec. 2006 Feb 11;158(6):185-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16474051</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2008 Jul;25(7):1253-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18397919</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2006 Dec;80(23):11887-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16987977</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2010 Oct 1;26(19):2455-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20671151</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2010 Apr;16(4):699-702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20350392</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 May;89(10):5406-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25740996</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 Mar;88(6):3568-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24403592</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Clin North Am Equine Pract. 2014 Dec;30(3):507-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25282321</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2001 Aug;17(8):754-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11524383</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet J. 2012 Mar;191(3):312-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22178358</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1991 Jul;65(7):3704-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2041090</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MBio. 2018 Jun 5;9(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29871917</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 Nov;89(22):11190-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26311894</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pathogens. 2016 Aug 31;5(3):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27589809</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1992 Feb;66(2):1129-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1731092</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2016;182:95-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26711034</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dev Biol Stand. 1977 Jun 1-3;39:461-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">604130</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2011;6(6):e20823</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21695145</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Res. 1994 Nov;34(2):153-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7545975</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Clin North Am Equine Pract. 1993 Aug;9(2):257-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8358645</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Evol Biol. 2007 Nov 08;7:214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17996036</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1998 Dec 20;252(2):324-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9878611</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2018 Aug 29;92(18):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29997206</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Rev Sci Tech. 2011 Apr;30(1):87-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21809755</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2015 May;32(5):1342-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25697341</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Rec. 2007 Nov 3;161(18):635</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17982150</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Rec. 1974 Mar 30;94(13):282-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4826197</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2010 Jul;84(14):6943-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20444896</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Virol. 2001;146(6):1063-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11504416</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2013 May;30(5):1196-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23420840</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virol J. 2016 Mar 19;13:45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26993620</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2014 Nov 20;5:5509</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25409547</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Aust Vet J. 2011 Jul;89 Suppl 1:163-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21711321</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Res. 2004 Mar 15;100(2):159-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15019234</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 Mar;88(5):2844-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24371052</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2005 Oct 21;310(5747):482-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16186182</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2017 Jan 22;482(4):1107-1113</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27914808</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Res. 1998 Jun;55(2):143-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9725667</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Genet. 2012;8(7):e1002764</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22807683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Biol. 2005 Sep;3(9):e300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16026181</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 Jul;89(13):6860-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25903329</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbiol Rev. 1992 Mar;56(1):152-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1579108</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 1977 Jun 24;196(4297):1454-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">867041</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet J. 2011 Jul;189(1):7-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20685140</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2006 Nov 1;22(21):2688-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16928733</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Intervirology. 1975-1976;6(4-5):315-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1235862</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1990 Oct;64(10):4893-902</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2398532</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2010 Dec;84(24):12636-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20943966</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2016 Jul;33(7):1870-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27004904</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2010 May;91(Pt 5):1284-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20016035</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2012 Jan;93(Pt 1):119-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21976611</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2008 Mar;14(3):461-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18325262</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pathogens. 2016 Oct 16;5(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27754468</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Zoonoses. 1976 Jun;3(1):61-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">977232</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2004 Mar 19;32(5):1792-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15034147</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Res. 2008 Feb;131(2):243-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17996973</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 Nov;88(22):13436-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25210184</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Am Vet Med Assoc. 1963 Sep 15;143:587-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14077956</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10736-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12149435</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31666017</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2334</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>19</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC infectious diseases</Title>
                <ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>More than a &quot;touch of the flu&quot;: a response to Mayrhuber et al's &quot;with fever it's the real flu I would say&quot;: laypersons' perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia&quot;.</ArticleTitle>
            <Pagination>
                <MedlinePgn>921</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-019-4437-x</ELocationID>
            <Abstract>
                <AbstractText>This short reply contests two assumptions made by the authors of Mayrhuber et al's. &quot;With fever it's the real flu I would say.&quot; The first is that there is influenza can be reliably defined by a medical case definition. The second is that this small qualitative study can be generalisable. However, it does underline the important point that technical diagnostic terms may be used on different registers by a variety of actors in the medical setting.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jutel</LastName>
                    <ForeName>Annemarie</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7131-3838</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Victoria University of Wellington (NZ), Wellington, New Zealand. Annemarie.jutel@vuw.ac.nz.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Infect Dis</MedlineTA>
            <NlmUniqueID>100968551</NlmUniqueID>
            <ISSNLinking>1471-2334</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Diagnosis</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>01</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31666017</ArticleId>
            <ArticleId IdType="doi">10.1186/s12879-019-4437-x</ArticleId>
            <ArticleId IdType="pii">10.1186/s12879-019-4437-x</ArticleId>
            <ArticleId IdType="pmc">PMC6820963</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Perspect Biol Med. 2013 Autumn;56(4):513-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24769745</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Pharm Ther. 2006 Aug;31(4):309-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16882099</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2005 Feb 23;293(8):987-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15728170</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Infect Dis. 2018 Dec 12;18(1):647</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30541479</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Soc Sci Med. 2011 Sep;73(6):922-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21186076</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Infect Dis. 2005 Nov;5(11):718-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16253889</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Public Health. 2013 Apr 25;13:388</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23617788</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Soc Sci Med. 2013 Dec;99:49-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24355470</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMJ Open. 2011 Jan 1;1(2):e000234</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22021887</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Epidemiol. 2008 Apr 1;167(7):775-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18230677</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Altern Med Rev. 2007 Mar;12(1):25-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17397266</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31665057</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1466-609X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>23</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Critical care (London, England)</Title>
                <ISOAbbreviation>Crit Care</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Preparing intensive care for the next pandemic influenza.</ArticleTitle>
            <Pagination>
                <MedlinePgn>337</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-019-2616-1</ELocationID>
            <Abstract>
                <AbstractText>Few viruses have shaped the course of human history more than influenza viruses. A century since the 1918-1919 Spanish influenza pandemic-the largest and deadliest influenza pandemic in recorded history-we have learned much about pandemic influenza and the origins of antigenic drift among influenza A viruses. Despite this knowledge, we remain largely underprepared for when the next major pandemic occurs.While emergency departments are likely to care for the first cases of pandemic influenza, intensive care units (ICUs) will certainly see the sickest and will likely have the most complex issues regarding resource allocation. Intensivists must therefore be prepared for the next pandemic influenza virus. Preparation requires multiple steps, including careful surveillance for new pandemics, a scalable response system to respond to surge capacity, vaccine production mechanisms, coordinated communication strategies, and stream-lined research plans for timely initiation during a pandemic. Conservative models of a large-scale influenza pandemic predict more than 170% utilization of ICU-level resources. When faced with pandemic influenza, ICUs must have a strategy for resource allocation as strain increases on the system.There are several current threats, including avian influenza A(H5N1) and A(H7N9) viruses. As humans continue to live in closer proximity to each other, travel more extensively, and interact with greater numbers of birds and livestock, the risk of emergence of the next pandemic influenza virus mounts. Now is the time to prepare and coordinate local, national, and global efforts.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kain</LastName>
                    <ForeName>Taylor</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Critical Care, University of Toronto, Toronto, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fowler</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Critical Care, University of Toronto, Toronto, ON, Canada. rob.fowler@sunnybrook.ca.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sunnybrook Health Sciences Centre, Room D478, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. rob.fowler@sunnybrook.ca.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Crit Care</MedlineTA>
            <NlmUniqueID>9801902</NlmUniqueID>
            <ISSNLinking>1364-8535</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Health care worker safety</Keyword>
            <Keyword MajorTopicYN="N">Highly pathogenic avian influenza</Keyword>
            <Keyword MajorTopicYN="N">Human</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Intensive care</Keyword>
            <Keyword MajorTopicYN="N">Pandemic</Keyword>
            <Keyword MajorTopicYN="N">Preparation</Keyword>
            <Keyword MajorTopicYN="N">Research</Keyword>
            <Keyword MajorTopicYN="N">Resource allocation</Keyword>
            <Keyword MajorTopicYN="N">Triage</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31665057</ArticleId>
            <ArticleId IdType="doi">10.1186/s13054-019-2616-1</ArticleId>
            <ArticleId IdType="pii">10.1186/s13054-019-2616-1</ArticleId>
            <ArticleId IdType="pmc">PMC6819413</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2009 Nov 4;302(17):1888-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19822628</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Healthc Q. 2014;17(2):44-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25191808</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Epidemiol Infect. 2016 Jan;144(2):408-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26119282</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Public Health. 2016 Apr;106(4):642-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26959269</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2017 Sep 15;65(6):1037-1039</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28541414</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2012 Mar 9;335(6073):1173-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22345402</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Public Health Rep. 2010 Apr;125 Suppl 3:16-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20568566</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 1998 Jul;178(1):53-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9652423</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Virol. 2018 Apr;163(4):831-844</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29322273</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2005 Oct 6;437(7060):889-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16208372</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2016 Oct 26;34(45):5410-5413</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27531411</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2018 May 24;378(21):1965-1975</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29791822</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Intensive Care Med. 2011 Nov;37(11):1746-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21847646</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Rev Vaccines. 2016;15(2):215-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26641724</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1991 Jul;65(7):3704-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2041090</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chest. 2014 Oct;146(4 Suppl):e168S-77S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25144410</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2011 Jul 13;306(2):200-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21750298</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chest. 2008 May;133(5 Suppl):18S-31S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18460504</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Crit Care. 2015 Apr 01;19:133</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25888116</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19465683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Emerg Trauma Shock. 2009 Sep;2(3):175-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20009307</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Protein Cell. 2010 Jan;1(1):9-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21203993</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2003 Jul 16;290(3):367-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12865378</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chest. 2014 Oct;146(4 Suppl):e87S-e102S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25144713</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11709-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19597152</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2016 Mar 1;213(5):738-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26908781</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2013 Jun;19(6):879-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23731839</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Res Notes. 2012 Jan 23;5:62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22268987</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2018 Dec 4;320(21):2251-2259</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30347031</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chest. 2019 Apr;155(4):848-854</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30316913</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbiol Rev. 1992 Mar;56(1):152-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1579108</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Crit Care Med. 2010 Apr;38(4 Suppl):e120-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20101176</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Virol. 2014 Jun;6:34-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24705137</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Disaster Med Public Health Prep. 2017 Oct;11(5):612-620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28264731</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Public Health Manag Pract. 2011 Jan-Feb;17(1):72-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21135664</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chest. 2015 Jan;147(1):102-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25079506</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2009 Oct 17;374(9698):1351-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19762075</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2007 Oct 19;3(10):1470-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17953482</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Trauma Acute Care Surg. 2013 Jun;74(6):1493-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23694877</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Crit Care. 2017 Aug;40:7-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28288355</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2016 May 12;11(5):e0155044</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27170999</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2005 Nov 24;353(21):2209-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16306515</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11875246</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31659871</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1750-2659</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Influenza and other respiratory viruses</Title>
                <ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12698</ELocationID>
            <Abstract>
                <AbstractText>A major lesson learned from the public health response to the 2009 H1N1 pandemic was the need to shorten the vaccine delivery timeline to achieve the best pandemic mitigation results. A gap analysis of previous pre-pandemic vaccine development activities identified possible changes in the Select Agent exclusion process that would maintain safety and shorten the timeline to develop candidate vaccine viruses (CVVs) for use in pandemic vaccine manufacture. Here, we review the biosafety characteristics of CVVs developed in the past 15 years to support a shortened preparedness timeline for A(H5) and A(H7) subtype highly pathogenic avian influenza (HPAI) CVVs. Extensive biosafety experimental evidence supported recent changes in the implementation of Select Agent regulations that eliminated the mandatory chicken pathotype testing requirements and expedited distribution of CVVs to shorten pre-pandemic and pandemic vaccine manufacturing by up to 3 weeks.</AbstractText>
                <CopyrightInformation>Published 2019. This article is a U.S. Government work and is in the public domain in the USA. Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Li-Mei</ForeName>
                    <Initials>LM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology, Surveillance, and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donis</LastName>
                    <ForeName>Ruben O</ForeName>
                    <Initials>RO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology, Surveillance, and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suarez</LastName>
                    <ForeName>David L</ForeName>
                    <Initials>DL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Agricultural Research Service, U.S. National Poultry Research Center, U.S. Department of Agriculture, Athens, GA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wentworth</LastName>
                    <ForeName>David E</ForeName>
                    <Initials>DE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology, Surveillance, and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Webby</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4397-7132</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Engelhardt</LastName>
                    <ForeName>Othmar G</ForeName>
                    <Initials>OG</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0465-9908</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, National Institute for Biological Standards and Control, Potters Bar, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swayne</LastName>
                    <ForeName>David E</ForeName>
                    <Initials>DE</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7472-1992</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Exotic and Emerging Avian Viral Diseases Research Unit, Agricultural Research Service, U.S. National Poultry Research Center, U.S. Department of Agriculture, Athens, GA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Influenza Other Respir Viruses</MedlineTA>
            <NlmUniqueID>101304007</NlmUniqueID>
            <ISSNLinking>1750-2640</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">avian influenza</Keyword>
            <Keyword MajorTopicYN="N">biosafety</Keyword>
            <Keyword MajorTopicYN="N">candidate vaccine viruses</Keyword>
            <Keyword MajorTopicYN="N">influenza vaccine</Keyword>
            <Keyword MajorTopicYN="N">pandemics</Keyword>
            <Keyword MajorTopicYN="N">pre-pandemic</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31659871</ArticleId>
            <ArticleId IdType="doi">10.1111/irv.12698</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31659236</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5365</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Bone marrow transplantation</Title>
                <ISOAbbreviation>Bone Marrow Transplant.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41409-019-0728-5</ELocationID>
            <Abstract>
                <AbstractText>Influenza vaccination is recommended for children following allogeneic haematopoietic stem cell transplant (HSCT), however there is limited evidence regarding its benefit. A prospective multicentre study was conducted to evaluate the immunogenicity of the inactivated influenza vaccine in children who have undergone HSCT compared with healthy age-matched controls. Participants were vaccinated between 2013 and 2016 according to Australian guidelines. Influenza-specific hemagglutinin inhibition antibody titres were performed prior to each vaccination and 4 weeks following the final vaccination. A nasopharyngeal aspirate for influenza was performed on participants that developed influenza-like illness. There were 86 children recruited; 43 who had undergone HSCT and 43 controls. For the HSCT group, seroprotection and seroconversion rates were 81.4% and 60.5% for H3N2, 41.9% and 32.6% for H1N1, and 44.2% and 39.5% for B strain respectively. There was a significant geometric mean fold increase to the H3N2 (GMFI 5.80, 95% CI 3.68-9.14, p &lt; 0.001) and B (GMFI 3.44, 95% CI 2.36-5.00, p = 0.048) strains. Serological response was superior in age-matched controls to all vaccine strains. There were no serious adverse events following vaccination. For children who underwent HSCT, incidence of laboratory-proven influenza infection was 2.3%. Overall, this study provides evidence to support annual inactivated influenza vaccine administration to children following HSCT.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ryan</LastName>
                    <ForeName>Anne L</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Haematology, Oncology and Bone Marrow Transplantation, Perth Children's Hospital, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wadia</LastName>
                    <ForeName>Ushma D</ForeName>
                    <Initials>UD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Perth Children's Hospital, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jacoby</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheung</LastName>
                    <ForeName>Laurence C</ForeName>
                    <Initials>LC</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6298-5288</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmacy and Biomedical Sciences, Curtin University, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kerr</LastName>
                    <ForeName>Fiona</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Haematology, Oncology and Bone Marrow Transplantation, Perth Children's Hospital, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fraser</LastName>
                    <ForeName>Chris</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Blood and Bone Marrow Transplant Program, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tapp</LastName>
                    <ForeName>Heather</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Haematology and Oncology, Women's and Children's Hospital, Adelaide, SA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mechinaud</LastName>
                    <ForeName>Francoise</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Children's Cancer Centre, Royal Children's Hospital, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carolan</LastName>
                    <ForeName>Louise A</ForeName>
                    <Initials>LA</Initials>
                    <AffiliationInfo>
                        <Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Laurie</LastName>
                    <ForeName>Karen L</ForeName>
                    <Initials>KL</Initials>
                    <AffiliationInfo>
                        <Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barr</LastName>
                    <ForeName>Ian G</ForeName>
                    <Initials>IG</Initials>
                    <AffiliationInfo>
                        <Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Blyth</LastName>
                    <ForeName>Christopher C</ForeName>
                    <Initials>CC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Perth Children's Hospital, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Paediatrics, School of Medicine, University of Western Australia, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>PathWest Laboratory Medicine WA, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gottardo</LastName>
                    <ForeName>Nicholas G</ForeName>
                    <Initials>NG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Haematology, Oncology and Bone Marrow Transplantation, Perth Children's Hospital, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Paediatrics, School of Medicine, University of Western Australia, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Richmond</LastName>
                    <ForeName>Peter C</ForeName>
                    <Initials>PC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Perth Children's Hospital, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Paediatrics, School of Medicine, University of Western Australia, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kotecha</LastName>
                    <ForeName>Rishi S</ForeName>
                    <Initials>RS</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1836-4075</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Haematology, Oncology and Bone Marrow Transplantation, Perth Children's Hospital, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmacy and Biomedical Sciences, Curtin University, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Paediatrics, School of Medicine, University of Western Australia, Perth, WA, Australia. rishi.kotecha@health.wa.gov.au.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Bone Marrow Transplant</MedlineTA>
            <NlmUniqueID>8702459</NlmUniqueID>
            <ISSNLinking>0268-3369</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31659236</ArticleId>
            <ArticleId IdType="doi">10.1038/s41409-019-0728-5</ArticleId>
            <ArticleId IdType="pii">10.1038/s41409-019-0728-5</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31657061</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1521-4184</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Archiv der Pharmazie</Title>
                <ISOAbbreviation>Arch. Pharm. (Weinheim)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1900174</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/ardp.201900174</ELocationID>
            <Abstract>
                <AbstractText>Four series of ferulic acid derivatives were designed, synthesized, and evaluated for their neuraminidase (NA) inhibitory activities against influenza virus H1N1 in vitro. The pharmacological results showed that the majority of the target compounds exhibited moderate influenza NA inhibitory activity, which was also better than that of ferulic acid. The two most potent compounds were 1m and 4a with IC<sub>50</sub> values of 12.77 ± 0.47 and 12.96 ± 1.34 μg/ml, respectively. On the basis of the biological results, a preliminary structure-activity relationship (SAR) was derived and discussed. Besides, molecular docking was performed to study the possible interactions of compounds 1p, 2d, 3b, and 4a with the active site of NA. It was found that the 4-OH-3-OMe group and the amide group (CON) of ferulic acid amide derivatives were two key pharmacophores for NA inhibitory activity. It is meaningful to further modify the natural product ferulic acid to improve its influenza NA inhibitory activity.</AbstractText>
                <CopyrightInformation>© 2019 Deutsche Pharmazeutische Gesellschaft.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cui</LastName>
                    <ForeName>Man-Ying</ForeName>
                    <Initials>MY</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiao</LastName>
                    <ForeName>Meng-Wu</ForeName>
                    <Initials>MW</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Lv-Jie</ForeName>
                    <Initials>LJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Ai-Lin</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Jiao</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Ai-Xi</ForeName>
                    <Initials>AX</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8676-6020</Identifier>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2019JJ40030</GrantID>
                    <Agency>Hunan Provincial Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Arch Pharm (Weinheim)</MedlineTA>
            <NlmUniqueID>0330167</NlmUniqueID>
            <ISSNLinking>0365-6233</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ferulic acid derivatives</Keyword>
            <Keyword MajorTopicYN="N">molecular docking</Keyword>
            <Keyword MajorTopicYN="N">neuraminidase inhibitors</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31657061</ArticleId>
            <ArticleId IdType="doi">10.1002/ardp.201900174</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31656240</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1347-7439</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of veterinary medical science</Title>
                <ISOAbbreviation>J. Vet. Med. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with Montanide<sup>TM</sup> Pet Gel in murine model.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1292/jvms.19-0399</ELocationID>
            <Abstract>
                <AbstractText>Equine influenza is a leading cause for respiratory illness in equines. Major control measures involve vaccination which requires continuous harmonization owing to antigenic drift. The present study focused on assessing the protective efficacy of an inactivated recombinant equine influenza virus (rgEIV) vaccine candidate adjuvanted with Montanide<sup>TM</sup> Pet Gel in murine model. The rgEIV was generated using reverse genetics by incorporating HA and NA segments from EIV/H3N8, clade 2 - Florida sublineage in an A/WSN/33 /H1N1 backbone and inactivated by formalin. The vaccine was prepared by mixing inactivated rgEIV with Montanide<sup>TM</sup> Pet Gel adjuvant followed by intranasal inoculation into BALB/c mice intranasally. The immune responses and protective efficacy of the vaccine was evaluated by measurement of antibody titer, immunoglobulin subtyping, cytokines, clinical signs and pathological lesions after immunization and challenge with wild EIV. Serology and cytokine expression pattern indicated that the vaccine activated mixed Th1- and Th2-like responses of vaccine. Booster immunization stimulated strong antibody responses (HAI titre: 192 ± 28.6) at 42 days post immunization and the predominant antibody subtype was IgG1. Upregulation of IFN-gamma, IL-12 and IL-2 levels indicates effective induction of Th1 type response. We found that vaccination has protected mice against equine influenza virus challenge as adjudged through a lack of nonappearance of visible clinical signs of disease, no loss of body weight loss, reduced pathology in the lungs and markedly reduced virus shedding from the respiratory tract. Therefore, we conclude that recombinant EIV vaccine candidate adjuvanted with Montanide<sup>TM</sup> Pet Gel could aid in quick harmonization of the vaccines through replacement of HA and NA genes for control of EIV outbreaks.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mathew</LastName>
                    <ForeName>Manu Kurian</ForeName>
                    <Initials>MK</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Virmani</LastName>
                    <ForeName>Nitin</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bera</LastName>
                    <ForeName>Bidhan Chandra</ForeName>
                    <Initials>BC</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Anand</LastName>
                    <ForeName>Taruna</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumar</LastName>
                    <ForeName>Ramesh</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lala Lajpat Rai University of Veterinary &amp; Animal Sciences.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Balena</LastName>
                    <ForeName>Venkataramireddy</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sansanwal</LastName>
                    <ForeName>Rekha</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pavulraj</LastName>
                    <ForeName>Selvaraj</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sundaram</LastName>
                    <ForeName>Karthik</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Virmani</LastName>
                    <ForeName>Meenakshi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lala Lajpat Rai University of Veterinary &amp; Animal Sciences.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tripathi</LastName>
                    <ForeName>Bhupendra Nath</ForeName>
                    <Initials>BN</Initials>
                    <AffiliationInfo>
                        <Affiliation>ICAR-National Research Centre on Equines.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>J Vet Med Sci</MedlineTA>
            <NlmUniqueID>9105360</NlmUniqueID>
            <ISSNLinking>0916-7250</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">MontanideTM Pet Gel</Keyword>
            <Keyword MajorTopicYN="N">adjuvant</Keyword>
            <Keyword MajorTopicYN="N">equine influenza</Keyword>
            <Keyword MajorTopicYN="N">reverse genetics</Keyword>
            <Keyword MajorTopicYN="N">vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31656240</ArticleId>
            <ArticleId IdType="doi">10.1292/jvms.19-0399</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31654637</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1525-2191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The American journal of pathology</Title>
                <ISOAbbreviation>Am. J. Pathol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A guide for the use of the ferret model for influenza virus infection.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0002-9440(19)30769-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajpath.2019.09.017</ELocationID>
            <Abstract>
                <AbstractText>As influenza viruses continue to jump species barriers to cause human infection, assessments of disease severity and viral replication kinetics in vivo provide crucial information for public health professionals. The ferret model is a valuable resource for evaluating influenza virus pathogenicity; thus, understanding the most effective sample collection and usage techniques, as well as the full spectrum of attainable data following experimental inoculation in this species, is paramount. This is especially true for scheduled necropsy of virus-infected ferrets, a standard component in evaluation of influenza virus pathogenicity, as necropsy findings can provide important information regarding disease severity and pathogenicity that is not otherwise available from the live animal. In this review, we describe the range of influenza viruses assessed in ferrets, the measures of experimental disease severity in this model, and optimal sample collection during necropsy of virus-infected ferrets. Collectively, this information is critical for assessing systemic involvement following influenza virus infection in mammals.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Belser</LastName>
                    <ForeName>Jessica A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases,. Electronic address: jax6@cdc.gov.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eckert</LastName>
                    <ForeName>Alissa M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Communication Services, Office of the Associate Director for Communication.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huynh</LastName>
                    <ForeName>Thanhthao</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia 30333.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gary</LastName>
                    <ForeName>Joy M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia 30333.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ritter</LastName>
                    <ForeName>Jana M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia 30333.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tumpey</LastName>
                    <ForeName>Terrence M</ForeName>
                    <Initials>TM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maines</LastName>
                    <ForeName>Taronna R</ForeName>
                    <Initials>TR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Pathol</MedlineTA>
            <NlmUniqueID>0370502</NlmUniqueID>
            <ISSNLinking>0002-9440</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31654637</ArticleId>
            <ArticleId IdType="pii">S0002-9440(19)30769-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ajpath.2019.09.017</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31653528</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(19)31405-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2019.10.032</ELocationID>
            <Abstract>
                <AbstractText>2018/19 was the first season of introduction in England of a newly licensed adjuvanted influenza vaccine (aTIV) for adults 65 years or older, who were previously offered standard-dose, non-adjuvanted vaccine, achieving uptake levels &gt;70%, often with poor effectiveness. This paper presents the end-of-season adjusted vaccine effectiveness (aVE) against laboratory confirmed influenza hospitalisation in this population. A frequency-matched test negative case control approach was used to estimate aVE by influenza A subtype and vaccine type. Cases were influenza confirmed hospitalisations and controls influenza negative hospitalisations who were 65 years or more. Cases and controls were selected from a sentinel laboratory surveillance system which collates details of inpatients and outpatients routinely tested on clinical advice for influenza infection with reverse-transcription polymerase chain reaction (RT-PCR) on respiratory samples. Vaccine and clinical history was obtained from the general practitioners of study participants. A total of 428 cases and 1013 controls were included in the analysis. End-of-season any-influenza aVE against hospitalisation was 53.4% (95% CI: 39.9, 63.9). By influenza A subtype, aVE was 64.8% (95% CI: 49.6, 75.3) against influenza A(H1N1)pdm09 and 39.3% (95% CI: 6.5, 60.6) against influenza A(H3N2). There was insufficient data to estimate influenza B VE. aVE estimates for all influenza, influenza A(H1N1)pdm09 and influenza A(H3N2) for aTIV were 53.8% (39.8, 64.5); 65.9% (50.6, 76.4) and 39.5% (4.8, 61.5) respectively. We provide evidence of significant influenza VE in the elderly, most notably against influenza A(H1N1)pdm09, but also against A(H3N2) for aTIV.</AbstractText>
                <CopyrightInformation>Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pebody</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, UK. Electronic address: richard.pebody@phe.gov.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Whitaker</LastName>
                    <ForeName>Heather</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Hongxin</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrews</LastName>
                    <ForeName>Nick</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ellis</LastName>
                    <ForeName>Joanna</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donati</LastName>
                    <ForeName>Matthew</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, Bristol, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zambon</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adjuvanted vaccine</Keyword>
            <Keyword MajorTopicYN="N">Effectiveness</Keyword>
            <Keyword MajorTopicYN="N">Elderly</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31653528</ArticleId>
            <ArticleId IdType="pii">S0264-410X(19)31405-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2019.10.032</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31651763</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1538-8662</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>44</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Nurse practitioner</Title>
                <ISOAbbreviation>Nurse Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Increasing influenza vaccination acceptance in the homeless: A quality improvement project.</ArticleTitle>
            <Pagination>
                <MedlinePgn>48-54</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/01.NPR.0000586012.31046.c9</ELocationID>
            <Abstract>
                <AbstractText>The US homeless population is predisposed to serious complications of influenza with increased likelihood of hospitalization and death. This quality improvement project sought to increase influenza vaccination in the homeless population of a rural area in the Midwest and improve provider knowledge of risks and preventive care responsibilities.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Beers</LastName>
                    <ForeName>Lorraine</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lorraine Beers is a volunteer FNP at Traverse Health Clinic, Traverse City, Mich. Marilyn Filter is an associate professor at the University of Michigan-Flint, Flint, Mich. Marilyn McFarland is a professor at the University of Michigan-Flint, Flint, Mich.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Filter</LastName>
                    <ForeName>Marilyn</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McFarland</LastName>
                    <ForeName>Marilyn</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Nurse Pract</MedlineTA>
            <NlmUniqueID>7603663</NlmUniqueID>
            <ISSNLinking>0361-1817</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31651763</ArticleId>
            <ArticleId IdType="doi">10.1097/01.NPR.0000586012.31046.c9</ArticleId>
            <ArticleId IdType="pii">00006205-201911000-00011</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31651074</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1750-2659</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Influenza and other respiratory viruses</Title>
                <ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The financial burden of an influenza outbreak in a small rehabilitation centre.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12696</ELocationID>
            <Abstract>
                <AbstractText>We report an influenza outbreak in a 75-bed rehabilitation centre and present the detailed microeconomic impact that it had during the season 2016/2017. The direct medical, direct non-medical and indirect costs were calculated. The outbreak included 18 patients with influenza and 8 contact patients, leading to 86 days with isolation precautions. During the outbreak month, 25 (15%) employees were absent from work for 89 days (mean 3.6 days, SD ± 1.8), and during the entire influenza season 33 for 175 (5.3 ± SD 4.6) days, respectively. The economic burden related to the outbreak was 114 373 CHF (106 890 €, 112 131 $).</AbstractText>
                <CopyrightInformation>© 2019 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sendi</LastName>
                    <ForeName>Parham</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7347-6312</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute for Infectious Diseases, University of Bern, Bern, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dräger</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Batzer</LastName>
                    <ForeName>Bettina</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walser</LastName>
                    <ForeName>Susanne</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Bürgerspital Basel, Reha Chrischona, Bettingen, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dangel</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Widmer</LastName>
                    <ForeName>Andreas F</ForeName>
                    <Initials>AF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Influenza Other Respir Viruses</MedlineTA>
            <NlmUniqueID>101304007</NlmUniqueID>
            <ISSNLinking>1750-2640</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cost-of-illness</Keyword>
            <Keyword MajorTopicYN="N">disease burden</Keyword>
            <Keyword MajorTopicYN="N">economic burden</Keyword>
            <Keyword MajorTopicYN="N">influenza</Keyword>
            <Keyword MajorTopicYN="N">influenza outbreak</Keyword>
            <Keyword MajorTopicYN="N">productivity</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31651074</ArticleId>
            <ArticleId IdType="doi">10.1111/irv.12696</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31650680</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1865-1682</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Transboundary and emerging diseases</Title>
                <ISOAbbreviation>Transbound Emerg Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization of H7N9 avian influenza viruses isolated from duck meat products.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/tbed.13398</ELocationID>
            <Abstract>
                <AbstractText>Avian influenza H7N9 viruses have caused five epidemic waves of human infections since the first human cases were reported in 2013. In 2016, the initial low pathogenic avian influenza (LPAI) H7N9 viruses became highly pathogenic, acquiring multi-basic amino acids at the haemagglutinin cleavage site. These highly pathogenic avian influenza (HPAI) H7N9 viruses have been detected in poultry and humans in China, causing concerns of a serious threat to global public health. In Japan, both HPAI and LPAI H7N9 viruses were isolated from duck meat products carried illegally and relinquished voluntarily at the border by passengers on flights from China to Japan between 2016 and 2017. Some of the LPAI and HPAI H7N9 viruses detected at the border in Japan were characterized previously in chickens and ducks; however, their pathogenicity and replicative ability in mammals remain unknown. In this study, we assessed the biological features of two HPAI H7N9 virus isolates [A/duck/Japan/AQ-HE29-22/2017 (HE29-22) and A/duck/Japan/AQ-HE29-52/2017 (HE29-52); both of these viruses were isolated from duck meat at the border)] and an LPAI H7N9 virus isolate [A/duck/Japan/AQ-HE28-3/2016 (HE28-3)] in mice and ferrets. In mice, HE29-52 was more pathogenic than HE29-22 and HE28-3. In ferrets, the two HPAI virus isolates replicated more efficiently in the lower respiratory tract of the animals than did the LPAI virus isolate. Our results indicate that HPAI H7N9 viruses with the potential to cause severe diseases in mammals have been illegally introduced to Japan.</AbstractText>
                <CopyrightInformation>© 2019 Blackwell Verlag GmbH.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mitake</LastName>
                    <ForeName>Hiromichi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kiso</LastName>
                    <ForeName>Maki</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ito</LastName>
                    <ForeName>Mutsumi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iwatsuki-Hirimoto</LastName>
                    <ForeName>Kiyoko</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamayoshi</LastName>
                    <ForeName>Seiya</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7768-5157</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lopes</LastName>
                    <ForeName>Tiago J S</ForeName>
                    <Initials>TJS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>Huapeng</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sumiyoshi</LastName>
                    <ForeName>Riho</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic Disease Inspection Division, Laboratory Department, Animal Quarantine Service, Ministry of Agriculture, Forestry and Fisheries, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shibata</LastName>
                    <ForeName>Akihiro</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic Disease Inspection Division, Laboratory Department, Animal Quarantine Service, Ministry of Agriculture, Forestry and Fisheries, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Osaka</LastName>
                    <ForeName>Hiroyuki</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Exotic Disease Inspection Division, Laboratory Department, Animal Quarantine Service, Ministry of Agriculture, Forestry and Fisheries, Aichi, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Imai</LastName>
                    <ForeName>Masaki</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Watanabe</LastName>
                    <ForeName>Tokiko</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-6461-5379</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kawaoka</LastName>
                    <ForeName>Yoshihiro</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Department of Microbiology and Immunoslogy, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>16H06429</GrantID>
                    <Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>16H06434</GrantID>
                    <Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>16K21723</GrantID>
                    <Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>JP18am001007</GrantID>
                    <Agency>Japan Agency for Medical Research and Development</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>JP19fk0108031</GrantID>
                    <Agency>Japan Agency for Medical Research and Development</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>JP19fk0108056</GrantID>
                    <Agency>Japan Agency for Medical Research and Development</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>JP19fm0108006</GrantID>
                    <Agency>Japan Agency for Medical Research and Development</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Transbound Emerg Dis</MedlineTA>
            <NlmUniqueID>101319538</NlmUniqueID>
            <ISSNLinking>1865-1674</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">H7N9</Keyword>
            <Keyword MajorTopicYN="N">highly pathogenic avian influenza</Keyword>
            <Keyword MajorTopicYN="N">pathogenicity in mammals</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31650680</ArticleId>
            <ArticleId IdType="doi">10.1111/tbed.13398</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31649200</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1095-9203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>366</Volume>
                    <Issue>6464</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>10</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Science (New York, N.Y.)</Title>
                <ISOAbbreviation>Science</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Broadly protective human antibodies that target the active site of influenza virus neuraminidase.</ArticleTitle>
            <Pagination>
                <MedlinePgn>499-504</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1126/science.aay0678</ELocationID>
            <Abstract>
                <AbstractText>Better vaccines against influenza virus are urgently needed to provide broader protection against diverse strains, subtypes, and types. Such efforts are assisted by the identification of novel broadly neutralizing epitopes targeted by protective antibodies. Influenza vaccine development has largely focused on the hemagglutinin, but the other major surface antigen, the neuraminidase, has reemerged as a potential target for universal vaccines. We describe three human monoclonal antibodies isolated from an H3N2-infected donor that bind with exceptional breadth to multiple different influenza A and B virus neuraminidases. These antibodies neutralize the virus, mediate effector functions, are broadly protective in vivo, and inhibit neuraminidase activity by directly binding to the active site. Structural and functional characterization of these antibodies will inform the development of neuraminidase-based universal vaccines against influenza virus.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Stadlbauer</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">0000-0001-6792-7650</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, University of Natural Resources and Life Sciences, A-1190 Vienna, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Xueyong</ForeName>
                    <Initials>X</Initials>
                    <Identifier Source="ORCID">0000-0002-6021-3740</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McMahon</LastName>
                    <ForeName>Meagan</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">0000-0002-7450-6624</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Turner</LastName>
                    <ForeName>Jackson S</ForeName>
                    <Initials>JS</Initials>
                    <Identifier Source="ORCID">0000-0002-4396-6265</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wohlbold</LastName>
                    <ForeName>Teddy J</ForeName>
                    <Initials>TJ</Initials>
                    <Identifier Source="ORCID">0000-0003-0982-6004</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Columbia Irving Medical Center, New York, NY 10032, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY 10032, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmitz</LastName>
                    <ForeName>Aaron J</ForeName>
                    <Initials>AJ</Initials>
                    <Identifier Source="ORCID">0000-0002-8077-6751</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Strohmeier</LastName>
                    <ForeName>Shirin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Wenli</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nachbagauer</LastName>
                    <ForeName>Raffael</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">0000-0001-5568-5420</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mudd</LastName>
                    <ForeName>Philip A</ForeName>
                    <Initials>PA</Initials>
                    <Identifier Source="ORCID">0000-0002-3860-5473</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Emergency Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wilson</LastName>
                    <ForeName>Ian A</ForeName>
                    <Initials>IA</Initials>
                    <Identifier Source="ORCID">0000-0002-6469-2419</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. wilson@scripps.edu ellebedy@wustl.edu florian.krammer@mssm.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ellebedy</LastName>
                    <ForeName>Ali H</ForeName>
                    <Initials>AH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. wilson@scripps.edu ellebedy@wustl.edu florian.krammer@mssm.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krammer</LastName>
                    <ForeName>Florian</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">0000-0003-4121-776X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. wilson@scripps.edu ellebedy@wustl.edu florian.krammer@mssm.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>Y01 GM1104-11</GrantID>
                    <Acronym>GM</Acronym>
                    <Agency>NIGMS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AI117287</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P41 GM103393</GrantID>
                    <Acronym>GM</Acronym>
                    <Agency>NIGMS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>Y01 CO1020-11</GrantID>
                    <Acronym>CO</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R56 AI117675</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R21 AI139813</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 TR002345</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 AI141990</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Science</MedlineTA>
            <NlmUniqueID>0404511</NlmUniqueID>
            <ISSNLinking>0036-8075</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31649200</ArticleId>
            <ArticleId IdType="pii">366/6464/499</ArticleId>
            <ArticleId IdType="doi">10.1126/science.aay0678</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31648914</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(19)31408-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2019.10.035</ELocationID>
            <Abstract>
                <AbstractText>2013/14 saw the start of the introduction of a new live attenuated influenza vaccine (LAIV) programme for children in England. 2018/19 saw co-circulation of both A(H1N1)pdm09 and A(H3N2), when LAIV was offered to all healthy children 2-9 years of age. LAIV effectiveness against influenza hospitalisation is not well described. This paper presents the 2018/19 end-of-season adjusted vaccine effectiveness (aVE) against laboratory confirmed influenza related hospitalisation in children aged 2-17. The test negative case control approach was used to estimate aVE by influenza A subtype and vaccine type. Cases and controls were selected from a sentinel laboratory surveillance system which collates details of individuals tested for influenza with reverse-transcription polymerase chain reaction (RT-PCR) on respiratory samples. Vaccine and clinical history was obtained from general practitioners of study participants. There were 307 hospitalised cases and 679 hospitalised controls. End-of-season influenza aVE was 53.0% (95% CI: 33.3, 66.8) against influenza confirmed hospitalisation; 63.5% (95% CI: 34.4, 79.7) against influenza A(H1N1)pdm09 hospitalisation and 31.1% (95% CI: -53.9, 69.2) against influenza A(H3N2). LAIV aVE was 49.1% (95% CI: 25.9, 65.0) for any influenza and 70.7% (95% CI: 41.8, 85.3) for A(H1N1)pdm09, whereas for those receiving quadrivalent inactivated influenza vaccine (QIV), aVE was 64.4% (95% CI: 29.4, 82.0) and 44.4% (95% CI: -51.9, 79.6) respectively. We provide evidence of overall significant VE for both LAIV and QIV against influenza associated hospitalisation in children 2-17 years of age, most notably against influenza A(H1N1)pdm09, with non-significant protection against A(H3N2).</AbstractText>
                <CopyrightInformation>Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pebody</LastName>
                    <ForeName>R G</ForeName>
                    <Initials>RG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England National Infection Service, Colindale, London, UK. Electronic address: Richard.Pebody@phe.gov.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England National Infection Service, Colindale, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Whitaker</LastName>
                    <ForeName>H J</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England National Infection Service, Colindale, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ellis</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England National Infection Service, Colindale, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donati</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England National Infection Service, Bristol, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zambon</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England National Infection Service, Colindale, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrews</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health England National Infection Service, Colindale, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Children</Keyword>
            <Keyword MajorTopicYN="N">Hospitalisation</Keyword>
            <Keyword MajorTopicYN="N">Influenza vaccine effectiveness</Keyword>
            <Keyword MajorTopicYN="N">LAIV</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31648914</ArticleId>
            <ArticleId IdType="pii">S0264-410X(19)31408-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2019.10.035</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31647875</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-4804</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medicinal chemistry</Title>
                <ISOAbbreviation>J. Med. Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jmedchem.9b01091</ELocationID>
            <Abstract>
                <AbstractText>In the search for novel influenza inhibitors we evaluated 7-fluoro-substituted indoles as bioisosteric replacements for the 7-azaindole scaffold of Pimodivir, a PB2 (polymerase basic protein 2) inhibitor currently in clinical development. Specifically, a 5,7-difluoroindole derivative <b>11a</b> was identified as a potent and metabolically stable influenza inhibitor. <b>11a</b> demonstrated a favorable oral pharmacokinetic profile and in vivo efficacy in mice. In addition, it was found that <b>11a</b> was not at risk of metabolism via aldehyde oxidase, an advantage over previously described inhibitors of this class. The crystal structure of <b>11a</b> bound to influenza A PB2 cap region is disclosed here and deposited to the PDB.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>McGowan</LastName>
                    <ForeName>David C</ForeName>
                    <Initials>DC</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3759-6771</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Balemans</LastName>
                    <ForeName>Wendy</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Embrechts</LastName>
                    <ForeName>Werner</ForeName>
                    <Initials>W</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2880-2534</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Motte</LastName>
                    <ForeName>Magali</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen-Cilag , Campus de Maigremont BP615 , F-27106 Val de Reuil , Cedex , France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keown</LastName>
                    <ForeName>Jeremy R</ForeName>
                    <Initials>JR</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0159-9257</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Structural Biology, Henry Wellcome Building for Genomic Medicine , University of Oxford , Oxford OX3 7BN , United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buyck</LastName>
                    <ForeName>Christophe</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Corbera</LastName>
                    <ForeName>Jordi</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eurofins Villapharma Research, S.L., Avda. Isaac Peral , Parque Tecnológico de Fuente Álamo , Ctra. El Estrecho-Lobosillo , 30320 Murcia , Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Funes</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eurofins Villapharma Research, S.L., Avda. Isaac Peral , Parque Tecnológico de Fuente Álamo , Ctra. El Estrecho-Lobosillo , 30320 Murcia , Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moreno</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eurofins Villapharma Research, S.L., Avda. Isaac Peral , Parque Tecnológico de Fuente Álamo , Ctra. El Estrecho-Lobosillo , 30320 Murcia , Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cooymans</LastName>
                    <ForeName>Ludwig</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tahri</LastName>
                    <ForeName>Abdellah</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eymard</LastName>
                    <ForeName>Julien</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Novalix (site Janssen-Cilag) , Campus de Maigremont BP615 , F-27106 Val de Reuil , Cedex , France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stoops</LastName>
                    <ForeName>Bart</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Strijbos</LastName>
                    <ForeName>Rudy</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Charles River Laboratories Beerse , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van den Berg</LastName>
                    <ForeName>Joke</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fodor</LastName>
                    <ForeName>Ervin</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sir William Dunn School of Pathology , University of Oxford , South Parks Road , Oxford OX1 3RE , United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grimes</LastName>
                    <ForeName>Jonathan M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Structural Biology, Henry Wellcome Building for Genomic Medicine , University of Oxford , Oxford OX3 7BN , United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Diamond Light Source , Harwell Science and Innovation Campus , Didcot OX11 0DE , United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koul</LastName>
                    <ForeName>Anil</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jonckers</LastName>
                    <ForeName>Tim H M</ForeName>
                    <Initials>THM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raboisson</LastName>
                    <ForeName>Pierre</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Pharmaceutica, N.V. , Turnhoutseweg 30 , 2340 Beerse , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guillemont</LastName>
                    <ForeName>Jérôme</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen-Cilag , Campus de Maigremont BP615 , F-27106 Val de Reuil , Cedex , France.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Med Chem</MedlineTA>
            <NlmUniqueID>9716531</NlmUniqueID>
            <ISSNLinking>0022-2623</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31647875</ArticleId>
            <ArticleId IdType="doi">10.1021/acs.jmedchem.9b01091</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31647348</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2164-554X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human vaccines &amp; immunotherapeutics</Title>
                <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2019.1682843</ELocationID>
            <Abstract>
                <AbstractText>Children have a high burden of influenza and play a central role in spreading influenza. Routinely vaccinating children against influenza may, thus, not only reduce their disease burden, but also that of the general population, including the elderly who frequently suffer severe complications. Using the published individual-based tool 4Flu, we simulated how pediatric vaccination would change infection incidence in Germany. Transmission of four influenza strains was simulated in 100,000 individuals with German demography and contact structure. After initialization with the recorded trivalent influenza vaccination coverage for 20 years (1997-2016), all vaccinations were switched to quadrivalent influenza vaccine (QIV). Scenarios where vaccination coverage of children (0.5-17-year-old) was increased from the current value (4.3%) to a maximum of 10-60% were compared to baseline with unchanged coverage, averaging results of 1,000 pairs of simulations over a 20-year evaluation period (2017-2036). Pediatric vaccination coverage of 10-60% annually prevented 218-1,732 (6.3-50.5%) infections in children, 204-1,961 (2.9-28.2%) in young adults and 95-868 (3.1-28.9%) in the elderly in a population of 100,000 inhabitants; overall, 34.1% of infections in the total population (3.7 million infections per year in Germany) can be prevented if 60% of all children are vaccinated annually. 4.4-4.6 vaccinations were needed to prevent one infection among children; 1.7-1.8 were needed to prevent one in the population. Enhanced pediatric vaccination prevents many infections in children and even more in young adults and the elderly.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Schmidt-Ott</LastName>
                    <ForeName>Ruprecht</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>GSK , Wavre , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Molnar</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>GSK , Wavre , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Anastassopoulou</LastName>
                    <ForeName>Anastassia</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>GSK , Munich , Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yanni</LastName>
                    <ForeName>Emad</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>GSK , Rockville , MD , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krumm</LastName>
                    <ForeName>Claudia</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>GSK , Munich , Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bekkat-Berkani</LastName>
                    <ForeName>Rafik</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>GSK , Philadelphia , PA , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dos Santos</LastName>
                    <ForeName>Gaël</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8623-3478</Identifier>
                    <AffiliationInfo>
                        <Affiliation>GSK , Wavre , Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Henneke</LastName>
                    <ForeName>Philipp</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Chronic Immunodeficiency and Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg , Freiburg , Germany .</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Knuf</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Helios Dr Horst Schmidt Kliniken Wiesbaden , Wiesbaden , Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schwehm</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>ExploSYS GmbH , Leinfelden-Echterdingen , Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eichner</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epimos GmbH , Dusslingen , Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Tübingen , Tübingen , Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Vaccin Immunother</MedlineTA>
            <NlmUniqueID>101572652</NlmUniqueID>
            <ISSNLinking>2164-5515</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Mathematical model</Keyword>
            <Keyword MajorTopicYN="N">Pediatric</Keyword>
            <Keyword MajorTopicYN="N">Simulation</Keyword>
            <Keyword MajorTopicYN="N">Vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31647348</ArticleId>
            <ArticleId IdType="doi">10.1080/21645515.2019.1682843</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31645453</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1946-6242</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>515</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Science translational medicine</Title>
                <ISOAbbreviation>Sci Transl Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">eaax5866</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.aax5866</ELocationID>
            <Abstract>
                <AbstractText>Influenza viruses constitute a major health threat and economic burden globally, frequently exacerbated by preexisting or rapidly emerging resistance to antiviral therapeutics. To address the unmet need of improved influenza therapy, we have created EIDD-2801, an isopropylester prodrug of the ribonucleoside analog <i>N</i><sup>4</sup>-hydroxycytidine (NHC, EIDD-1931) that has shown broad anti-influenza virus activity in cultured cells and mice. Pharmacokinetic profiling demonstrated that EIDD-2801 was orally bioavailable in ferrets and nonhuman primates. Therapeutic oral dosing of influenza virus-infected ferrets reduced group pandemic 1 and group 2 seasonal influenza A shed virus load by multiple orders of magnitude and alleviated fever, airway epithelium histopathology, and inflammation, whereas postexposure prophylactic dosing was sterilizing. Deep sequencing highlighted lethal viral mutagenesis as the underlying mechanism of activity and revealed a prohibitive barrier to the development of viral resistance. Inhibitory concentrations were low nanomolar against influenza A and B viruses in disease-relevant well-differentiated human air-liquid interface airway epithelia. Correlating antiviral efficacy and cytotoxicity thresholds with pharmacokinetic profiles in human airway epithelium models revealed a therapeutic window &gt;1713 and established dosing parameters required for efficacious human therapy. These data recommend EIDD-2801 as a clinical candidate with high potential for monotherapy of seasonal and pandemic influenza virus infections. Our results inform EIDD-2801 clinical trial design and drug exposure targets.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Toots</LastName>
                    <ForeName>Mart</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5049-3400</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoon</LastName>
                    <ForeName>Jeong-Joong</ForeName>
                    <Initials>JJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9379-0416</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cox</LastName>
                    <ForeName>Robert M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hart</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9557-0783</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sticher</LastName>
                    <ForeName>Zachary M</ForeName>
                    <Initials>ZM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7022-1410</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Makhsous</LastName>
                    <ForeName>Negar</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Division, Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plesker</LastName>
                    <ForeName>Roland</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7597-780X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Veterinary Medicine Division, Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barrena</LastName>
                    <ForeName>Alec H</ForeName>
                    <Initials>AH</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0672-6756</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reddy</LastName>
                    <ForeName>Prabhakar G</ForeName>
                    <Initials>PG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mitchell</LastName>
                    <ForeName>Deborah G</ForeName>
                    <Initials>DG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shean</LastName>
                    <ForeName>Ryan C</ForeName>
                    <Initials>RC</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7855-4976</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Virology Division, Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bluemling</LastName>
                    <ForeName>Gregory R</ForeName>
                    <Initials>GR</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9138-7578</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kolykhalov</LastName>
                    <ForeName>Alexander A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greninger</LastName>
                    <ForeName>Alexander L</ForeName>
                    <Initials>AL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7443-0527</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Virology Division, Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Natchus</LastName>
                    <ForeName>Michael G</ForeName>
                    <Initials>MG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Painter</LastName>
                    <ForeName>George R</ForeName>
                    <Initials>GR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Emory University, Atlanta, GA 30322, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plemper</LastName>
                    <ForeName>Richard K</ForeName>
                    <Initials>RK</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2034-2107</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA. rplemper@gsu.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 AI141222</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Sci Transl Med</MedlineTA>
            <NlmUniqueID>101505086</NlmUniqueID>
            <ISSNLinking>1946-6234</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31645453</ArticleId>
            <ArticleId IdType="pii">11/515/eaax5866</ArticleId>
            <ArticleId IdType="doi">10.1126/scitranslmed.aax5866</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31645133</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1029-046X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>30</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>SAR and QSAR in environmental research</Title>
                <ISOAbbreviation>SAR QSAR Environ Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Peramivir binding affinity with influenza A neuraminidase and research on its mutations using an induced-fit docking approach.</ArticleTitle>
            <Pagination>
                <MedlinePgn>899-917</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/1062936X.2019.1679248</ELocationID>
            <Abstract>
                <AbstractText>Influenza A virus (IAV) has caused epidemic infections worldwide, with many strains resistant to inhibitors of a surface protein, neuraminidase (NA), due to point mutations on its structure. A novel NA inhibitor named peramivir was recently approved, but no exhaustive computational research regarding its binding affinity with wild-type and mutant NA has been conducted. In this study, a thorough investigation of IAV-NA PDB entries of 9 subtypes is described, providing a list of residues constituting the protein-ligand binding sites. The results of induced-fit docking approach point out key residues of wild-type NA participating in hydrogen bonds and/or ionic interactions with peramivir, among which Arg 368 is responsible for a peramivir-NA ionic interaction. Mutations on this residue greatly reduced the binding affinity of peramivir with NA, with 3 mutations R378Q, R378K and R378L (NA6) capable of deteriorating the docking performance of peramivir by over 50%. 200 compounds from 6-scaffolds were docked into these 3 mutant versions, revealing 18 compounds giving the most promising results. Among them, CMC-2012-7-1527-56 (benzoic acid scaffold, IC50 = 32 nM in inhibitory assays with IAV) is deemed the most potential inhibitor of mutant NA resisting both peramivir and zanamivir, and should be further investigated.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tran-Nguyen</LastName>
                    <ForeName>V K</ForeName>
                    <Initials>VK</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7497-333X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Le</LastName>
                    <ForeName>M T</ForeName>
                    <Initials>MT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tran</LastName>
                    <ForeName>T D</ForeName>
                    <Initials>TD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Truong</LastName>
                    <ForeName>V D</ForeName>
                    <Initials>VD</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0018-8336</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thai</LastName>
                    <ForeName>K M</ForeName>
                    <Initials>KM</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-5279-9614</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>SAR QSAR Environ Res</MedlineTA>
            <NlmUniqueID>9440156</NlmUniqueID>
            <ISSNLinking>1026-776X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Influenza A virus</Keyword>
            <Keyword MajorTopicYN="N">binding affinity</Keyword>
            <Keyword MajorTopicYN="N">in silico mutation</Keyword>
            <Keyword MajorTopicYN="N">induced-fit docking</Keyword>
            <Keyword MajorTopicYN="N">inhibitor</Keyword>
            <Keyword MajorTopicYN="N">neuraminidase</Keyword>
            <Keyword MajorTopicYN="N">peramivir</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31645133</ArticleId>
            <ArticleId IdType="doi">10.1080/1062936X.2019.1679248</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31641151</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) animal.</ArticleTitle>
            <Pagination>
                <MedlinePgn>15128</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-51356-w</ELocationID>
            <Abstract>
                <AbstractText>Enterotoxin-based adjuvants including cholera toxin and heat-labile toxin (LT) are powerful manipulators of mucosal immunity; however, past clinical trials identified unacceptable neurological toxicity when LT or mutant AB<sub>5</sub> adjuvant proteins were added to intranasal vaccines. Here, we examined the isolated enzymatic A1 domain of LT (LTA1) for intranasal safety and efficacy in combination with influenza (flu) vaccination. LTA1-treated mice exhibited no neurotoxicity, as measured by olfactory system testing and H&amp;E staining of nasal tissue in contrast with cholera toxin. In vaccination studies, intranasal LTA1 enhanced immune responses to inactivated virus antigen and subsequent protection against H1N1 flu challenge in mice (8-week or 24-months). In addition, lung H1N1 viral titers post-challenge correlated to serum antibody responses; however, enhanced protection was also observed in μMT mice lacking B-cells while activation and recruitment of CD4 T-cells into the lung was apparent. Thus, we report that LTA1 protein is a novel, safe and effective enterotoxin adjuvant that improves protection of an intranasal flu vaccination by a mechanism that does not appear to require B-cells.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Valli</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology &amp; Immunology, Tulane University School of Medicine, New Orleans, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Harriett</LastName>
                    <ForeName>A J</ForeName>
                    <Initials>AJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7858-1592</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology &amp; Immunology, Tulane University School of Medicine, New Orleans, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nowakowska</LastName>
                    <ForeName>M K</ForeName>
                    <Initials>MK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology &amp; Immunology, Tulane University School of Medicine, New Orleans, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baudier</LastName>
                    <ForeName>R L</ForeName>
                    <Initials>RL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology &amp; Immunology, Tulane University School of Medicine, New Orleans, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Provosty</LastName>
                    <ForeName>W B</ForeName>
                    <Initials>WB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology &amp; Immunology, Tulane University School of Medicine, New Orleans, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McSween</LastName>
                    <ForeName>Z</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology &amp; Immunology, Tulane University School of Medicine, New Orleans, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lawson</LastName>
                    <ForeName>L B</ForeName>
                    <Initials>LB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology &amp; Immunology, Tulane University School of Medicine, New Orleans, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakanishi</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology &amp; Laboratory Medicine, Tulane University School of Medicine, New Orleans, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Norton</LastName>
                    <ForeName>E B</ForeName>
                    <Initials>EB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology &amp; Immunology, Tulane University School of Medicine, New Orleans, USA. enorton@tulane.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>01</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31641151</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-019-51356-w</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-019-51356-w</ArticleId>
            <ArticleId IdType="pmc">PMC6805908</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Microbiol Rev. 2001 Apr;14(2):430-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11292646</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2011 May 15;186(10):5896-906</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21490151</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Exp Toxicol Pathol. 2004 Jul;55(6):413-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15384248</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2006 May 12;55(18):511-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16691182</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2009 Sep 16;4(9):e6999</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19756141</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Immunol. 2015 Aug;35:48-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26091979</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Top Microbiol Immunol. 2014;385:119-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25085014</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pediatr Res. 2018 Jan;83(1-1):31-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28945700</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunol Cell Biol. 1998 Jun;76(3):280-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9682972</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2010 Mar;84(6):2983-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20053748</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Immun. 2001 Mar;69(3):1528-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11179323</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2015 Apr 15;194(8):3829-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25786687</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Rev Vaccines. 2004 Feb;3(1):35-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14761242</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Pharm Sci. 2009 Mar;98(3):812-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18661544</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Respir Res. 2018 Jan 05;19(1):3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29304863</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Annu Rev Immunol. 2015;33:747-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25706098</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Infect Dis. 2016 Dec;16(12):1377-1384</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27638357</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2009 Apr 21;27(18):2418-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19368783</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Rev Vaccines. 2003 Apr;2(2):295-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12899579</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>mSphere. 2018 Jul 25;3(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30045966</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Immun. 2005 Oct;73(10):6892-902</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16177369</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(12):e51718</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23284753</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Deliv Transl Res. 2013 Feb;3(1):100-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23316448</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Immunol. 2016 Feb 25;7:41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26941738</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2004 Feb 26;350(9):896-903</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14985487</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 1981 Dec 25;256(24):12861-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6273411</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 1999 Apr 15;162(8):5011-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10202050</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 1988 Jun;6(3):269-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3048010</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2005 Feb 12-18;365(9459):618-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15708108</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 1991 Apr 4;350(6317):423-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1901381</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2009 Oct 15;183(8):5032-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19786541</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2011 Apr;18(4):546-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21288994</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20798667</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2009 Jul 15;200(2):172-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19508159</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 Sep 30;10(9):e0139368</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26422280</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mucosal Immunol. 2012 May;5(3):258-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22294047</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Pathol. 2013 Apr;182(4):1286-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23490254</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):787-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24277828</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Med. 1997 Dec 15;186(12):2063-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9396777</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 Aug 25;10(8):e0136302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26305793</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mucosal Immunol. 2008 Jan;1(1):59-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19079161</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Immun. 2012 Jul;80(7):2426-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22526674</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31640786</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0127</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>26</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biomedical science</Title>
                <ISOAbbreviation>J. Biomed. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Development of effective anti-influenza drugs: congeners and conjugates - a review.</ArticleTitle>
            <Pagination>
                <MedlinePgn>84</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-019-0567-0</ELocationID>
            <Abstract>
                <AbstractText>Influenza is a long-standing health problem. For treatment of seasonal flu and possible pandemic infections, there is a need to develop new anti-influenza drugs that have good bioavailability against a broad spectrum of influenza viruses, including the resistant strains. Relenza™ (zanamivir), Tamiflu™ (the phosphate salt of oseltamivir), Inavir™ (laninamivir octanoate) and Rapivab™ (peramivir) are four anti-influenza drugs targeting the viral neuraminidases (NAs). However, some problems of these drugs should be resolved, such as oral availability, drug resistance and the induced cytokine storm. Two possible strategies have been applied to tackle these problems by devising congeners and conjugates. In this review, congeners are the related compounds having comparable chemical structures and biological functions, whereas conjugate refers to a compound having two bioactive entities joined by a covalent bond. The rational design of NA inhibitors is based on the mechanism of the enzymatic hydrolysis of the sialic acid (Neu5Ac)-terminated glycoprotein. To improve binding affinity and lipophilicity of the existing NA inhibitors, several methods are utilized, including conversion of carboxylic acid to ester prodrug, conversion of guanidine to acylguanidine, substitution of carboxylic acid with bioisostere, and modification of glycerol side chain. Alternatively, conjugating NA inhibitors with other therapeutic entity provides a synergistic anti-influenza activity; for example, to kill the existing viruses and suppress the cytokines caused by cross-species infection.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shie</LastName>
                    <ForeName>Jiun-Jie</ForeName>
                    <Initials>JJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Chemistry, Academia Sinica, Taipei, 115, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>Jim-Min</ForeName>
                    <Initials>JM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6070-3408</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, National Taiwan University, Taipei, 106, Taiwan. jmfang@ntu.edu.tw.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The Genomics Research Center, Academia Sinica, Taipei, 115, Taiwan. jmfang@ntu.edu.tw.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Biomed Sci</MedlineTA>
            <NlmUniqueID>9421567</NlmUniqueID>
            <ISSNLinking>1021-7770</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Congener</Keyword>
            <Keyword MajorTopicYN="N">Conjugate</Keyword>
            <Keyword MajorTopicYN="N">Drug</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Inhibitor</Keyword>
            <Keyword MajorTopicYN="N">Neuraminidase</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31640786</ArticleId>
            <ArticleId IdType="doi">10.1186/s12929-019-0567-0</ArticleId>
            <ArticleId IdType="pii">10.1186/s12929-019-0567-0</ArticleId>
            <ArticleId IdType="pmc">PMC6806523</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Med Chem. 2018 Jun 25;154:314-323</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29843102</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochemistry. 1994 Jul 12;33(27):8172-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8031750</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2008 Jan 31;451(7178):591-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18235503</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Org Lett. 2016 Sep 2;18(17):4400-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27541804</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>ChemMedChem. 2009 Mar;4(3):335-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19156651</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Med. 2012 Sep 13;10:104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22973873</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2005 Feb 15;15(4):1087-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15686918</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>ChemMedChem. 2013 Mar;8(3):385-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23361977</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chem Rev. 2005 Jan;105(1):67-114</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15720152</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2005 Oct 20;48(21):6523-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16220969</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antivir Chem Chemother. 2010;21(2):71-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21107016</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drugs. 2001;61(2):263-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11270942</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Microbiol. 2016 Mar 31;7:450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27065996</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 1998 Mar 12;41(6):787-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9526555</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20385-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23185023</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2002 Dec;46(12):3809-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12435681</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2000 Jul;47(1):1-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10930642</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2005 Sep 29;353(13):1363-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16192481</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Org Biomol Chem. 2013 Nov 28;11(44):7687-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24108094</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Carbohydr Res. 1994 Jun 17;259(2):301-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8050102</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pediatr Pulmonol. 2003 Oct;36(4):290-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12950040</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2016 Jun 9;59(11):5297-310</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27167096</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 1994 Mar 4;37(5):616-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8126701</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Molecules. 2016 Nov 11;21(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27845731</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pharm Res. 2010 Feb;27(2):259-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20013036</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chem Rev. 2002 Feb;102(2):555-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11841254</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 1993 Jun 3;363(6428):418-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8502295</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Microbiol Infect. 2016 Dec;22(12):975-983</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27424943</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Structure. 1993 Sep 15;1(1):19-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8069621</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Pharmacol. 2010 Nov;50(11):1319-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20145259</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2010 Mar;54(3):1256-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20047917</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2012 Oct 11;55(19):8493-501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22963087</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Med Chem. 2018 Feb 10;145:224-234</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29324342</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2005 Apr 21;48(8):2964-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15828835</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochim Biophys Acta. 2008 Apr;1778(4):811-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18178146</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drugs. 2004;64(18):2031-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15341496</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Photodiagnosis Photodyn Ther. 2004 Dec;1(4):279-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25048432</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chem Rev. 1996 Dec 19;96(8):3147-3176</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11848856</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2009 Aug;83(16):8021-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19494001</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Pharm Sci. 2011 Mar;100(3):831-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20740680</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2002 May 23;45(11):2207-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12014958</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21973296</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Opin Ther Pat. 2013 Apr;23(4):409-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23369206</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>ChemMedChem. 2018 Apr 23;13(8):785-789</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29453852</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2006 Jan;12(1):15-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16494711</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochim Biophys Acta. 1960 Oct 21;44:185-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13782886</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2010 Jun 4;328(5983):1272-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20522774</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Pharmacokinet. 2002;41(1):19-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11825095</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Photochem Photobiol Sci. 2004 May;3(5):406-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15122356</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19465683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2012 Jul 26;55(14):6263-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22612288</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 1998 Mar 12;41(6):798-807</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9526556</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Pharm. 2010 Aug 2;7(4):1223-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20536260</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2009 Dec 3;361(23):2204-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19884645</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drugs. 2002;62(1):71-106</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11790157</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2004 Dec;48(12):4542-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15561823</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biotechnology (N Y). 1994 Jul;12(7):703-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7764916</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2009 Apr;15(4):552-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19331731</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Angew Chem Int Ed Engl. 2008;47(31):5788-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18613158</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2008 Oct;36(18):5855-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18790806</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2006 Sep 7;443(7107):45-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16915235</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Infect Dis. 2009 Sep;9(9):537-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19665930</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2013;9(10):e1003657</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24130481</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drugs. 1999 Oct;58(4):761-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10551442</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2015 Jul 7;12(1):1-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26119736</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Discov Today. 2013 May;18(9-10):495-501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23340113</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19067613</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2014 Sep 29;9(9):e108538</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25265186</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2000 Sep 21;43(19):3482-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11000002</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2012 Oct 25;55(20):8657-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23009169</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2011 Jan 1;203(1):13-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21148491</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Am Chem Soc. 2007 Jun 27;129(25):7764-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17539643</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Med Chem. 2019 Feb 1;163:710-721</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30576902</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2009 Aug 13;52(15):4903-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19522501</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2012 Jul 13;337(6091):199-204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22745253</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Photochem Photobiol Sci. 2004 May;3(5):436-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15122361</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 1998 Jul 2;41(14):2451-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9651151</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Influenza Other Respir Viruses. 2009 Jul;3(4):129-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19627370</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2002 Aug 5;12(15):1921-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12113809</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2006 Dec;5(12):1015-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17139286</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Am Chem Soc. 2007 Oct 3;129(39):11892-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17850083</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem. 2017 May 15;25(10):2772-2781</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28385598</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Pharmacokinet. 1999;36 Suppl 1:1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10429835</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 Aug 15;7(1):8239</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28811524</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2007 Jul 15;196(2):249-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17570112</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2007 Sep 1;17(17):4851-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17611105</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2008 Jan 31;451(7178):596-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18235504</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2011 Mar 15;52(6):707-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21367723</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12479-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17640882</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Am Chem Soc. 2011 Nov 9;133(44):17959-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21942552</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 1995 Oct 13;38(21):4179-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7473545</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Med Chem. 2016 Nov 10;123:397-406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27487569</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2007 Dec;6(12):967-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18049471</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2006 Nov;5(11):881-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17117518</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Pharmacokinet. 2010 Nov;49(11):741-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20923248</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2011 Dec;7(12):e1002431</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22174688</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Org Biomol Chem. 2013 Jun 28;11(24):3943-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23695381</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Microbiol. 2018 Feb 06;9:123</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29467737</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Protein Sci. 1995 Jun;4(6):1081-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7549872</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drugs. 2009;69(18):2523-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19943705</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Res. 2011 Dec;162(1-2):19-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21963677</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Antimicrob Chemother. 2019 Mar 1;74(3):654-662</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30476172</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Opin Investig Drugs. 2002 Jun;11(6):859-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12036429</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2004 Dec;10(12 Suppl):S82-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15577936</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2009 Jan;53(1):186-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18955520</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29711117</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2010 Nov 16;1:113</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21081911</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Microbiol. 2013 Oct;21(10):544-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23770275</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8091-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18523003</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2018 Sep 6;379(10):913-923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30184455</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Pharm. 2011 Dec 5;8(6):2358-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21905667</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Proteome Res. 2005 Jul-Aug;4(4):1397-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16083292</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2011 Apr 28;54(8):2529-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21413808</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Struct Mol Biol. 2010 May;17(5):530-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20383144</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Chem Inf Model. 2009 Oct;49(10):2323-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19780597</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Org Biomol Chem. 2017 Jun 27;15(25):5249-5253</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28540971</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem. 2011 Aug 15;19(16):4796-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21778065</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Med Chem. 1999 Jul-Aug;34(7-8):563-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11278042</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2011 Mar 15;411(2):229-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21237476</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2004 Mar 22;14(6):1589-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15006410</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2008 Jun 26;453(7199):1258-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18480754</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Theranostics. 2017 Feb 8;7(4):826-845</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28382157</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31638222</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1791-3004</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular medicine reports</Title>
                <ISOAbbreviation>Mol Med Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a.</ArticleTitle>
            <Pagination>
                <MedlinePgn>5041-5049</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/mmr.2019.10743</ELocationID>
            <Abstract>
                <AbstractText>Influenza virus A (IVA) is one of the predominant causative agents of the seasonal flu and has become an important cause of morbidity worldwide. Great efforts have been paid to develop vaccines against IVA. However, due to antigenic drift in influenza virus A and rapid emergence of drug‑resistant strains, current available vaccines or anti‑IVA chemotherapeutics are consistently inefficient. Hence, various more broadly effective drugs have become important for the prevention and treatment of IVA. Of these drugs, baicalin, a flavonoid isolated from Radix Scutellaria, is a promising example. However, little is known in regards to its pharmacological mechanism. Here, it was demonstrated that baicalin inhibits the H1N1 and H3N2 viruses in A549 cells. Subsequently, it was found that miR‑146a was markedly downregulated by treatment of baicalin. Additionally, further experiments revealed that miR‑146a was able to promote the replication of H1N1 and H3N2 by targeting TNF receptor‑associated factor 6 (TRAF6), a pivotal adaptor in the interferon (IFN) production signaling pathway, to downregulate type I IFN production, and enrichment of miR‑146a eliminated the anti‑IVA effects of baicalin on the H1N1 and H3N2 viruses. Additionally, in vivo experiments demonstrated that baicalin could protect mice during H1N1 infection. Taken together, our findings firstly illustrated the anti‑IVA molecular mechanism of baicalin and provide new evidence for targeting miRNAs to prevent and treat viral infection, such as the H1N1 and H3N2 viruses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Rui</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Traditional Chinese Medicine, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 400014, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Lianxin</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Basic Research of Traditional Chinese Medicine in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Mol Med Rep</MedlineTA>
            <NlmUniqueID>101475259</NlmUniqueID>
            <ISSNLinking>1791-2997</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31638222</ArticleId>
            <ArticleId IdType="doi">10.3892/mmr.2019.10743</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31636302</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2052-4463</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>6</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>10</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific data</Title>
                <ISOAbbreviation>Sci Data</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The FluPRINT dataset, a multidimensional analysis of the influenza vaccine imprint on the immune system.</ArticleTitle>
            <Pagination>
                <MedlinePgn>214</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41597-019-0213-4</ELocationID>
            <Abstract>
                <AbstractText>Machine learning has the potential to identify novel biological factors underlying successful antibody responses to influenza vaccines. The first attempts have revealed a high level of complexity in establishing influenza immunity, and many different cellular and molecular components are involved. Of note is that the previously identified correlates of protection fail to account for the majority of individual responses across different age groups and influenza seasons. Challenges remain from the small sample sizes in most studies and from often limited data sets, such as transcriptomic data. Here we report the creation of a unified database, FluPRINT, to enable large-scale studies exploring the cellular and molecular underpinnings of successful antibody responses to influenza vaccines. Over 3,000 parameters were considered, including serological responses to influenza strains, serum cytokines, cell phenotypes, and cytokine stimulations. FluPRINT, facilitates the application of machine learning algorithms for data mining. The data are publicly available and represent a resource to uncover new markers and mechanisms that are important for influenza vaccine immunogenicity.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tomic</LastName>
                    <ForeName>Adriana</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0001-9885-3535</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94304, USA. info@adrianatomic.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, OX3 9DU, UK. info@adrianatomic.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomic</LastName>
                    <ForeName>Ivan</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Independent Researcher, Stanford, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dekker</LastName>
                    <ForeName>Cornelia L</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94304, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maecker</LastName>
                    <ForeName>Holden T</ForeName>
                    <Initials>HT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Human Immune Monitoring Center, Stanford University, Stanford, CA, 94304, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Davis</LastName>
                    <ForeName>Mark M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94304, USA. mmdavis@stanford.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94304, USA. mmdavis@stanford.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Howard Hughes Medical Institute, Stanford University, Stanford, CA, 94304, USA. mmdavis@stanford.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>FluPRINT, No 796636</GrantID>
                    <Agency>EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <GrantID>U19 AI090019</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 RR025744</GrantID>
                    <Acronym>RR</Acronym>
                    <Agency>NCRR NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U19 AI057229</GrantID>
                    <Acronym>AI</Acronym>
                    <Agency>NIAID NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <Acronym>HHMI</Acronym>
                    <Agency>Howard Hughes Medical Institute</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Data</MedlineTA>
            <NlmUniqueID>101640192</NlmUniqueID>
            <ISSNLinking>2052-4463</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31636302</ArticleId>
            <ArticleId IdType="doi">10.1038/s41597-019-0213-4</ArticleId>
            <ArticleId IdType="pii">10.1038/s41597-019-0213-4</ArticleId>
            <ArticleId IdType="pmc">PMC6803714</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Immunol. 2011 Jul 10;12(8):786-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21743478</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2016 Feb;137(2):579-586.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26309181</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2014 Apr 10;157(2):499-513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24725414</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2016 Mar 23;7:11112</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27005435</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Med. 1942 Jan 1;75(1):49-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19871167</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2015 Jan 15;160(1-2):37-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25594173</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Immunol. 2016 Feb;17(2):204-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26726811</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2014 Jan 15;192(2):603-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24337376</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Transl Med. 2013 Mar 13;5(176):176ra32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23486778</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Host Microbe. 2014 Jul 9;16(1):105-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24981332</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2016 Feb 9;14(5):1218-1231</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26832412</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2018 Mar 31;391(10127):1285-1300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29248255</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2015 Sep 15;212(6):861-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25740957</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2017 Feb;23(2):174-184</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28092664</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Transl Med. 2013 Oct 23;5(208):208ra145</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24154599</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2017 Mar 1;215(5):740-749</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28007925</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Invest. 2011 Aug;121(8):3109-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21785218</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2018 Feb;24(2):144-153</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29309059</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bio Protoc. 2015 Jun 5;5(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27135045</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24367114</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2014 Oct 14;32(45):5989-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25203448</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 Jul 21;10(7):e0133627</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26197454</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1853-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26755593</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2012 May;54(10):1427-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22495079</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Syst Biol. 2013 Apr 16;9:659</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23591775</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2015 Apr 1;211(7):1051-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25336731</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol Methods. 2011 Feb 28;365(1-2):67-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21182843</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2013 Oct;19(10):1305-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24056771</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2015 Dec 15;43(6):1186-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26682988</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Immunol. 2018 Apr;51:187-196</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29655022</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Vis Exp. 2012 Nov 02;(69):e4398</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23149654</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13463-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23898164</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1105-1110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28096374</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2019 Mar;25(3):487-495</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30842675</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Autoimmunity. 2015;48(8):513-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26333287</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dev Biol (Basel). 2003;115:63-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15088777</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2013 Jan 15;207(2):288-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23107783</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Data. 2018 Feb 27;5:180015</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29485622</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Immunol. 2017 Sep 29;2(15):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28963118</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Immunol. 2012 Jul;33(7):323-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22476049</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2012 Jan 27;36(1):142-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22265676</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14506-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25246558</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Transl Med. 2013 Feb 6;5(171):171ra19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23390249</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2018 May 31;173(6):1385-1397.e14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29706550</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bio Protoc. 2015 Jun 5;5(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27446979</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 May 29;8(5):e64555</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23734205</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2015 Sep 29;33(40):5294-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25858860</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Syst. 2016 Oct 26;3(4):374-384.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27746093</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Immunol. 2019 Feb;49(2):212-220</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30653669</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Transl Med. 2015 Apr 1;7(281):281ra43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25834109</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Transl Med. 2015 Aug 26;7(302):302ra135</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26311730</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Immunol. 2014 Feb;15(2):128-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24448570</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2016 Dec 1;214(11):1666-1671</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27655870</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bio Protoc. 2015;5(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27390767</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Transl Med. 2012 Mar 28;10:62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22452993</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2016 Aug 02;5:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27481325</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31635972</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-0067</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Epidemics</Title>
                <ISOAbbreviation>Epidemics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transmission of and susceptibility to seasonal influenza in Switzerland from 2003 to 2015.</ArticleTitle>
            <Pagination>
                <MedlinePgn>100373</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1755-4365(18)30008-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.epidem.2019.100373</ELocationID>
            <Abstract>
                <AbstractText>Understanding the seasonal patterns of influenza transmission is critical to help plan public health measures for the management and control of epidemics. Mathematical models of infectious disease transmission have been widely used to quantify the transmissibility of and susceptibility to past influenza seasons in many countries. The objective of this study was to obtain a detailed picture of the transmission dynamics of seasonal influenza in Switzerland from 2003 to 2015. To this end, we developed a compartmental influenza transmission model taking into account social mixing between different age groups and seasonal forcing. We applied a Bayesian approach using Markov chain Monte Carlo (MCMC) methods to fit the model to the reported incidence of influenza-like-illness (ILI) and virological data from Sentinella, the Swiss Sentinel Surveillance Network. The maximal basic reproduction number, R<sub>0</sub>, ranged from 1.46 to 1.81 (median). Median estimates of susceptibility to influenza ranged from 29% to 98% for different age groups, and typically decreased with age. We also found a decline in ascertainability of influenza cases with age. Our study illustrates how influenza surveillance data from Switzerland can be integrated into a Bayesian modeling framework in order to assess age-specific transmission of and susceptibility to influenza.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Brugger</LastName>
                    <ForeName>Jon</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. Electronic address: jon.brugger@students.unibe.ch.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Althaus</LastName>
                    <ForeName>Christian L</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. Electronic address: christian.althaus@alumni.ethz.ch.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Epidemics</MedlineTA>
            <NlmUniqueID>101484711</NlmUniqueID>
            <ISSNLinking>1878-0067</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Basic reproduction number</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Mathematical model</Keyword>
            <Keyword MajorTopicYN="N">Surveillance</Keyword>
            <Keyword MajorTopicYN="N">Switzerland</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>01</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31635972</ArticleId>
            <ArticleId IdType="pii">S1755-4365(18)30008-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.epidem.2019.100373</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31635892</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1464-3391</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>27</Volume>
                    <Issue>23</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Bioorganic &amp; medicinal chemistry</Title>
                <ISOAbbreviation>Bioorg. Med. Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.</ArticleTitle>
            <Pagination>
                <MedlinePgn>115147</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0968-0896(19)30941-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bmc.2019.115147</ELocationID>
            <Abstract>
                <AbstractText>Viral entry inhibitors are of great importance in current efforts to develop a new generation of anti-influenza drugs. Inspired by the discovery of a series of pentacyclic triterpene derivatives as entry inhibitors targeting the HA protein of influenza virus, we designed and synthesized 32 oleanolic acid (OA) analogues in this study by conjugating different amino acids to the 28-COOH of OA. The antiviral activity of these compounds was evaluated in vitro. Some of these compounds revealed impressive anti-influenza potencies against influenza A/WSN/33 (H1N1) virus. Among them, compound 15a exhibited robust potency and broad antiviral spectrum with IC<sub>50</sub> values at the low-micromolar level against four different influenza strains. Hemagglutination inhibition (HI) assay and docking experiment indicated that these OA analogues may act in the same way as their parent compound by interrupting the interaction between HA protein of influenza virus and the host cell sialic acid receptor via binding to HA, thus blocking viral entry.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Meng</LastName>
                    <ForeName>Lingkuan</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical School of Kunming University of Science and Technology, Kunming, Yunnan 650500, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Yangqing</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical School of Kunming University of Science and Technology, Kunming, Yunnan 650500, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Fan</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical School of Kunming University of Science and Technology, Kunming, Yunnan 650500, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiao</LastName>
                    <ForeName>Sulong</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yin</LastName>
                    <ForeName>Zhili</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical School of Kunming University of Science and Technology, Kunming, Yunnan 650500, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Jiaxin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical School of Kunming University of Science and Technology, Kunming, Yunnan 650500, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhong</LastName>
                    <ForeName>Jindong</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Life Science and Technology of Kunming University of Science and Technology, Kunming, Yunnan 650500, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Demin</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Fei</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical School of Kunming University of Science and Technology, Kunming, Yunnan 650500, China. Electronic address: feiyuz8@kmust.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Bioorg Med Chem</MedlineTA>
            <NlmUniqueID>9413298</NlmUniqueID>
            <ISSNLinking>0968-0896</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Amino acids</Keyword>
            <Keyword MajorTopicYN="N">Entry inhibitor</Keyword>
            <Keyword MajorTopicYN="N">Hemagglutinin</Keyword>
            <Keyword MajorTopicYN="N">Influenza A virus</Keyword>
            <Keyword MajorTopicYN="N">Oleanolic acid</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31635892</ArticleId>
            <ArticleId IdType="pii">S0968-0896(19)30941-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bmc.2019.115147</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31635227</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">2076-0817</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pathogens (Basel, Switzerland)</Title>
                <ISOAbbreviation>Pathogens</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antigenic Site Variation in the Hemagglutinin of Pandemic Influenza A(H1N1)pdm09 Viruses between 2009-2017 in Ukraine.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E194</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens8040194</ELocationID>
            <Abstract>
                <AbstractText>The hemagglutinin (HA) is a major influenza virus antigen, which, once recognized by antibodies and substitutions in HA genes, helps virus in escaping the human immune response. It is therefore critical to perform genetic and phylogenetic analysis of HA in circulating influenza viruses. We performed phylogenetic and genetic analysis of isolates from Ukraine, the vaccine strain and reference strains were used to phylogenetically identify trends in mutation locations and substitutions. Ukrainian isolates were collected between 2009-2017 and clustered in the influenza genetic groups 2, 6, 7, and 8. Genetic changes were observed in each of the antigenic sites: Sa - S162T, K163Q, K163I; Sb - S185T, A186T, S190G, S190R; Ca1 - S203T, R205K, E235V, E235D, S236P; Ca2 - P137H, H138R, A141T, D222G, D222N; Cb - A73S, S74R, S74N. In spite of detected mutations in antigenic sites, Ukrainian isolates retained similarity to the vaccine strain A/California/07/09 circulated during 2009-2017. However, WHO recommended a new vaccine strain A/Michigan/45/2015 for the Southern Hemisphere after the emergence of the new genetic groups 6B.1 and 6B.2. Our study demonstrated genetic variability of HA protein of A(H1N1)pdm09 viruses isolated in 2009-2017 in Ukraine. Influenza surveillance is very important for understanding epidemiological situations.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zolotarova</LastName>
                    <ForeName>Oksana</ForeName>
                    <Initials>O</Initials>
                    <Identifier Source="ORCID">0000-0002-9614-1419</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Educational Scientific Centre &quot;Institute of Biology and Medicine&quot;, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine. oksanasmutko@gmail.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>&quot;Gromashevsky L.V. Institute of epidemiology and infectious diseases, National Academy of Medical Sciences of Ukraine&quot; 03680 Kyiv, Ukraine. oksanasmutko@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Budzanivska</LastName>
                    <ForeName>Iryna</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Educational Scientific Centre &quot;Institute of Biology and Medicine&quot;, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine. birishechka68@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leibenko</LastName>
                    <ForeName>Liudmyla</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>&quot;Gromashevsky L.V. Institute of epidemiology and infectious diseases, National Academy of Medical Sciences of Ukraine&quot; 03680 Kyiv, Ukraine. liudmyla.leib@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Radchenko</LastName>
                    <ForeName>Larysa</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>&quot;Gromashevsky L.V. Institute of epidemiology and infectious diseases, National Academy of Medical Sciences of Ukraine&quot; 03680 Kyiv, Ukraine. larysa_rad@ukr.net.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mironenko</LastName>
                    <ForeName>Alla</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>&quot;Gromashevsky L.V. Institute of epidemiology and infectious diseases, National Academy of Medical Sciences of Ukraine&quot; 03680 Kyiv, Ukraine. miralla@ukr.net.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>6NU51IP000855</GrantID>
                    <Agency>Centers for Disease Control and Prevention</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Pathogens</MedlineTA>
            <NlmUniqueID>101596317</NlmUniqueID>
            <ISSNLinking>2076-0817</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">antigenic site</Keyword>
            <Keyword MajorTopicYN="N">genetic analysis</Keyword>
            <Keyword MajorTopicYN="N">influenza A(H1N1)pdm09 virus</Keyword>
            <Keyword MajorTopicYN="N">mutation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31635227</ArticleId>
            <ArticleId IdType="pii">pathogens8040194</ArticleId>
            <ArticleId IdType="doi">10.3390/pathogens8040194</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31634645</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1567-7257</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</Title>
                <ISOAbbreviation>Infect. Genet. Evol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic characterization and pathogenesis of the first H9N2 low pathogenic avian influenza viruses isolated from chickens in Kenyan live bird markets.</ArticleTitle>
            <Pagination>
                <MedlinePgn>104074</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1567-1348(19)30300-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.meegid.2019.104074</ELocationID>
            <Abstract>
                <AbstractText>Poultry production plays an important role in the economy and livelihoods of rural households in Kenya. As part of a surveillance program, avian influenza virus (AIV)-specific real-time RT-PCR (RRT-PCR) was used to screen 282 oropharyngeal swabs collected from chickens at six live bird markets (LBMs) and 33 backyard poultry farms in Kenya and 8 positive samples were detected. Virus was isolated in eggs from five samples, sequenced, and identified as H9N2 low pathogenic AIV (LPAIV) G1 lineage, with highest nucleotide sequence identity (98.6-99.9%) to a 2017 Ugandan H9N2 isolate. The H9N2 contained molecular markers for mammalian receptor specificity, implying their zoonotic potential. Virus pathogenesis and transmissibility was assessed by inoculating low and medium virus doses of a representative Kenyan H9N2 LPAIV isolate into experimental chickens and exposing them to naïve uninfected chickens at 2 -days post inoculation (dpi). Virus shedding was determined at 2/4/7 dpi and 2/5 days post placement (dpp), and seroconversion determined at 14 dpi/12 dpp. None of the directly-inoculated or contact birds exhibited any mortality or clinical disease signs. All directly-inoculated birds in the low dose group shed virus during the experiment, while only one contact bird shed virus at 2 dpp. Only two directly-inoculated birds that shed high virus titers seroconverted in that group. All birds in the medium dose group shed virus at 4/7 dpi and at 5 dpp, and they all seroconverted at 12/14 dpp. This is the first reported detection of H9N2 LPAIV from Kenya and it was shown to be infectious and transmissible in chickens by direct contact and represents a new disease threat to poultry and potentially to people.</AbstractText>
                <CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kariithi</LastName>
                    <ForeName>Henry M</ForeName>
                    <Initials>HM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biotechnology Research Institute, Kenya Agricultural and Livestock Research Organization, P.O Box 57811, 00200, Kaptagat Road, Loresho, Nairobi, Kenya; Southeast Poultry Research Laboratory, US National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, Athens, GA 30605, USA. Electronic address: henry.kariithi@kalro.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Welch</LastName>
                    <ForeName>Catharine N</ForeName>
                    <Initials>CN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Southeast Poultry Research Laboratory, US National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, Athens, GA 30605, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferreira</LastName>
                    <ForeName>Helena L</ForeName>
                    <Initials>HL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Southeast Poultry Research Laboratory, US National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, Athens, GA 30605, USA; University of Sao Paulo, ZMV- FZEA, Pirassununga 13635900, Brazil. Electronic address: hlage@usp.br.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pusch</LastName>
                    <ForeName>Elizabeth A</ForeName>
                    <Initials>EA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Southeast Poultry Research Laboratory, US National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, Athens, GA 30605, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ateya</LastName>
                    <ForeName>Leonard O</ForeName>
                    <Initials>LO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biotechnology Research Institute, Kenya Agricultural and Livestock Research Organization, P.O Box 57811, 00200, Kaptagat Road, Loresho, Nairobi, Kenya. Electronic address: leonard.ateya@kalro.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Binepal</LastName>
                    <ForeName>Yatinder S</ForeName>
                    <Initials>YS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biotechnology Research Institute, Kenya Agricultural and Livestock Research Organization, P.O Box 57811, 00200, Kaptagat Road, Loresho, Nairobi, Kenya. Electronic address: yatinder.binepal@kalro.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Apopo</LastName>
                    <ForeName>Auleria A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Directorate of Veterinary Services, State Department of Livestock, Ministry of Agriculture, Livestock, Fisheries and Irrigation, Private Bag-00625, Nairobi, Kenya.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dulu</LastName>
                    <ForeName>Thomas D</ForeName>
                    <Initials>TD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Directorate of Veterinary Services, State Department of Livestock, Ministry of Agriculture, Livestock, Fisheries and Irrigation, Private Bag-00625, Nairobi, Kenya.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Afonso</LastName>
                    <ForeName>Claudio L</ForeName>
                    <Initials>CL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Southeast Poultry Research Laboratory, US National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, Athens, GA 30605, USA. Electronic address: cafonso@uga.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suarez</LastName>
                    <ForeName>David L</ForeName>
                    <Initials>DL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Southeast Poultry Research Laboratory, US National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, Athens, GA 30605, USA. Electronic address: david.suarez@usda.gov.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Infect Genet Evol</MedlineTA>
            <NlmUniqueID>101084138</NlmUniqueID>
            <ISSNLinking>1567-1348</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Backyard poultry farms</Keyword>
            <Keyword MajorTopicYN="N">G1 lineage</Keyword>
            <Keyword MajorTopicYN="N">H9N2 LPAIV</Keyword>
            <Keyword MajorTopicYN="N">Live-bird markets</Keyword>
            <Keyword MajorTopicYN="N">Oropharyngeal</Keyword>
            <Keyword MajorTopicYN="N">Zoonotic</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31634645</ArticleId>
            <ArticleId IdType="pii">S1567-1348(19)30300-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.meegid.2019.104074</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31634025</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2164-554X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human vaccines &amp; immunotherapeutics</Title>
                <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2019.1677437</ELocationID>
            <Abstract>
                <AbstractText>A trivalent high-dose inactivated influenza vaccine has been licensed in healthy adults ≥65 years of age and provides better protection against influenza infection and related complications than trivalent standard-dose vaccine. This phase I/II clinical trial (NCT03233217), conducted at two sites in Japan, examined the safety and immunogenicity of a quadrivalent formulation of the high-dose inactivated influenza vaccine (IIV4-HD). Healthy adults ≥65 years of age were randomized to receive IIV4-HD by intramuscular injection (n=60), IIV4-HD by subcutaneous injection (n=60), or a quadrivalent standard-dose inactivated influenza vaccine (IIV4-SD) by subcutaneous injection (n=55). Irrespective of administration route, post-vaccination (day 28-35) hemagglutination inhibition geometric mean titers and seroconversion rates were higher for IIV4-HD than for IIV4-SD. Hemagglutination inhibition geometric mean titers and seroconversion rates were also higher for intramuscular than subcutaneous administration of IIV4-HD. Solicited reactions were more common in participants who received IIV4-HD administered subcutaneously than in those who received IIV4-HD administered intramuscularly or IIV4-SD administered subcutaneously. Unsolicited adverse events were similar between the vaccine groups, and no safety signals were detected. This study showed that IIV4-HD administered by either intramuscular or subcutaneous injection was well tolerated and highly immunogenic in healthy Japanese adults ≥65 years of age. Although this study was descriptive, the results add to the evidence that high-dose inactivated influenza vaccines are more immunogenic than standard-dose vaccines in this age group and that intramuscular administration provides greater immunogenicity and lower reactogenicity than subcutaneous administration.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sanchez</LastName>
                    <ForeName>Leilani</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7543-0473</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sanofi Pasteur , Taguig , Philippines.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsuoka</LastName>
                    <ForeName>Osamu</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Corporation Heishinkai ToCROM Clinic , Tokyo , Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Inoue</LastName>
                    <ForeName>Satoshi</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Corporation Heishinkai OCROM Clinic , Osaka , Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Inoue</LastName>
                    <ForeName>Takahiro</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sanofi K.K , Tokyo , Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meng</LastName>
                    <ForeName>Ya</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sanofi Pasteur , Swiftwater , PA , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakama</LastName>
                    <ForeName>Takahiro</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-3821-4445</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sanofi K.K , Tokyo , Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kato</LastName>
                    <ForeName>Kumiko</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sanofi K.K , Tokyo , Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pandey</LastName>
                    <ForeName>Aseem</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7753-798X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sanofi Pasteur , Swiftwater , PA , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Lee-Jah</ForeName>
                    <Initials>LJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sanofi Pasteur , Swiftwater , PA , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Vaccin Immunother</MedlineTA>
            <NlmUniqueID>101572652</NlmUniqueID>
            <ISSNLinking>2164-5515</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Japan</Keyword>
            <Keyword MajorTopicYN="Y">Quadrivalent influenza vaccine</Keyword>
            <Keyword MajorTopicYN="Y">elderly adults</Keyword>
            <Keyword MajorTopicYN="Y">high-dose influenza vaccine</Keyword>
            <Keyword MajorTopicYN="Y">immunogenicity</Keyword>
            <Keyword MajorTopicYN="Y">intramuscular</Keyword>
            <Keyword MajorTopicYN="Y">safety</Keyword>
            <Keyword MajorTopicYN="Y">subcutaneous</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31634025</ArticleId>
            <ArticleId IdType="doi">10.1080/21645515.2019.1677437</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31632600</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1947-2579</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>11</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Online journal of public health informatics</Title>
                <ISOAbbreviation>Online J Public Health Inform</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The design and evaluation of a Bayesian system for detecting and characterizing outbreaks of influenza.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e6</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5210/ojphi.v11i2.9952</ELocationID>
            <Abstract>
                <AbstractText>The prediction and characterization of outbreaks of infectious diseases such as influenza remains an open and important problem. This paper describes a framework for detecting and characterizing outbreaks of influenza and the results of testing it on data from ten outbreaks collected from two locations over five years. We model outbreaks with compartment models and explicitly model non-influenza influenza-like illnesses.</AbstractText>
                <CopyrightInformation>This is an Open Access article. Authors own copyright of their articles appearing in the Journal of Public Health Informatics. Readers may copy articles without permission of the copyright owner(s), as long as the author and OJPHI are acknowledged in the copy and the copy is used for educational, not-for-profit purposes.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Millett</LastName>
                    <ForeName>Nicholas E</ForeName>
                    <Initials>NE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Real-time Outbreak and Disease Surveillance (RODS) Laboratory, Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aronis</LastName>
                    <ForeName>John M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Real-time Outbreak and Disease Surveillance (RODS) Laboratory, Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wagner</LastName>
                    <ForeName>Michael M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Real-time Outbreak and Disease Surveillance (RODS) Laboratory, Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsui</LastName>
                    <ForeName>Fuchiang</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Real-time Outbreak and Disease Surveillance (RODS) Laboratory, Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Ye</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Real-time Outbreak and Disease Surveillance (RODS) Laboratory, Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferraro</LastName>
                    <ForeName>Jeffrey P</ForeName>
                    <Initials>JP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haug</LastName>
                    <ForeName>Peter J</ForeName>
                    <Initials>PJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gesteland</LastName>
                    <ForeName>Per H</ForeName>
                    <Initials>PH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cooper</LastName>
                    <ForeName>Gregory F</ForeName>
                    <Initials>GF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Real-time Outbreak and Disease Surveillance (RODS) Laboratory, Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 LM011370</GrantID>
                    <Acronym>LM</Acronym>
                    <Agency>NLM NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T15 LM007059</GrantID>
                    <Acronym>LM</Acronym>
                    <Agency>NLM NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U24 GM110707</GrantID>
                    <Acronym>GM</Acronym>
                    <Agency>NIGMS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Online J Public Health Inform</MedlineTA>
            <NlmUniqueID>101536954</NlmUniqueID>
            <ISSNLinking>1947-2579</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31632600</ArticleId>
            <ArticleId IdType="doi">10.5210/ojphi.v11i2.9952</ArticleId>
            <ArticleId IdType="pii">ojphi-11-e6</ArticleId>
            <ArticleId IdType="pmc">PMC6788888</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Biol. 2010 Feb 23;8(2):e1000316</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20186267</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2010 Apr 14;5(4):e10036</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20418945</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Online J Public Health Inform. 2011;3(3):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23569615</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Suppl. 2004 Sep 24;53:106-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15714638</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2005 Sep;11(9):1355-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16229762</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biomed Inform. 2015 Feb;53:15-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25181466</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2009 Feb 19;457(7232):1012-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19020500</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Online J Public Health Inform. 2011;3(3):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23569617</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20425-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23184969</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Curr. 2013 Jun 21;5:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23873050</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Epidemiol. 2008 Apr 1;167(7):775-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18230677</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2009 Jul 9;361(2):112-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19474417</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31631569</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1865-1682</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Transboundary and emerging diseases</Title>
                <ISOAbbreviation>Transbound Emerg Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The PB2 and M genes are critical for the superiority of genotype S H9N2 virus to genotype H in optimizing viral fitness of H5Nx and H7N9 avian influenza viruses in mice.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/tbed.13395</ELocationID>
            <Abstract>
                <AbstractText>Genotype S H9N2 avian influenza virus, which has been predominant in China since 2010, contributed its entire internal gene cassette to the genesis of novel reassortant influenza viruses, including H5Nx, H7N9 and H10N8 viruses that pose great threat to poultry and humans. A key feature of the genotype S H9N2 virus is the substitution of G1-like M and PB2 genes for the earlier F/98-like M and PB2 of genotype H virus. However, how this gene substitution has influenced viral adaptability of emerging influenza viruses in mammals remains unclear. We report here that reassortant H5Nx and H7N9 viruses with the genotype S internal gene cassette displayed enhanced replication and virulence over those with genotype H internal gene cassette in cell cultures as well as in the mouse models. We showed that the G1-like PB2 gene was associated with increased polymerase activity and improved nuclear accumulation compared with the F/98-like counterpart, while the G1-like M gene facilitated effective translocation of RNP to cytoplasm. Our findings suggest that the genotype S H9N2 internal gene cassette, which possesses G1-like M and PB2 genes, is superior to that of genotype H, in optimizing viral fitness, and thus have implications for assessing the potential risk of these gene introductions to generate emerging influenza viruses.</AbstractText>
                <CopyrightInformation>© 2019 Blackwell Verlag GmbH.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hao</LastName>
                    <ForeName>Xiaoli</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Jiao</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-6894-4436</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xiaoquan</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gu</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jiongjiong</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Dong</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Zhao</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Ruyi</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xiuli</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Zenglei</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Shunlin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xiaowen</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peng</LastName>
                    <ForeName>Daxin</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiao</LastName>
                    <ForeName>Xinan</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xiufan</ForeName>
                    <Initials>X</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9924-6646</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agri-food Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>31702245</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>31772755</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>31502076</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2016YFD0500202-1</GrantID>
                    <Agency>National Key Research and Development Project of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2016YFD0501601</GrantID>
                    <Agency>National Key Research and Development Project of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2019T120473</GrantID>
                    <Agency>China Postdocoral Science Foundation</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2018M642345</GrantID>
                    <Agency>China Postdocoral Science Foundation</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>&quot;Qing Lan Project&quot; of Higher Education Institutions of Jiangsu Province, China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>&quot;High-end talent support program&quot; of Yangzhon University, China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>CARS-40</GrantID>
                    <Agency>Earmarked Fund for China Agriculture Research System</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Transbound Emerg Dis</MedlineTA>
            <NlmUniqueID>101319538</NlmUniqueID>
            <ISSNLinking>1865-1674</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">G1-like M and PB2</Keyword>
            <Keyword MajorTopicYN="N">H5Nx</Keyword>
            <Keyword MajorTopicYN="N">H7N9</Keyword>
            <Keyword MajorTopicYN="N">avian influenza virus</Keyword>
            <Keyword MajorTopicYN="N">viral fitness</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31631569</ArticleId>
            <ArticleId IdType="doi">10.1111/tbed.13395</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31630939</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Novel calixarene-based surfactant enables low dose split inactivated vaccine protection against influenza infection.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(19)31381-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2019.10.018</ELocationID>
            <Abstract>
                <AbstractText>Influenza A viruses cause major morbidity and represent a severe global health problem. Current influenza vaccines are mainly egg-based products requiring the split of whole viruses using classical detergents such as Triton X-100, which implies certain limitations. Here, we report the use of the novel calixarene-based surfactant CALX133ACE as an alternative to classical detergents for influenza inactivated split vaccine preparation. We confirmed that CALX133ACE-based split HA antigens are fully functional and quantifiable by the &quot;gold standard&quot; method SRID. Additionally, as in the case of the Triton X-100-based split, the CALX133ACE-based split antigens are stable for at least 6 months at 4 °C. Moreover, immunization of mice with CALX133ACE-based split NYMC X-179A (H1N1) antigens harboring 10 to 30-fold less antigen than the commercialized trivalent inactivated vaccines Vaxigrip® or Fluviral® induced comparable efficient protection and neutralizing antibody responses against A(H1N1)pdm09 infection. Taken together, our results demonstrate for the first time the use of a calixarene-based detergent as an efficient splitting agent for the production of optimized influenza split antigens, paving the way for significant improvement in the vaccine manufacturing process, notably with regard to the current regulation on the prohibition of endocrine disruptors, such as Triton X-100.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mandon</LastName>
                    <ForeName>Elodie Desuzinges</ForeName>
                    <Initials>ED</Initials>
                    <AffiliationInfo>
                        <Affiliation>CALIXAR, 60 Avenue Rockefeller 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pizzorno</LastName>
                    <ForeName>Andrés</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virologie et Pathologie Humaine-VirPath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Traversier</LastName>
                    <ForeName>Aurélien</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virologie et Pathologie Humaine-VirPath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France; VirNext, Faculté de Médecine RTH Laennec, Université Claude Bernard Lyon 1, Université de Lyon, Lyon 69008, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Champagne</LastName>
                    <ForeName>Anne</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>CALIXAR, 60 Avenue Rockefeller 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamelin</LastName>
                    <ForeName>Marie Eve</ForeName>
                    <Initials>ME</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center in Infectious Diseases of the CHU de Quebec and Laval University, Quebec City, QC G1V 4G2, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lina</LastName>
                    <ForeName>Bruno</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virologie et Pathologie Humaine-VirPath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France; Laboratoire de Virologie, Centre National de Référence des virus Influenza Sud, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon F-69317, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boivin</LastName>
                    <ForeName>Guy</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center in Infectious Diseases of the CHU de Quebec and Laval University, Quebec City, QC G1V 4G2, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dejean</LastName>
                    <ForeName>Emmanuel</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>CALIXAR, 60 Avenue Rockefeller 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosa-Calatrava</LastName>
                    <ForeName>Manuel</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virologie et Pathologie Humaine-VirPath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France; VirNext, Faculté de Médecine RTH Laennec, Université Claude Bernard Lyon 1, Université de Lyon, Lyon 69008, France. Electronic address: manuel.rosa-calatrava@univ-lyon1.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jawhari</LastName>
                    <ForeName>Anass</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>CALIXAR, 60 Avenue Rockefeller 69008, Lyon, France. Electronic address: ajawhari@calixar.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Calixarene</Keyword>
            <Keyword MajorTopicYN="N">Detergent/surfactant</Keyword>
            <Keyword MajorTopicYN="N">H1N1</Keyword>
            <Keyword MajorTopicYN="N">Hemagglutinin</Keyword>
            <Keyword MajorTopicYN="N">Immunization</Keyword>
            <Keyword MajorTopicYN="N">Split inactivated influenza antigen</Keyword>
            <Keyword MajorTopicYN="N">Triton</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31630939</ArticleId>
            <ArticleId IdType="pii">S0264-410X(19)31381-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2019.10.018</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31629405</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0127</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>26</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biomedical science</Title>
                <ISOAbbreviation>J. Biomed. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>M2e-based universal influenza vaccines: a historical overview and new approaches to development.</ArticleTitle>
            <Pagination>
                <MedlinePgn>76</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-019-0572-3</ELocationID>
            <Abstract>
                <AbstractText>The influenza A virus was isolated for the first time in 1931, and the first attempts to develop a vaccine against the virus began soon afterwards. In addition to causing seasonal epidemics, influenza viruses can cause pandemics at random intervals, which are very hard to predict. Vaccination is the most effective way of preventing the spread of influenza infection. However, seasonal vaccination is ineffective against pandemic influenza viruses because of antigenic differences, and it takes approximately six months from isolation of a new virus to develop an effective vaccine. One of the possible ways to fight the emergence of pandemics may be by using a new type of vaccine, with a long and broad spectrum of action. The extracellular domain of the M2 protein (M2e) of influenza A virus is a conservative region, and an attractive target for a universal influenza vaccine. This review gives a historical overview of the study of M2 protein, and summarizes the latest developments in the preparation of M2e-based universal influenza vaccines.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mezhenskaya</LastName>
                    <ForeName>Daria</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Institute of Experimental Medicine, 12 Acad. Pavlov Street, St. Petersburg, 197376, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Isakova-Sivak</LastName>
                    <ForeName>Irina</ForeName>
                    <Initials>I</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2801-1508</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Institute of Experimental Medicine, 12 Acad. Pavlov Street, St. Petersburg, 197376, Russia. isakova.sivak@iemspb.ru.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rudenko</LastName>
                    <ForeName>Larisa</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virology, Institute of Experimental Medicine, 12 Acad. Pavlov Street, St. Petersburg, 197376, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>19-15-00015</GrantID>
                    <Agency>Russian Science Foundation</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Biomed Sci</MedlineTA>
            <NlmUniqueID>9421567</NlmUniqueID>
            <ISSNLinking>1021-7770</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Conserved protein</Keyword>
            <Keyword MajorTopicYN="N">Cross-protection</Keyword>
            <Keyword MajorTopicYN="N">Influenza M2 ectodomain</Keyword>
            <Keyword MajorTopicYN="N">Influenza a virus</Keyword>
            <Keyword MajorTopicYN="N">Universal influenza vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31629405</ArticleId>
            <ArticleId IdType="doi">10.1186/s12929-019-0572-3</ArticleId>
            <ArticleId IdType="pii">10.1186/s12929-019-0572-3</ArticleId>
            <ArticleId IdType="pmc">PMC6800501</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Physiol. 1996 Jul 15;494 ( Pt 2):329-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8841994</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2009 Jun 25;459(7250):1122-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19516283</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Genes. 2011 Feb;42(1):1-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21082230</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2008 Jan 31;451(7178):591-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18235503</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 1993 Jan;74 ( Pt 1):143-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8423445</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S68-S74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30715367</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 1997 Dec 1;159(11):5197-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9548456</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2011 Jul;92(Pt 7):1627-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21402597</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Host Microbe. 2014 Feb 12;15(2):239-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24528869</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(9):e45765</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23029232</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2018 Jan 11;13(1):e0190868</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29324805</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2013 Jan 21;31(5):806-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23246552</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Rev Vaccines. 2017 Feb;16(2):123-136</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27653543</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immune Netw. 2015 Oct;15(5):213-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26557805</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2016 Aug 12;90(17):7991-8004</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27356897</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2004 May 1;172(9):5598-605</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15100303</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2002 Oct 18;277(42):39880-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12183461</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2015 Jun 26;33(29):3398-406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25976545</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2010 Dec 28;5(12):e14442</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21203437</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2008 Jan 10;26(2):201-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18063235</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Immunol. 2019 Jun 25;10:1457</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31316510</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1989 Feb;86(3):1061-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2915973</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2016 Jan 20;34(4):466-473</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26709639</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2017 Oct 30;65(10):1644-1651</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29020179</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1976 Sep;73(9):3045-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1067600</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Sci. 2017 Dec 07;18(12):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29215568</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1995 Oct 1;212(2):411-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7571410</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2012 Jan;93(Pt 1):113-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21918006</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2018 Aug 9;36(33):5097-5103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30007825</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2003 Feb 1;306(1):7-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12620792</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virol J. 2010 Jul 12;7:151</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20624292</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biomed Sci. 2018 Apr 9;25(1):33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29631629</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2017 Mar 13;91(7):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28077656</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 1983 Mar;130(3):1317-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6822737</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2017 Jul 24;35(33):4177-4183</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28668565</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2014 Apr 1;209(7):986-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24325965</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Immunol Immunopathol. 2004 Dec 28;102(4):351-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15541789</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2012;8(11):e1002998</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23133386</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1976 Feb;69(2):789-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1258370</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biotechnol J. 2015 May;10(5):690-701</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25728134</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 Nov;88(22):13029-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25165113</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1979 Oct;76(10):4908-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">291907</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Immunol. 2018 Apr 24;9:865</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29740451</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1988 Aug;62(8):2762-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2455818</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 1994 Apr;75 ( Pt 4):945-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8151308</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccines (Basel). 2015 Feb 13;3(1):105-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26344949</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2016 Jun 3;34(26):2926-2933</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27038130</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2013 Jun;87(12):6542-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23576508</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>ACS Infect Dis. 2016 Jan 8;2(1):5-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26977452</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Top Microbiol Immunol. 2015;386:275-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25033754</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Pharm Des. 2013;19(31):5587-600</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23394564</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Vaccin Immunother. 2018 Mar 4;14(3):630-636</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29090968</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1990 Mar;64(3):1375-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2304147</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Host Microbe. 2009 Oct 22;6(4):367-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19837376</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1982 Dec;123(2):237-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6184879</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1996 Jul;70(7):4411-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8676464</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunol Cell Biol. 2010 Jul;88(5):605-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20177411</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2011 Jul 26;29(33):5481-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21664216</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1976 Mar;17(3):876-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1255862</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Virol. 2013 Oct;3(5):521-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23978327</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1981 Jul 30;112(2):746-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7257189</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2013 Oct;87(19):10435-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23903831</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1991 Jul;183(1):32-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2053285</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2015 Apr 1;211(7):1038-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25281755</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1981 Jul 30;112(2):729-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7257188</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2002 Feb;76(3):1391-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11773413</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1991 Oct;65(10):5491-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1895397</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Oct 02;8(10):e77084</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24098576</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2014 Sep 16;5:4816</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25226414</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30931475</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Ther. 2013 Feb;21(2):485-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23247101</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2011 Jan 15;186(2):1022-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21169548</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mucosal Immunol. 2018 Jan;11(1):273-289</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28295019</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Comp Immunol Microbiol Infect Dis. 2019 Aug;65:76-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31300131</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2013 Oct;19(10):1305-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24056771</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15409-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20713739</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2004 Oct;78(20):11007-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15452221</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2008 Dec;82(23):11869-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18815307</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2005 Jun;79(11):6644-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15890902</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochemistry. 2010 Feb 2;49(4):696-708</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20028125</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2008 Nov;80(2):168-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18598723</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 1992 May 1;69(3):517-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1374685</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunology. 2014 Oct;143(2):300-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24773389</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2011 Feb;92(Pt 2):301-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20965983</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 Apr 27;10(4):e0124677</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25915748</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Struct Mol Biol. 2009 Dec;16(12):1267-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19898475</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbes Infect. 2005 Feb;7(2):171-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15777646</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2004 Aug 13;22(23-24):2993-3003</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15297047</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2015 Mar;14(3):167-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25722244</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2005 May;86(Pt 5):1447-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15831957</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 1985 Mar;40(3):627-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3882238</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virol J. 2006 Dec 06;3:102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17150104</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2008 Feb 26;26(9):1243-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18243429</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2010 Sep 17;142(6):902-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20850012</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1996 Dec 15;226(2):430-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8955065</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2008 Oct;82(20):10059-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18701586</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2009 Oct 23;27(45):6280-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19840661</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2005 Mar;79(6):3595-605</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15731254</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2008 Jan 31;451(7178):596-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18235504</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2011 Jul 18;29(32):5145-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21624416</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 1992 May 15;69(4):577-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1375129</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2016 Apr 13;6:24402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27072615</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Liposome Res. 2017 Sep;27(3):210-220</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28922045</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunol Lett. 2004 May 15;93(2-3):131-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15158608</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2001 Jun;75(12):5656-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11356973</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2016 Sep 30;34(42):5090-5098</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27595896</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 Apr;89(7):3700-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25609808</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Brief Bioinform. 2019 Jul 19;20(4):1160-1166</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28968734</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2013 Sep;99(3):328-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23811283</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virol J. 2009 May 29;6:67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19476650</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2011 Jan 18;6(1):e14538</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21267073</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2002 Aug;83(Pt 8):1851-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12124449</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(10):e46395</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23049700</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 1999 Oct;5(10):1157-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10502819</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Immunol. 2000 May;61(5):438-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10773346</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2007 Dec 17;25(52):8868-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18061317</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Immunol. 2007 Sep;37(9):2441-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17668898</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 May 14;10(5):e0126650</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25973787</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2005 Jun 3;280(22):21463-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15784624</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2019 May 16;177(5):1124-1135.e16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31100267</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):141-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12628550</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2018 Oct;158:244-254</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30179634</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2019 May 16;177(5):1136-1152.e18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31100268</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 Oct 14;90(1):611-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26468526</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12658-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20615945</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 1980 May;124(5):2507-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7365263</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2019 Mar;529:111-121</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30685658</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Immunol. 2010 May;11(5):404-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20383149</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2015 Jul 20;5:11757</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26190831</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 1999 Jun 15;162(12):7578-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10358215</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2001 Jun 14;19(27):3681-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11395202</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Ther. 2014 Jul;22(7):1364-1374</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24590045</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Epidemiol. 2018 Dec 1;187(12):2603-2614</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30084906</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2009 Mar 1;385(1):218-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19070878</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2018 Oct 29;92(22):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30158290</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 1980 May 10;8(9):1965-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6927841</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dev Cell. 2003 Jul;5(1):175-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12852861</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2008 Apr 25;283(17):11382-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18252707</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6324-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7541537</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2007 Mar;13(3):426-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17552096</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1996 Jul;70(7):4800-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8676511</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31627841</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2163</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>345</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Cellular immunology</Title>
                <ISOAbbreviation>Cell. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Diminished immune responses with aging predispose older adults to common and uncommon influenza complications.</ArticleTitle>
            <Pagination>
                <MedlinePgn>103992</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0008-8749(19)30298-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cellimm.2019.103992</ELocationID>
            <Abstract>
                <AbstractText>Influenza (flu) is a serious disease for older adults, with increased severity of infection and greater risk for hospitalization and death. Flu infection is limited to pulmonary epithelial cells, yet there are many systemic symptoms and older adults are more susceptible to flu-related complications. In older adults, flu rarely comes without additional complications and there is a perfect storm for enhanced disease due to multiple factors including existing co-morbidities, plus impaired lung function and dysregulated immune responses that occur with even healthy aging. Commonly, opportunistic secondary bacterial infections prosper in damaged lungs. Intensified systemic inflammation with aging can cause dysfunction in extra-pulmonary organs and tissues such as cardiovascular, musculoskeletal, neuropathologic, hepatic, and renal complications. Often overlooked is the underappreciated connections between many of these conditions, which exacerbate one another when in parallel. This review focuses on flu infection and the numerous complications in older adults associated with diminished immune responses.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Keilich</LastName>
                    <ForeName>Spencer R</ForeName>
                    <Initials>SR</Initials>
                    <AffiliationInfo>
                        <Affiliation>UConn Center on Aging, University of Connecticut School of Medicine, Farmington, CT 06030, USA. Electronic address: keilich@uchc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bartley</LastName>
                    <ForeName>Jenna M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>UConn Center on Aging, University of Connecticut School of Medicine, Farmington, CT 06030, USA; Department of Immunology, University of Connecticut School of Medicine, Farmington, CT 06030, USA. Electronic address: jbartley@uchc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haynes</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>UConn Center on Aging, University of Connecticut School of Medicine, Farmington, CT 06030, USA; Department of Immunology, University of Connecticut School of Medicine, Farmington, CT 06030, USA. Electronic address: lhaynes@uchc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Cell Immunol</MedlineTA>
            <NlmUniqueID>1246405</NlmUniqueID>
            <ISSNLinking>0008-8749</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aging</Keyword>
            <Keyword MajorTopicYN="N">Cardiovascular</Keyword>
            <Keyword MajorTopicYN="N">Hepatic</Keyword>
            <Keyword MajorTopicYN="N">Immunology</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Musculoskeletal</Keyword>
            <Keyword MajorTopicYN="N">Neuropathologic</Keyword>
            <Keyword MajorTopicYN="N">Renal</Keyword>
            <Keyword MajorTopicYN="N">Secondary bacteria infection</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31627841</ArticleId>
            <ArticleId IdType="pii">S0008-8749(19)30298-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cellimm.2019.103992</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31622404</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A novel framework for evaluating the impact of individual decision-making on public health outcomes and its potential application to study antiviral treatment collection during an influenza pandemic.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0223946</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0223946</ELocationID>
            <Abstract>
                <AbstractText>The importance of accounting for social and behavioural processes when studying public health emergencies has been well-recognised. For infectious disease outbreaks in particular, several methods of incorporating individual behaviour have been put forward, but very few are based on established psychological frameworks. In this paper, we develop a decision framework based on the COM-B model of behaviour change to investigate the impact of individual decision-making on public health outcomes. We demonstrate the application of our decision framework in a proof-of-concept case study based on the 2009 A(H1N1) influenza pandemic in the UK. The National Pandemic Flu Service (NPFS) was set up in England during the pandemic as a means to provide antiviral (AV) treatment to clinically ill patients with influenza-like illness, via telephone calls or internet screening, thereby averting the need to see a doctor. The evaluated patients based on a clinical algorithm and authorised AV drugs for collection via community collection points. We applied our behavioural framework to evaluate the influence of human behaviour on AV collection rates, and subsequently to identify interventions that could help improve AV collection rates. Our model was validated against empirically collected pandemic data from 2009 in the UK. We also performed a sensitivity analysis to identify potentially effective interventions by varying model parameters. Using our behavioural framework in a proof-of-concept case study, we found that interventions geared towards increasing people's 'Capability' and 'Opportunity' are likely to result in increased AV collection, potentially resulting in fewer influenza-related hospitalisations and deaths. We note that important behavioural data from public health emergencies are largely scarce. Insights obtained from models such as ours can, not only be very useful in designing healthcare interventions, but also inform future data collection.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Venkatesan</LastName>
                    <ForeName>Sudhir</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2093-5781</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Epidemiology and Public Health, University of Nottingham, Nottingham, England, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nguyen-Van-Tam</LastName>
                    <ForeName>Jonathan S</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Epidemiology and Public Health, University of Nottingham, Nottingham, England, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siebers</LastName>
                    <ForeName>Peer-Olaf</ForeName>
                    <Initials>PO</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Computer Science, University of Nottingham, Nottingham, England, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>SV and JSN-V-T are currently working on outputs from the PRIDE study which is supported by an unrestricted educational grant from F. Hoffman La Roche. F. Hoffman La Roche had no role in any aspect of this study. JSN-V-T reports grants from F. Hoffmann-La Roche, personal fees from Shionogi Ltd. (in 2016) outside the submitted work; he is currently on secondment from the University of Nottingham to the Department of Health and Social Care (England). The work and conclusions presented here are those of the authors and do not necessarily represent the official position of the Department of Health and Social Care (England). P-OS and SV reports no competing interests. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31622404</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0223946</ArticleId>
            <ArticleId IdType="pii">PONE-D-18-36740</ArticleId>
            <ArticleId IdType="pmc">PMC6797120</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Epidemiol. 1999 Jun;28(3):550-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10405863</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Public Health (Oxf). 2019 Jun 1;41(2):379-390</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29955851</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Public Health (Oxf). 2011 Dec;33(4):503-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21460370</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6872-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19332788</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2007 Apr 12;446(7137):733</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17429381</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J R Soc Interface. 2016 Dec;13(125):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28003528</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMJ. 2008 Sep 29;337:a1655</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18824488</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2008;3(2):e1558</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19050769</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Virol. 2011 Feb;50(2):183</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21112812</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Health Care Manag Sci. 2015 Sep;18(3):318-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25578039</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J R Soc Interface. 2012 Mar 7;9(68):562-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21775324</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Epidemics. 2015 Mar;10:21-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25843377</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Epidemics. 2012 Aug;4(3):132-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22939310</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Risk Anal. 2012 Dec;32(12):2020-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22563796</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2017 May 15;64(10):1328-1334</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28199524</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J R Soc Interface. 2010 Sep 6;7(50):1247-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20504800</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2015 May 2;385(9979):1729-1737</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25640810</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Curr. 2009 Nov 16;1:RRN1130</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20029668</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Public Health. 2011 Feb;101(2):285-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21164098</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Public Health. 2015 Feb 27;15:190</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25884522</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Respir Med. 2014 May;2(5):395-404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24815805</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Implement Sci. 2011 Apr 23;6:42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21513547</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Public Health. 2011 Jan 03;11:2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21199571</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Behav Med. 2009;16(1):7-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19214752</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Infect Dis. 2010 Oct 14;10:296</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20946662</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Epidemiol Infect. 2018 Mar;146(4):496-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29446343</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMJ Open. 2014 Feb 03;4(2):e004174</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24491382</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Med. 2008 Mar 25;5(3):e74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18366252</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Behav Med. 2007 Feb;33(1):1-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17291165</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31620483</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2314-4599</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of veterinary science and medicine</Title>
                <ISOAbbreviation>Int J Vet Sci Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Molecular pathogenic and host range determinants of reassortant Egyptian low pathogenic avian influenza H9N2 viruses from backyard chicken.</ArticleTitle>
            <Pagination>
                <MedlinePgn>10-19</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/23144599.2019.1637046</ELocationID>
            <Abstract>
                <AbstractText>Since the introduction of H9N2 low pathogenic avian influenza virus in Egypt, it became an endemic disease causing considerable economic losses in different poultry sectors especially in the presence of other secondary bacterial and viral infections. The H9N2 viruses in Egypt are in continuous evolution that needs deep analysis for their evolution pattern based on the genetic constitutions of the pathogenic determinant genes (HA, PB2, PB1, PA, and NS). In this work, samples were collected from the backyard chickens from 3 Egyptian governorates. Five selected viruses were sequenced and analyzed for the hemagglutinin gene which showed genetic relatedness to the Asian G1 lineage group B, similar to the circulating H9N2 viruses in Egypt since 2013. The sequence for PB2, PB1, PA, HA and NS genes of the selected five viruses indicate a natural re-assortment event with recent Eurasian subtypes and similar to Egyptian H9N2 virus isolated from pigeon in Egypt during 2014. The Egyptian viruses of our study possess amino acids signatures including S42, V127, L550, L672 and V504 in the internal genes NS1, PA, and PB2, of respectively of an impact on virus transmission and replication. This work indicates that the H9N2 is in continuous evolution with alarming to the reassortment occurrence.</AbstractText>
                <CopyrightInformation>© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Samir</LastName>
                    <ForeName>Abdelhafez</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Reference Laboratory for Veterinary Quality Control on Poultry Production, Animal Health Research Institute, Giza, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adel</LastName>
                    <ForeName>Amany</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Reference Laboratory for Veterinary Quality Control on Poultry Production, Animal Health Research Institute, Giza, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arafa</LastName>
                    <ForeName>Abdelsatar</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Reference Laboratory for Veterinary Quality Control on Poultry Production, Animal Health Research Institute, Giza, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sultan</LastName>
                    <ForeName>Hesham</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian and Rabbit Diseases Dept., Faculty of Veterinary Medicine, University of Sadat, City Sadat, Minoufiya, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hussein Ahmed</LastName>
                    <ForeName>Hussein A</ForeName>
                    <Initials>HA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Virology Dept., Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Int J Vet Sci Med</MedlineTA>
            <NlmUniqueID>101626221</NlmUniqueID>
            <ISSNLinking>2314-4599</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hemagglutinin</Keyword>
            <Keyword MajorTopicYN="N">LPAI H9N2</Keyword>
            <Keyword MajorTopicYN="N">NS</Keyword>
            <Keyword MajorTopicYN="N">PA</Keyword>
            <Keyword MajorTopicYN="N">PB1</Keyword>
            <Keyword MajorTopicYN="N">PB2</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31620483</ArticleId>
            <ArticleId IdType="doi">10.1080/23144599.2019.1637046</ArticleId>
            <ArticleId IdType="pii">1637046</ArticleId>
            <ArticleId IdType="pmc">PMC6776986</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(7):e40752</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22808250</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2000 May 22;74(1-2):15-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10799775</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Res Vet Sci. 2017 Jun;112:132-140</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28254685</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2006 Jan;23(1):7-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16177232</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 May 5;106(18):7565-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19380727</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2003 Mar;77(5):3148-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12584339</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Genes. 2012 Oct;45(2):283-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22752536</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2001 Mar 15;281(2):156-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11277689</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2008 Sep 18;131(1-2):82-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18403137</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2017 Apr;98(4):548-562</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27902350</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2017 Nov 14;91(23):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28931674</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pac Symp Biocomput. 2002;:310-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11928486</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Jun 14;8(6):e67616</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23799150</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Microbiol. 2002 Sep;40(9):3256-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12202562</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2008 Aug 13;3(8):e2923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18698430</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol Methods. 2010 Sep;168(1-2):72-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20435070</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2006 Jun;12(6):881-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16707041</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Evol Biol. 2007 Nov 08;7:214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17996036</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2002 Sep;8(9):950-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12195436</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1998 Dec 20;252(2):324-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9878611</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2008 Oct;89(Pt 10):2359-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18796704</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virol J. 2011 Nov 04;8:505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22050764</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2014 Oct;20(10):1745-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25271444</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2013 Dec;30(12):2725-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24132122</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1999 May 25;258(1):1-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10329563</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2015 Sep;96(9):2587-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26296365</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2009 Jul;83(13):6673-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19403683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2007 Jul;88(Pt 7):2035-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17554038</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2008 Feb;82(3):1146-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18032512</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2000 May 22;74(1-2):3-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10799774</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2014 Jan 10;168(1):208-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24315038</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbiol Rev. 1992 Mar;56(1):152-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1579108</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2011 Aug;85(16):8413-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21680519</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Oct 30;43(19):9405-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26384413</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2012;8(11):e1003059</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23209422</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2009 Jun 11;4(6):e5788</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19517011</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2011 Nov;85(22):11544-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21775458</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12084-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21730147</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Mol Evol. 1996 May;42(5):587-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8662011</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Ecol Epidemiol. 2019 Feb 20;9(1):1575687</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30815236</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2007 Oct;81(19):10389-401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17652402</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2011 Feb 28;6(2):e17212</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21386964</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2000 Feb 15;267(2):279-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10662623</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31618691</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1567-7257</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>77</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</Title>
                <ISOAbbreviation>Infect. Genet. Evol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>New molecular evolutionary characteristics of H9N2 avian influenza virus in Guangdong Province, China.</ArticleTitle>
            <Pagination>
                <MedlinePgn>104064</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1567-1348(19)30290-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.meegid.2019.104064</ELocationID>
            <Abstract>
                <AbstractText>To understand the evolution of H9N2 avian influenza virus genotype and its molecular evolution rate, we systematically analyzed 72 H9N2 avian influenza virus sequences isolated from Guangdong province from 2014 to 2018. We found three genotypes (G57, G68, and G118) of the H9N2 avian influenza virus, of which G118 is a newly discovered genotype and G57 is the dominant genotype. The internal gene cassette of the G57 genotype H9N2 avian influenza virus is a stable combination that can easily transport internal genes to other novel avian influenza viruses, and the internal gene cassettes of the G68 and G118 are identical to those of G57.In addition, we estimated the nucleotide substitution rate of the HA and NA genes of the H9N2 influenza virus from 2014 to 2018.The nucleotide substitution rate of HA and NA genes showed an upward trend in 2015 and 2016. In the past two years, H9N2 avian influenza virus recombination has produced genotype G68, which disappeared in 2014 for one year. And very coincidentally, in 2015, there was a new genotype G118. We observed that the emergence of new genotypes was accompanied by a slight increase in overall nucleotide substitution rate. Therefore we hypothesize that the emergence of new genotypes could accelerate the molecular evolution rate of genes. Our research shows that the H9N2 avian influenza virus in Guangdong province has been undergoing intense evolution, demonstrating the need to strengthen influenza surveillance in the region.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jin</LastName>
                    <ForeName>Xuanjiang</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zha</LastName>
                    <ForeName>Yunfeng</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Center for Animal Disease Control and Prevention, Guangzhou 510230, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Jingkai</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xiao</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Jianglin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Shumin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Experimental Animal Center, South China agricultural university,Guangzhou,China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dai</LastName>
                    <ForeName>Yixue</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Zhixian</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xiao</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Fuguang</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Center for Animal Disease Control and Prevention, Guangzhou 510230, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qi</LastName>
                    <ForeName>Wenbao</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China; Key Laboratory of Zoonoses, Key Laboratory of Animal Vaccine Development, Ministry of Agriculture,Guangzhou, China; Key Laboratory of Zoonoses Prevention and Control of Guangdong Province, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liao</LastName>
                    <ForeName>Ming</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China; Key Laboratory of Zoonoses, Key Laboratory of Animal Vaccine Development, Ministry of Agriculture,Guangzhou, China; Key Laboratory of Zoonoses Prevention and Control of Guangdong Province, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jia</LastName>
                    <ForeName>Weixin</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, College of Veterinary Medicine, South China Agricultural University, China; Department of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA. Electronic address: jiaweixin@scau.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Infect Genet Evol</MedlineTA>
            <NlmUniqueID>101084138</NlmUniqueID>
            <ISSNLinking>1567-1348</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Evolution rate</Keyword>
            <Keyword MajorTopicYN="N">Genotype</Keyword>
            <Keyword MajorTopicYN="N">H9N2</Keyword>
            <Keyword MajorTopicYN="N">Internal gene cassette</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31618691</ArticleId>
            <ArticleId IdType="pii">S1567-1348(19)30290-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.meegid.2019.104064</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31613887</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>27</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transgenic mouse model for conditional expression of influenza hemagglutinin-tagged human SLC20A1/PIT1.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0223052</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0223052</ELocationID>
            <Abstract>
                <AbstractText>To further investigate the role of the phosphate (Pi) transporter PIT1 in Pi homeostasis and tissue mineralization, we developed a transgenic mouse expressing the C-terminal influenza hemagglutinin (HA) epitope-tagged human PIT1 transporter under control of the cytomegalovirus/chicken beta actin/rabbit beta-globin gene (CAG) promotor and a loxP-stop-loxP (LSL) cassette permitting conditional activation of transgene expression (LSL-HA-hPITtg/+). For an initial characterization of this conditional mouse model, germline excision of the LSL cassette was performed to induce expression of the transgene in all mouse tissues (HA-hPIT1tg/+). Recombination was confirmed using genomic DNA obtained from blood samples of these mice. Furthermore, expression of HA-hPIT1 was found to be at least 10-fold above endogenous mouse Pit1 in total RNA isolated from multiple tissues and from cultured primary calvaria osteoblasts (PCOB) estimated by semi-quantitative RT-PCR. Robust expression of the HA-hPIT1 protein was also observed upon immunoblot analysis in most tissues and permits HA-mediated immunoprecipitation of the transporter. Characterization of the phenotype of HA-hPIT1tg/+ mice at 80 days of age when fed a standard chow (0.7% Pi and 1% calcium) showed elevated plasma Pi, but normal plasma iPTH, iFGF23, serum calcium, BUN, 1,25-dihydroxy vitamin D levels and urine Pi, calcium and protein excretion when compared to WT littermates. Likewise, no change in bone mineral density was observed upon uCT analysis of the distal femur obtained from these mice. In conclusion, heterozygous overexpression of HA-hPIT1 is compatible with life and causes hyperphosphatemia while bone and mineral metabolism of these mice are otherwise normal.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chande</LastName>
                    <ForeName>Sampada</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ho</LastName>
                    <ForeName>Bryan</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fetene</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bergwitz</LastName>
                    <ForeName>Clemens</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7518-249X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31613887</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0223052</ArticleId>
            <ArticleId IdType="pii">PONE-D-19-19083</ArticleId>
            <ArticleId IdType="pmc">PMC6793878</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2018 Feb 9;293(6):2102-2114</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29233890</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Bone Miner Res. 2016 Jun;31(6):1275-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26773408</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Bone Miner Res. 2019 Jun;34(6):1101-1114</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30721528</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Bone Miner Metab. 2010 Mar;28(2):139-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19795094</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2009 Nov 6;284(45):31363-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19726692</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2016 Sep 6;16(10):2736-2748</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27568561</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2018 Jan 1;495(1):553-559</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29133259</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2010 Feb 10;5(2):e9148</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20161774</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Physiol Rev. 2018 Oct 1;98(4):2317-2348</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30109818</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2009 Oct 23;284(43):29979-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19717569</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1980 Dec;77(12):7380-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6261253</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Metab. 2018 May;11:197-204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29551636</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Exp Cell Res. 2015 Apr 10;333(1):39-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25684711</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Bone Miner Res. 2019 Feb;34(2):387-398</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30347511</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Endocrinol Metab. 2018 Nov;29(11):755-767</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30217676</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Endocrinol. 2018 Nov;14(11):637-655</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30218014</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Jun 13;8(6):e65979</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23785462</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Mol Life Sci. 2011 Jan;68(2):205-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20848155</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2017 Apr 27;12(4):e0176232</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28448530</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Dent Res. 2007 Apr;86(4):320-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17384025</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CRISPR J. 2018 Apr;1:130-131</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31021203</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Physiol Renal Physiol. 2011 Apr;300(4):F848-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21307129</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2011 May 10;108(19):7902-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21464299</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genesis. 2009 Dec;47(12):858-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19882669</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Bone Miner Res. 1999 Dec;14(12):2015-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10620060</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bone. 2017 Jul;100:87-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27847254</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31609986</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>27</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0223784</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0223784</ELocationID>
            <Abstract>
                <AbstractText>Currently, influenza vaccine manufacturers need to produce 1-5 x 107 PFU of each vaccine strain to fill one dose of the current live-attenuated-influenza-vaccine (LAIV). To make a single dose of inactivated vaccine (15 ug of each hemagglutinin), the equivalent of 1010 PFU of each vaccine strains need to be grown. This high dose requirement is a major drawback for manufacturing as well as rapidly sourcing sufficient doses during a pandemic. Using our computer-aided vaccine platform Synthetic Attenuated Virus Engineering (SAVE), we created a vaccine candidate against pandemic H1N1 A/CA/07/2009 (CodaVax-H1N1) with robust efficacy in mice and ferrets, and is protective at a much lower dose than the current LAIV. CodaVax-H1N1 is currently in Phase I/II clinical trials. The hemagglutinin (HA) and neuraminidase (NA) gene segments of A/California/07/2009 (H1N1) (CA07) were &quot;de-optimized&quot; and a LAIV was generated ex silico using DNA synthesis. In DBA/2 mice, vaccination at a very low dose (100 or approximately 1 PFU) with CodaVax-H1N1 prevented disease after lethal challenge with wild-type H1N1. In BALB/c mice, as little as 103 PFU was protective against lethal challenge with mouse-adapted H1N1. In ferrets, CodaVax-H1N1 was more potent compared to currently licensed LAIV and still effective at a low dose of 103 PFU at preventing replication of challenge virus.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Stauft</LastName>
                    <ForeName>Charles B</ForeName>
                    <Initials>CB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Codagenix, Inc., Farmingdale, New York, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Chen</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Codagenix, Inc., Farmingdale, New York, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Coleman</LastName>
                    <ForeName>J Robert</ForeName>
                    <Initials>JR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Codagenix, Inc., Farmingdale, New York, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boltz</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Life Sciences Group, IIT Research Institute, Chicago, Illinois, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chin</LastName>
                    <ForeName>Chiahsuan</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Codagenix, Inc., Farmingdale, New York, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kushnir</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Codagenix, Inc., Farmingdale, New York, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mueller</LastName>
                    <ForeName>Steffen</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Codagenix, Inc., Farmingdale, New York, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>I have read the journal's policy and the authors of this manuscript have the following competing interests: CBS, CY, JRC, CC, AK and SM are employees of Codagenix, Inc. DB is an employee of IITRI. This commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31609986</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0223784</ArticleId>
            <ArticleId IdType="pii">PONE-D-19-11687</ArticleId>
            <ArticleId IdType="pmc">PMC6791556</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2018 Jul 2;218(3):347-354</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29506129</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2006 Dec;80(23):11756-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16971435</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2014 Jun 6;63(22):477-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24898164</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2011 Dec;85(23):12825-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21917963</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19423869</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2018 Feb 14;36(8):1101-1107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29366707</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2010 Aug;84(15):7662-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20484500</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E386-E395</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28049853</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Biotechnol. 2010 Jul;28(7):723-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20543832</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13169-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25157129</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9481-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23690603</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Public Health. 2008 Feb;122(2):183-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17825858</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2008 Nov 20;359(21):2283-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19020330</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2010 Oct 14;6(10):e1001145</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20976194</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4749-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25825721</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Infect Dis. 2012 Jan;12(1):36-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22032844</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2008 Jun 27;320(5884):1784-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18583614</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Urban Health. 2006 May;83(3):351-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16739036</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2016 Jan 20;34(4):563-570</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26655630</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2004 Jan;78(2):995-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14694130</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31608791</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2222-1751</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Emerging microbes &amp; infections</Title>
                <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Insights into species-specific regulation of ANP32A on the mammalian-restricted influenza virus polymerase activity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1465-1478</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2019.1676625</ELocationID>
            <Abstract>
                <AbstractText>The ANP32A is responsible for mammalian-restricted influenza virus polymerase activity. However, the mechanism of ANP32A modulation of polymerase activity remains poorly understood. Here, we report that chicken ANP32A (chANP32A) -X1 and -X2 stimulated mammalian-restricted PB2 627E polymerase activity in a dose-dependent manner. Distinct effects of ANP32A constructs suggested that the <sup>180</sup>VK<sup>181</sup> residues within chANP32A-X1 are necessary but not sufficient to stimulate PB2 627E polymerase activity. The PB2 N567D, T598V, A613V or F636L mutations promoted PB2 627E polymerase activity and chANP32A-X1 showed additive effects, providing further support that species-specific regulation of ANP32A might be only relevant with the PB2 E627K mutation. Rescue of cycloheximide-mediated inhibition showed that ANP32A is species-specific for modulation of vRNA but not mRNA and cRNA, demonstrating chANP32A-X1 compensated for defective cRNPs produced by PB2 627E virus in mammalian cells. The promoter mutations of cRNA enhanced the restriction of PB2 627E polymerase in mammalian cells, which could be restored by chANP32A-X1, indicating that ANP32A is likely to regulate the interaction of viral polymerase with RNA promoter. Coimmunoprecipitation showed that ANP32A did not affect the primary cRNPs assembly. We propose a model that chANP32A-X1 regulates PB2 627E polymerase for suitable interaction with cRNA promoter for vRNA replication.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bi</LastName>
                    <ForeName>Zhenwei</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University , Nanjing , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Hongliu</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University , Nanjing , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xingbo</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>MOA Key Laboratory of Animal Virology, Institute of Preventive Veterinary Sciences and Department of Veterinary Medicine, Zhejiang University , Hangzhou , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Collaborative innovation center and State Key laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejiang University , Hangzhou , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>An</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University , Nanjing , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Tianqi</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University , Nanjing , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>MOA Key Laboratory of Animal Virology, Institute of Preventive Veterinary Sciences and Department of Veterinary Medicine, Zhejiang University , Hangzhou , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Collaborative innovation center and State Key laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejiang University , Hangzhou , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Liping</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University , Nanjing , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Jiyong</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>MOA Key Laboratory of Animal Virology, Institute of Preventive Veterinary Sciences and Department of Veterinary Medicine, Zhejiang University , Hangzhou , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Collaborative innovation center and State Key laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejiang University , Hangzhou , People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Emerg Microbes Infect</MedlineTA>
            <NlmUniqueID>101594885</NlmUniqueID>
            <ISSNLinking>2222-1751</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ANP32A</Keyword>
            <Keyword MajorTopicYN="N">influenza A virus</Keyword>
            <Keyword MajorTopicYN="N">mammalian adaption</Keyword>
            <Keyword MajorTopicYN="N">polymerase activity</Keyword>
            <Keyword MajorTopicYN="N">viral RNA</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31608791</ArticleId>
            <ArticleId IdType="doi">10.1080/22221751.2019.1676625</ArticleId>
            <ArticleId IdType="pmc">PMC6818127</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2019 Jun 04;8:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31159925</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cell. 2016 Jan 7;61(1):125-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26711008</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2013 Jan;87(2):1278-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23115299</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2019 Aug 13;93(17):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31217244</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Microbiol. 2017 Sep;25(9):713-728</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28734617</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Host Microbe. 2015 Mar 11;17(3):309-319</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25704008</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 1999 Sep 11;354(9182):916-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10489954</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2006 Mar;80(5):2337-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16474140</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Respir Med. 2013 Dec;1(10):771-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24461756</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2019 Jun 14;93(13):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30996088</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2010 Feb;84(3):1414-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19939920</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Microbiol. 2018 Mar 29;9:559</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29651275</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2014 Dec 18;516(7531):355-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25409142</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2016 Jun 10;90(13):5928-5938</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27076644</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Res. 2017 Apr 15;234:103-117</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28115197</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Genet Evol. 2017 Nov;55:269-276</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28943407</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2017 Sep 12;20(11):2538-2546</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28903035</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Respirology. 2008 Mar;13 Suppl 1:S2-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18366524</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2013 May;87(10):5746-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23487452</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2012 May 01;3:802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22549831</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MBio. 2019 Jun 18;10(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31213560</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2016 Jan 7;529(7584):101-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26738596</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Microbiol. 2016 Aug;14(8):479-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27396566</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 Jan;88(1):339-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24155385</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Microbiol Infect. 2018 Mar;24(3):321-323</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29104171</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2018 Sep 4;24(10):2581-2588.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30184493</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2004 Sep;78(17):9568-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15308750</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MBio. 2017 Jun 13;8(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28611246</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2006 Apr 21;312(5772):394-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16627737</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 Feb;88(3):1694-702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24257603</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol Methods. 2011 Apr;173(1):1-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21185869</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Res. 2016 Jun 24;47(1):67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27342800</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2012 Jan;8(1):e1002488</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22275867</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2005 Nov;79(21):13811-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16227302</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2013 Nov;57(9):1367-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23881153</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2015 Oct 29;4:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26512887</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2017 Mar 13;91(7):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28122973</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2017 Jan 15;501:92-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27889648</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 1997 Mar 21;275(5307):1793-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9065404</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2014 Feb 22;383(9918):714-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24507376</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">31607059</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0253-9624</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>53</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title>
                <ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Original antigenic sin in the influenza vaccination and its influence].</ArticleTitle>
            <Pagination>
                <MedlinePgn>1070-1074</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2019.10.023</ELocationID>
            <Abstract>
                <AbstractText>Original antigenic sin may exist in the influenza virus infection or vaccination, which possibly reduces the protective efficacy in repeated influenza vaccination. This paper reviews the literature on the original antigenic sin and its influence in influenza vaccination, and interprets the possible mechanism of this phenomenon from the three aspects of influenza virus structure, humoral immunity and cellular immunity. A large number of studies have shown that original antigen sin has a negative impact on influenza vaccination, but the evidence disproveing this phenomenon also exist, so multi-center large-scale clinical trials should be conducted to provide evidence-based basis for reaearching whether original antigen sin exists and its effects. in order to provide reference for the development and update of noval influenza vaccines and its formulation of immunization strategies.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>H D C</ForeName>
                    <Initials>HDC</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>F C</ForeName>
                    <Initials>FC</Initials>
                    <AffiliationInfo>
                        <Affiliation>NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2018ZX09734004</GrantID>
                    <Agency>National Scientific and Technology Major Project</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA>
            <NlmUniqueID>7904962</NlmUniqueID>
            <ISSNLinking>0253-9624</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009975" MajorTopicYN="Y">Orthomyxoviridae</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherAbstract Type="Publisher" Language="chi">
            <AbstractText>流感病毒感染或疫苗接种可能存在原始抗原效应，可能会降低重复接种的流感疫苗的保护效果。本文对流感疫苗接种中的原始抗原效应及其影响的文献进行综述，并从流感病毒结构、体液免疫与细胞免疫三个角度解释该现象的可能发生机制。目前有大量研究显示原始抗原效应对流感疫苗的接种产生负面影响，但也有相关不支持该现象的证据，应开展多中心大型临床试验，为研究接种流感疫苗是否存在原始抗原效应及其影响提供循证依据，为新型流感疫苗的研制和更新及其免疫策略的制定提供借鉴和参考。.</AbstractText>
        </OtherAbstract>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Influenza vaccines</Keyword>
            <Keyword MajorTopicYN="N">Mechanism</Keyword>
            <Keyword MajorTopicYN="N">Original antigenic sin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31607059</ArticleId>
            <ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2019.10.023</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">31607058</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0253-9624</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>53</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title>
                <ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Research progress in establishing baselines and thresholds of influenza epidemic].</ArticleTitle>
            <Pagination>
                <MedlinePgn>1066-1070</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2019.10.022</ELocationID>
            <Abstract>
                <AbstractText>Influenza is an acute respiratory infection that seriously harms the world and public health. Because influenza viruses are prone to mutations and difficult to predict, the World Health Organization has been promoting global continuous strengthening of influenza surveillance to monitor the level of influenza activity and epidemic trends in real time. Establishing baselines and thresholds for influenza epidemic helps to gauge the start and severity of influenza seasons. At present, there are various methods for calculating baseline and threshold, such as annual median value, percentile approach, moving epidemic method, and control chart method. This paper will summarize the methods of establishing influenza baseline or threshold at home and abroad, and hope to provide reference for the establishment of baseline or threshold of influenza in China.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Guo</LastName>
                    <ForeName>Q</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention; WHO Collaborating Center for Reference and Research on Influenza, Chinese Center for Disease Control and prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>L J</ForeName>
                    <Initials>LJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Science and Technology, Clinical Medical School of Yangzhou University, Yangzhou 225001, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>D Y</ForeName>
                    <Initials>DY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention; WHO Collaborating Center for Reference and Research on Influenza, Chinese Center for Disease Control and prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention; WHO Collaborating Center for Reference and Research on Influenza, Chinese Center for Disease Control and prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2018ZX10711001</GrantID>
                    <Agency>National Science and Technology Major Project</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA>
            <NlmUniqueID>7904962</NlmUniqueID>
            <ISSNLinking>0253-9624</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherAbstract Type="Publisher" Language="chi">
            <AbstractText>流感是严重危害全球和公众健康的急性呼吸道传染病。由于流感病毒容易发生变异，难以预测，WHO一直推动全球持续加强流感监测，以实时监测流感活动水平和流行趋势。通过建立流感流行基线和阈值有助于判断流感疫情的开始和严重程度。目前，计算基线和阈值的方法多样，例如年中位数、百分位数法、移动流行区间法和控制图法等。本文将对检索到的国内外制定流感基线或阈值的方法进行归纳总结，希望为我国流感基线或阈值的制定提供参考依据。.</AbstractText>
        </OtherAbstract>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Baseline</Keyword>
            <Keyword MajorTopicYN="N">Influenza, human</Keyword>
            <Keyword MajorTopicYN="N">Severity</Keyword>
            <Keyword MajorTopicYN="N">Threshold</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31607058</ArticleId>
            <ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2019.10.022</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">31607055</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0253-9624</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>53</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title>
                <ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Hospitalization rates for influenza-associated severe acute respiratory illness in children younger than five years old in Suzhou of China, 2016-2018].</ArticleTitle>
            <Pagination>
                <MedlinePgn>1056-1059</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2019.10.019</ELocationID>
            <Abstract>
                <AbstractText>We analyzed the influenza surveillance data of Children's Hospital of Suzhou University from 2016 to 2018 and estimated the hospitalization burden of children under 5 years old due to influenza infection in Suzhou. The results showed that the influenza virus positive rate of 1 451 severe acute respiratory infection (SARI) cases in Children's Hospital of Suzhou University was 13.6% (95<i>%CI</i>: 11.8%-15.3%; 197 cases), among which the influenza pandemic intensity in 2017-2018 was relatively high, and A/H1N1 was the main pandemic virus. It was estimated that the hospitalization rate of influenza-related SARI in children under 5 years old in Suzhou was 6.9‰ (95<i>%CI</i>: 6.6‰-7.2‰), among which the hospitalization rate of children aged&lt;6 months was higher, up to 11.4‰ (95<i>%CI</i>: 9.9‰-12.8‰).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>W Q</ForeName>
                    <Initials>WQ</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University/Key Laboratory of Public Health Safety, Ministry of Education, Shanghai 200032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University/Key Laboratory of Public Health Safety, Ministry of Education, Shanghai 200032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>L L</ForeName>
                    <Initials>LL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Prevention and control, Suzhou Center for Disease Control and Prevention, Suzhou 215004, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheng</LastName>
                    <ForeName>F F</ForeName>
                    <Initials>FF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of infection, Soochow University Affiliated Children's Hospital, Suzhou 21500, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>United States and China program office for emerging and re-emerging infectious diseases, China Center of Disease Control and Prevention, Beijing 100050, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>J M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University/Key Laboratory of Public Health Safety, Ministry of Education, Shanghai 200032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Prevention and control, Suzhou Center for Disease Control and Prevention, Suzhou 215004, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>G M</ForeName>
                    <Initials>GM</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University/Key Laboratory of Public Health Safety, Ministry of Education, Shanghai 200032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>J M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of infection, Soochow University Affiliated Children's Hospital, Suzhou 21500, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Fudan University/Key Laboratory of Public Health Safety, Ministry of Education, Shanghai 200032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>5U2GGH000018</GrantID>
                    <Agency>China-US Collaborative Program on Emerging and Re-emerging Infectious Disease</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>CN2017/2018</GrantID>
                    <Agency>Global Influenza Hospital Surveillance Network</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>SS201870</GrantID>
                    <Agency>Suzhou Health and Family Planning Commission</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA>
            <NlmUniqueID>7904962</NlmUniqueID>
            <ISSNLinking>0253-9624</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherAbstract Type="Publisher" Language="chi">
            <AbstractText>分析2016—2018年苏州大学附属儿童医院的流感监测数据，估算苏州5岁以下儿童因流感而导致的住院负担。结果显示，苏州大学附属儿童医院1 451例严重急性呼吸道感染（SARI）病例的流感病毒阳性率为13.6%（95<i>%CI</i>：11.8%~15.3%；197例）；2017—2018年度流感流行强度较高，以A/H1N1为流行株。估算苏州5岁以下儿童流感相关的SARI住院率为6.9‰（95<i>%CI</i>：6.6‰~7.2‰），其中&lt;6月龄儿童住院率较高，为11.4‰（95<i>%CI</i>：9.9‰~12.8‰）。.</AbstractText>
        </OtherAbstract>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Children</Keyword>
            <Keyword MajorTopicYN="N">Hospitalization</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31607055</ArticleId>
            <ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2019.10.019</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">31607040</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0253-9624</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>53</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title>
                <ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Current situation and related policies on the implementation and promotion of influenza vaccination among health care workers].</ArticleTitle>
            <Pagination>
                <MedlinePgn>973-977</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2019.10.004</ELocationID>
            <Abstract>
                <AbstractText>Health care workers have higher risk of influenza infection because of their occupational exposure to infected patients. Infection of the health care workers may not only result in the increasing risk of the nosocomial infection and family transmission, but also disrupt the health services due to absence from work. Health care workers were recommended as a priority group of influenza vaccinationin more than 40 countries and regions in the world. In recent years, domestic surveys show that the influenza vaccine coverage among health care workers was low. This paper outlines the current status and related policies of influenza vaccination among health care workers in China and global. Additionally, we analyzed and discussed the proper immunization strategy of influenza vaccine for medical staff in China.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>L L</ForeName>
                    <Initials>LL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Infectious Disease Control and Prevention, Qinghai Provincial Center for Disease Control and Prevention, Xining 810007, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>J H</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Infectious Disease Control and Prevention, Qinghai Provincial Center for Disease Control and Prevention, Xining 810007, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qin</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peng</LastName>
                    <ForeName>Z B</ForeName>
                    <Initials>ZB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>J D</ForeName>
                    <Initials>JD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>L P</ForeName>
                    <Initials>LP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>X J</ForeName>
                    <Initials>XJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Infectious Disease Control and Prevention, Qinghai Provincial Center for Disease Control and Prevention, Xining 810007, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>L Z</ForeName>
                    <Initials>LZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Y C</ForeName>
                    <Initials>YC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Infectious Disease Control and Prevention, Qinghai Provincial Center for Disease Control and Prevention, Xining 810007, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>6NU2GGH000961-05-02</GrantID>
                    <Agency>China-US Collaborative Program on Emerging and Re-emerging Infectious Disease</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2019-ZJ-7046</GrantID>
                    <Agency>Qinghai Applied Basic Research and Natural Science Foundation Project</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2018ZX10713001-005</GrantID>
                    <Agency>National Science and Technology Major Project</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>91846302</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA>
            <NlmUniqueID>7904962</NlmUniqueID>
            <ISSNLinking>0253-9624</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherAbstract Type="Publisher" Language="chi">
            <AbstractText>医务人员由于日常工作暴露，罹患流感的风险更高。同时医务人员感染流感病毒可增加院内和家庭传播的风险，由于疾病导致的缺勤还会影响医疗体系的正常运转。全球有40多个国家和地区均将医务人员纳入流感疫苗接种的优先人群。国内调查数据显示医务人员流感疫苗接种率普遍不高。本文主要对国内外流感疫苗的接种政策和现状进行概述，分析探讨符合我国实际的医务人员流感疫苗免疫策略。.</AbstractText>
        </OtherAbstract>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Health care workers</Keyword>
            <Keyword MajorTopicYN="N">Immunization strategy</Keyword>
            <Keyword MajorTopicYN="N">Influenza vaccines</Keyword>
            <Keyword MajorTopicYN="N">Influenza, human</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31607040</ArticleId>
            <ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2019.10.004</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">31607039</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0253-9624</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>53</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title>
                <ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Analysis on immunization policy and key elements from countries with high influenza vaccine converage].</ArticleTitle>
            <Pagination>
                <MedlinePgn>968-972</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2019.10.003</ELocationID>
            <Abstract>
                <AbstractText>Vaccination is the best intervention to prevent influenza and its complications. Effective influenza immunization strategy facilitates influenza vaccine coverage to protect the population and reduce disease burden. This paper analyzes related influenza policies from six countries with high vaccination rates and summarizes five common key elements of them. Additionally, we propose the proper immunization strategy of influenza vaccine in China.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>L Z</ForeName>
                    <Initials>LZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Chinese Center for Disease Control and Protection, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Z J</ForeName>
                    <Initials>ZJ</Initials>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA>
            <NlmUniqueID>7904962</NlmUniqueID>
            <ISSNLinking>0253-9624</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherAbstract Type="Publisher" Language="chi">
            <AbstractText>疫苗接种是预防流感及其并发症的最有效手段。有效的流感免疫政策和策略，可显著提高流感疫苗接种率以保护高危人群，降低疾病负担。本文通过分析6个流感疫苗高接种率国家的免疫政策，总结5个共性的关键要素，并基于国内实际情况提出建议策略。.</AbstractText>
        </OtherAbstract>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Immunization policy</Keyword>
            <Keyword MajorTopicYN="N">Influenza vaccines</Keyword>
            <Keyword MajorTopicYN="N">Influenza, human</Keyword>
            <Keyword MajorTopicYN="N">Vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31607039</ArticleId>
            <ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2019.10.003</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">31607037</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0253-9624</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>53</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title>
                <ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Strengthen operational researches on influenza polices, and promote influenza vaccination in China].</ArticleTitle>
            <Pagination>
                <MedlinePgn>961-963</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2019.10.001</ELocationID>
            <Abstract>
                <AbstractText>This year of 2019 is the 10(th) anniversary of the 2009 H1N1 influenza pandemic, and a series of paper on epidemiology, disease burden, vaccine usage and adverse events following immunization (AEFI) incidences, cost-effectiveness of influenza vaccination, are forming an important topic of &quot;influenza disease burden and vaccine policies&quot; in this journal, which provide evidences and options for China's influenza prevention and control. We should continue to strengthen the operational researches on influenza prevention and control polices, increase the influenza vaccine coverage in high-risk groups, and improve the capacities of control and pandemic preparedness.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>Z J</ForeName>
                    <Initials>ZJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA>
            <NlmUniqueID>7904962</NlmUniqueID>
            <ISSNLinking>0253-9624</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006293" MajorTopicYN="Y">Health Promotion</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016495" MajorTopicYN="N">Police</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherAbstract Type="Publisher" Language="chi">
            <AbstractText>今年是2009年甲型H1N1流感大流行10周年，本刊组织国内专家编写本期流感疾病负担和疫苗政策重点号，分别报道了近年来我国流感流行病学特征、疾病负担、疫苗应用现状及不良反应、接种成本效果等研究成果，为我国流感防控政策的开发和促进、公众宣传和健康教育提供证据支撑和更有效的选项。我国应持续积极推动促进流感疫苗接种的政策研究，逐步提升重点人群的流感疫苗接种率，提升我国流感防控和大流行防范能力。.</AbstractText>
        </OtherAbstract>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Influenza vaccines</Keyword>
            <Keyword MajorTopicYN="N">Influenza, human</Keyword>
            <Keyword MajorTopicYN="N">Operational researches</Keyword>
            <Keyword MajorTopicYN="N">Policy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31607037</ArticleId>
            <ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2019.10.001</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31605424</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1865-1682</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Transboundary and emerging diseases</Title>
                <ISOAbbreviation>Transbound Emerg Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Outbreaks of highly pathogenic avian influenza in zoo birds caused by HA clade 2.3.4.4 H5N6 subtype viruses in Japan in winter 2016.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/tbed.13386</ELocationID>
            <Abstract>
                <AbstractText>In late 2016, two zoos, one in northern Japan and the other in central Japan, experienced highly pathogenic avian influenza (HPAI) outbreaks, in which multiple zoo birds were infected with H5N6 subtype HPAI virus (HPAIV). Here, we report an overview of these HPAI outbreaks. HPAIV infections were confirmed by virus isolation in three black swans (Cygnus atratus) and three snowy owls (Bubo scandiacus) kept in the Omoriyama Zoo hospital. At Higashiyama Zoo and Botanical Gardens, following the death of a black swan at a zoo pond, nine waterfowl, including two black swans, four cackling geese (Branta hutchinsii leucopareia), two mallards (Anas platyrhynchos), and a wigeon (Anas penelope), died after HPAIV infection in isolation facilities. Based on the presence of H5-specific antibodies in their sera, two surviving black swans and a surviving mallard at Higashiyama Zoo appeared to have HPAIV infection, although the virus was not isolated. The detectable levels of antibodies (≥10 HI) were maintained for at least 5-9 months, as determined by haemagglutinin inhibition test. Isolation of two H5N6 subtype HPAIVs from an open-air pond where affected zoo birds were previously housed at Higashiyama Zoo strongly indicates that wild waterfowl associated with aquatic environments brought the virus to the zoo. The phylogenetic relationships of the 18 isolates indicated direct viral transmission among birds within each zoo. In both zoos, containment of suspected birds in isolation facilities might have allowed the virus spread among birds inside the facility. However, maintaining containment measures and strict sanitation procedures could facilitate successful physical containment and clearance of HPAIV in both zoos.</AbstractText>
                <CopyrightInformation>© 2019 Blackwell Verlag GmbH.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Usui</LastName>
                    <ForeName>Tatsufumi</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1726-1293</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Avian Zoonosis Research Center, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soda</LastName>
                    <ForeName>Kosuke</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Zoonosis Research Center, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sumi</LastName>
                    <ForeName>Kanae</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Zoonosis Research Center, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ozaki</LastName>
                    <ForeName>Hiroichi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Zoonosis Research Center, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomioka</LastName>
                    <ForeName>Yukiko</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Experimental Animal, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ito</LastName>
                    <ForeName>Hiroshi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Zoonosis Research Center, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murase</LastName>
                    <ForeName>Toshiyuki</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Zoonosis Research Center, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kawamoto</LastName>
                    <ForeName>Tomoyo</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Akita Omoriyama Zoo, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miura</LastName>
                    <ForeName>Masaya</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Akita Omoriyama Zoo, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Komatsu</LastName>
                    <ForeName>Mamoru</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Akita Omoriyama Zoo, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Imanishi</LastName>
                    <ForeName>Tetsuya</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nagoya Higashiyama Zoo and Botanical Gardens, Nagoya, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kurobe</LastName>
                    <ForeName>Masami</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nagoya Higashiyama Zoo and Botanical Gardens, Nagoya, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ito</LastName>
                    <ForeName>Toshihiro</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Zoonosis Research Center, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamaguchi</LastName>
                    <ForeName>Tsuyoshi</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0795-0143</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Avian Zoonosis Research Center, Tottori University, Tottori, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Agency>Ministry of Education, Culture, Sports, Science and Technology</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Transbound Emerg Dis</MedlineTA>
            <NlmUniqueID>101319538</NlmUniqueID>
            <ISSNLinking>1865-1674</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">H5N6 clade 2.3.4.4</Keyword>
            <Keyword MajorTopicYN="N">HPAI in zoo birds</Keyword>
            <Keyword MajorTopicYN="N">Japan</Keyword>
            <Keyword MajorTopicYN="N">cackling geese</Keyword>
            <Keyword MajorTopicYN="N">snowy owl</Keyword>
            <Keyword MajorTopicYN="N">viral antibodies</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31605424</ArticleId>
            <ArticleId IdType="doi">10.1111/tbed.13386</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31604969</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evolutionary, genetic, structural characterization and its functional implications for the influenza A (H1N1) infection outbreak in India from 2009 to 2017.</ArticleTitle>
            <Pagination>
                <MedlinePgn>14690</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-51097-w</ELocationID>
            <Abstract>
                <AbstractText>Influenza A (H1N1) continues to be a major public health threat due to possible emergence of a more virulent H1N1 strain resulting from dynamic changes in virus adaptability consequent to functional mutations and antigenic drift in the hemagglutinin (HA) and neuraminidase (NA) surface proteins. In this study, we describe the genetic and evolutionary characteristics of H1N1 strains that circulated in India over a period of nine years from 2009 to 2017 in relation to global strains. The finding is important from a global perspective since previous phylogenetic studies have suggested that the tropics contributed substantially to the global circulation of influenza viruses. Bayesian phylogenic analysis of HA sequences along with global strains indicated that there is a temporal pattern of H1N1 evolution and clustering of Indian isolates with globally circulating strains. Interestingly, we observed four new amino acid substitutions (S179N, I233T, S181T and I312V) in the HA sequence of H1N1 strains isolated during 2017 and two (S181T and I312V) were found to be unique in Indian isolates. Structurally these two unique mutations could lead to altered glycan specificity of the HA gene. Similarly, sequence and structural analysis of NA domain revealed that the presence of K432E mutation in H1N1 strains isolated after 2015 from India and in global strains found to induce a major loop shift in the vicinity of the catalytic site. The findings presented here offer an insight as to how these acquired mutations could be associated to an improved adaptability of the virus for efficient human transmissibility.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jones</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathogen Biology Program, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala, 695014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nelson-Sathi</LastName>
                    <ForeName>Shijulal</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interdiciplinary Biology Program, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala, 695014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yejun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen, 518060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prasad</LastName>
                    <ForeName>Raji</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathogen Biology Program, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala, 695014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rayen</LastName>
                    <ForeName>Sabrina</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interdiciplinary Biology Program, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala, 695014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nandel</LastName>
                    <ForeName>Vibhuti</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Interdiciplinary Biology Program, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala, 695014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Yueming</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen, 518060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Gen Read Technology, Shenzhen, 518000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nair</LastName>
                    <ForeName>Radhakrishnan</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory Medicine and Molecular Diagnostics Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, 695014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dharmaseelan</LastName>
                    <ForeName>Sanjai</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, 695014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chirundodh</LastName>
                    <ForeName>Dhanya Valaveetil</ForeName>
                    <Initials>DV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathogen Biology Program, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala, 695014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumar</LastName>
                    <ForeName>Rakesh</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, 695014, India. rakeshkumar@rgcb.res.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pillai</LastName>
                    <ForeName>Radhakrishna Madhavan</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathogen Biology Program, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala, 695014, India. mrpillai@rgcb.res.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>(T)387/KBC/2011/CSTE</GrantID>
                    <Agency>Department of Science and Technology, Government of Kerala (Department of Science and Technology, Kerala)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>BT/MB/Indo-US/HIPC/103</GrantID>
                    <Agency>Department of Biotechnology, Ministry of Science and Technology (DBT)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>01</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31604969</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-019-51097-w</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-019-51097-w</ArticleId>
            <ArticleId IdType="pmc">PMC6789102</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2009 Jun 25;459(7250):1122-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19516283</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2008 Jan;82(2):596-601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17942553</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2018 Jun 1;35(6):1547-1549</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29722887</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1:25-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23279894</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Evol. 2018 Jun 08;4(1):vey016</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29942656</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Acta Vet Scand. 2018 Jan 25;60(1):6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29370857</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Indian J Med Res. 2012 Apr;135(4):534-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22664503</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Syst Biol. 2018 Sep 1;67(5):901-904</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29718447</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Virol. 2015 Jan;87(1):45-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25042157</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2016 Jun 28;5:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27350259</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2013 Apr;30(4):772-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23329690</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(8):e37095</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22936969</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Virol. 2014 Dec;159(12):3167-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25078388</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Comput Biol. 2019 Apr 8;15(4):e1006650</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30958812</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2010 Jan 01;5(1):e8553</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20049332</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Chem Theory Comput. 2017 Jan 10;13(1):9-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28034310</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Rev Anti Infect Ther. 2006 Oct;4(5):795-805</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17140356</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2012 Jan;86(2):982-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22072785</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2010 Jul;87(1):16-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20385168</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2008 Jul;25(7):1253-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18397919</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proteins. 2004 Dec 1;57(4):702-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15476259</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Bioinformatics. 2008 Jan 23;9:40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18215316</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Curr. 2009 Nov 03;1:RRN1126</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20029664</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Glob Infect Dis. 2015 Apr-Jun;7(2):56-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26069423</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Virol. 2009 Jul;45(3):174-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19540156</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2004 Jan 15;350(3):218-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14724300</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2012 Jul 13;337(6091):183-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22798606</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2015 Aug 06;6:7952</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26245473</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proteins. 2002 May 15;47(3):393-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11948792</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Genet. 2008 Apr;9(4):267-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18319742</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2013 Dec;87(24):13868-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24109242</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11709-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19597152</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2009 May 1;25(9):1189-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19151095</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Jul 1;43(W1):W174-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25883148</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Acta Naturae. 2009 Jul;1(2):26-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22649600</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(7):e38665</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22808012</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Evol. 2011 Sep;28(9):2443-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21415025</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2013 Mar;9(3):e1003194</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23505366</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Med. 2006 Apr;3(4):e89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16509764</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 1982 Dec;31(2 Pt 1):417-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6186384</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int Rev Immunol. 2009;28(1):69-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19241254</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31603951</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1553-7374</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>15</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PLoS pathogens</Title>
                <ISOAbbreviation>PLoS Pathog.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lung transcriptional unresponsiveness and loss of early influenza virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1008072</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1008072</ELocationID>
            <Abstract>
                <AbstractText>Respiratory viral infections contribute substantially to global infant losses and disproportionately affect preterm neonates. Using our previously established neonatal murine model of influenza infection, we demonstrate that three-day old mice are exceptionally sensitive to influenza virus infection and exhibit high mortality and viral load. Intranasal pre- and post-treatment of neonatal mice with Lactobacillus rhamnosus GG (LGG), an immune modulator in respiratory viral infection of adult mice and human preterm neonates, considerably improves neonatal mice survival after influenza virus infection. We determine that both live and heat-killed intranasal LGG are equally efficacious in protection of neonates. Early in influenza infection, neonatal transcriptional responses in the lung are delayed compared to adults. These responses increase by 24 hours post-infection, demonstrating a delay in the kinetics of the neonatal anti-viral response. LGG pretreatment improves immune gene transcriptional responses during early infection and specifically upregulates type I IFN pathways. This is critical for protection, as neonatal mice intranasally pre-treated with IFNβ before influenza virus infection are also protected. Using transgenic mice, we demonstrate that the protective effect of LGG is mediated through a MyD88-dependent mechanism, specifically via TLR4. LGG can improve both early control of virus and transcriptional responsiveness and could serve as a simple and safe intervention to protect neonates.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kumova</LastName>
                    <ForeName>Ogan K</ForeName>
                    <Initials>OK</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8455-8850</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fike</LastName>
                    <ForeName>Adam J</ForeName>
                    <Initials>AJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7105-6162</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thayer</LastName>
                    <ForeName>Jillian L</ForeName>
                    <Initials>JL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8635-0914</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nguyen</LastName>
                    <ForeName>Linda T</ForeName>
                    <Initials>LT</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3134-022X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Pediatrics, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mell</LastName>
                    <ForeName>Joshua Chang</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pascasio</LastName>
                    <ForeName>Judy</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathology, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stairiker</LastName>
                    <ForeName>Christopher</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8503-0983</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leon</LastName>
                    <ForeName>Leticia G</ForeName>
                    <Initials>LG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Katsikis</LastName>
                    <ForeName>Peter D</ForeName>
                    <Initials>PD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carey</LastName>
                    <ForeName>Alison J</ForeName>
                    <Initials>AJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7610-5659</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Pediatrics, Drexel University College of Medicine, Philadelphia, PA, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS Pathog</MedlineTA>
            <NlmUniqueID>101238921</NlmUniqueID>
            <ISSNLinking>1553-7366</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31603951</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.ppat.1008072</ArticleId>
            <ArticleId IdType="pii">PPATHOGENS-D-19-00590</ArticleId>
            <ArticleId IdType="pmc">PMC6808501</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2013 Mar;97(3):270-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23274789</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microb Ecol. 2018 Feb;75(2):529-542</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28905200</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Inflamm Res. 2015 Aug;64(8):589-602</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26072063</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pediatr Res. 2006 Aug;60(2):205-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16864705</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Nov 26;8(11):e81695</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24303065</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Dis Child Fetal Neonatal Ed. 2012 Sep;97(5):F329-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22933090</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Inflam. 2012;2012:686739</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22762009</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2009 Dec 1;183(11):7150-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19917677</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2011 Apr;18(4):621-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21288993</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2017 Aug 24;548(7668):407-412</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28813414</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2015 Sep 03;11(9):e1005122</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26336095</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Diagn Lab Immunol. 2001 May;8(3):593-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11329464</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Med. 2015 May 4;212(5):699-714</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25897172</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Microbiol. 2015 Nov;53(11):796-803</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26502964</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Oct 04;8(10):e75368</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24124485</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2014 May;20(5):524-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24747744</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2008 Nov;1143:1-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19076341</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2012 Nov 16;37(5):771-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23159225</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2007 Dec 15;179(12):8491-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18056396</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2015 Jun 12;11(6):e1004869</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26070066</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Immunol. 2002 Sep;2(9):675-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12209136</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Rep. 2012 Dec;39(12):10957-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23065264</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Biol. 2014;15(12):550</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25516281</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Immunol. 2017 Aug;17(8):495-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28627520</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2010 Apr 28;5(4):e10407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20442853</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2016 Aug 04;6:31023</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27488092</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Top Microbiol Immunol. 2015;386:23-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25078919</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14046-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18780793</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5354-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21402903</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2006 Mar;24(3):317-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16546100</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int Immunopharmacol. 2010 Sep;10(9):1101-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20601181</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2009 Jun;83(11):5825-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19297490</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbiol Immunol. 2014 Jul;58(7):416-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24888715</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gut. 2011 Aug;60(8):1050-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21471573</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2017 Dec 15;196(12):1582-1590</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28665684</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Diagn Lab Immunol. 2004 Jul;11(4):675-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15242940</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Pharm Res. 2013 Dec;36(12):1525-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23657805</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2012 Sep 15;189(6):2860-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22896628</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):805-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24344318</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2018 Oct 12;92(21):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30111569</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2012 Jan;93(1):138-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22120759</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Med. 2006 May 15;203(5):1153-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16682497</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cytokine. 2016 Jul;83:99-109</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27081760</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2001 Jul 19;412(6844):346-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11460167</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lett Appl Microbiol. 2010 Jun 1;50(6):597-602</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20438620</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Transl Med. 2016 Jun 15;8(343):343ra82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27306664</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Immunol. 2012 Feb 03;12(3):168-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22301850</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Biol. 2010;11(10):R106</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20979621</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2012 Jul 27;37(1):158-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22705104</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mucosal Immunol. 2018 May;11(3):785-795</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29067994</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Am Thorac Soc. 2014 Jan;11 Suppl 1:S33-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24437403</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2007 Nov 15;179(10):6494-503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17982038</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biol Neonate. 2005;88(3):228-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16210845</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2011 Jan 15;186(2):1151-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21169550</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunol Rev. 2013 Sep;255(1):25-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23947345</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2006 Feb 24;124(4):783-801</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16497588</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbes Infect. 2017 Dec;19(12):580-586</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28918004</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Med. 2016 Mar 24;13(3):e1001977</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27011229</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Microbiol. 2003 Apr;5(4):277-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12675685</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2008 Aug 15;29(2):272-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18656388</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2011 Mar 14;6(3):e17618</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21423798</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2017 Mar;23(3):314-326</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28112736</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2007 Feb 15;178(4):2448-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17277152</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2017 Aug 4;357(6350):498-502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28774928</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2012 Dec 15;189(12):5942-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23136205</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Immunol. 2007 Feb;19(1):24-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17113765</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Pediatr. 2003 Nov;143(5 Suppl):S127-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14615711</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2011 Feb 24;364(8):701-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21345099</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Allergy Asthma Rep. 2015 Mar;15(3):504</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25777787</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 1994 Jun 24;264(5167):1918-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8009221</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 May 27;105(21):7528-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18490660</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Immunol. 2014 Jan 14;4:512</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24459463</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2007 Sep;81(18):9790-800</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17626092</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 Aug;88(16):9350-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24920801</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 Dec 12;7(1):17360</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29234060</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lett Appl Microbiol. 2014 Dec;59(6):565-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25294223</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Nutr. 2010 Jun;29(3):312-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19896252</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Interdiscip Perspect Infect Dis. 2019 Jul 4;2019:4124865</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31354812</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gut Microbes. 2012 Nov-Dec;3(6):510-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22895087</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Virol. 2004 Mar;29(3):179-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14962787</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Benef Microbes. 2012 Jun 1;3(2):91-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22476320</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2019 Sep 15;200(6):760-770</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30883192</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 1998 Dec 11;282(5396):2085-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9851930</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Nutr. 2016 Feb 28;115(4):567-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26769562</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2009 Feb 5;360(6):588-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19196675</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMJ. 2001 Jun 2;322(7298):1327</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11387176</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Diagn Lab Immunol. 2002 Jan;9(1):105-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11777838</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Semin Immunol. 2007 Feb;19(1):24-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17275323</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Korean J Pediatr. 2010 Dec;53(12):985-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21253311</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol. 2016 Mar 15;196(6):2602-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26873987</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31603050</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2222-1751</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Emerging microbes &amp; infections</Title>
                <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Novel reassortant of H1N1 swine influenza virus detected in pig population in Russia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1456-1464</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2019.1673136</ELocationID>
            <Abstract>
                <AbstractText>Pigs play an important role in interspecies transmission of the influenza virus, particularly as &quot;mixing vessels&quot; for reassortment. Two influenza A/H1N1 virus strains, A/swine/Siberia/1sw/2016 and A/swine/Siberia/4sw/2017, were isolated during a surveillance of pigs from private farms in Russia from 2016 to 2017. There was a 10% identity difference between the HA and NA nucleotide sequences of isolated strains and the most phylogenetically related sequences (human influenza viruses of 1980s). Simultaneously, genome segments encoding internal proteins were found to be phylogenetically related to the A/H1N1pdm09 influenza virus. In addition, two amino acids (129-130) were deleted in the HA of A/swine/Siberia/4sw/2017 compared to that of A/swine/Siberia/1sw/2016 HA.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sobolev</LastName>
                    <ForeName>Ivan</ForeName>
                    <Initials>I</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4561-6517</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Modeling and Pathogenesis of Infectious Diseases, Federal Research Center of Fundamental and Translational Medicine , Novosibirsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kurskaya</LastName>
                    <ForeName>Olga</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Modeling and Pathogenesis of Infectious Diseases, Federal Research Center of Fundamental and Translational Medicine , Novosibirsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leonov</LastName>
                    <ForeName>Sergey</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Siberian Federal Scientific Centre of Agro- BioTechnologies , Krasnoobsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kabilov</LastName>
                    <ForeName>Marsel</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2777-0833</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Chemical Biology and Fundamental Medicine , Novosibirsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alikina</LastName>
                    <ForeName>Tatyana</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Chemical Biology and Fundamental Medicine , Novosibirsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alekseev</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Modeling and Pathogenesis of Infectious Diseases, Federal Research Center of Fundamental and Translational Medicine , Novosibirsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yushkov</LastName>
                    <ForeName>Yuriy</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Siberian Federal Scientific Centre of Agro- BioTechnologies , Krasnoobsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saito</LastName>
                    <ForeName>Takehiko</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Transboundary Animal Disease, National Institute of Animal Health , Tsukuba , Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Uchida</LastName>
                    <ForeName>Yuko</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-5833-5917</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Transboundary Animal Disease, National Institute of Animal Health , Tsukuba , Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mine</LastName>
                    <ForeName>Junki</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Transboundary Animal Disease, National Institute of Animal Health , Tsukuba , Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shestopalov</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Modeling and Pathogenesis of Infectious Diseases, Federal Research Center of Fundamental and Translational Medicine , Novosibirsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharshov</LastName>
                    <ForeName>Kirill</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Modeling and Pathogenesis of Infectious Diseases, Federal Research Center of Fundamental and Translational Medicine , Novosibirsk , Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Emerg Microbes Infect</MedlineTA>
            <NlmUniqueID>101594885</NlmUniqueID>
            <ISSNLinking>2222-1751</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">H1N1</Keyword>
            <Keyword MajorTopicYN="N">Swine</Keyword>
            <Keyword MajorTopicYN="N">influenza</Keyword>
            <Keyword MajorTopicYN="N">phylogeny</Keyword>
            <Keyword MajorTopicYN="N">reassortant</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31603050</ArticleId>
            <ArticleId IdType="doi">10.1080/22221751.2019.1673136</ArticleId>
            <ArticleId IdType="pmc">PMC6818105</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2009 Jun 25;459(7250):1122-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19516283</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2016 Apr 15;5:e12217</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27113719</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2017 Nov;98(11):2663-2675</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29058649</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2007 Apr 15;44(8):1084-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17366454</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Zoonoses Public Health. 2014 Feb;61(1):4-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23556412</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Top Microbiol Immunol. 2013;370:201-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23023606</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 1994 Sep;75 ( Pt 9):2183-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8077918</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2012 May 4;156(3-4):265-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22112856</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2016 Jan 15;213(2):173-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26243317</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2012 Jan;86(2):982-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22072785</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Res. 2013 Dec 01;44:112</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24289094</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1178-1185</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30359347</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2015 Sep 18;64(36):1011-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26390411</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Infect Dis. 2013 Dec;57(12):1703-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24065322</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Res. 2002 May 10;85(2):199-210</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12034486</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1999 Oct;73(10):8851-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10482643</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2010 Jun 18;328(5985):1529</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20558710</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2002 Sep;8(9):950-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12195436</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>mSphere. 2016 Dec 14;1(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27981236</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Mol Biol. 2006 Feb 3;355(5):1143-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16343533</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Res. 2015 Apr 2;201:24-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25701742</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2011 Apr;92(Pt 4):919-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21177926</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21312-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19995968</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 1996 Nov;70(11):8041-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8892928</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Genes. 2009 Oct;39(2):176-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19597980</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Microbiol. 2002 Mar;40(3):1073-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11880444</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbiol Rev. 1992 Mar;56(1):152-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1579108</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Evol. 2016 Apr 09;2(1):vew007</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27774300</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 Oct;89(19):9920-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26202246</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2015 Aug;21(8):1339-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26196759</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 1993 Mar;193(1):503-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8438586</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2004 Mar 19;32(5):1792-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15034147</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2015 Nov 15;212(10):1592-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25948864</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31602672</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1467-9566</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Sociology of health &amp; illness</Title>
                <ISOAbbreviation>Sociol Health Illn</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Revisiting the pharmaceuticalisation of pandemic influenza using Lukes' framework of power.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/1467-9566.13006</ELocationID>
            <Abstract>
                <AbstractText>The power of social actors to drive or block pharmaceutical uptake has been a concern in sociological debates on pharmaceuticalisation, including in the case of pandemic vaccination. We build on Steven Lukes' three-dimensional view of power to explore the 2009 H1N1 pandemic vaccination in Sweden and Denmark - two similar countries that arrived at conflicting vaccination strategies. Drawing on interviews with members of each country's pandemic steering group and on document analysis, we explore three consecutive stages of pandemic vaccination response: planning, vaccine procurement and the vaccination campaign. The paper makes two contributions to studies of pharmaceuticalisation and pandemics. Conceptually, we advocate the suitability of Lukes' framework over the 'countervailing powers' framework repeatedly used to model power in the pharmaceutical field. Empirically, our study confirms that government-appointed experts steered pandemic planning in both countries, but we show that the state, industry and the WHO also exerted power by enabling and constraining experts' decision-making, including by keeping some information secret. Furthermore, we argue that mass vaccination in Sweden was a pervasive expression of state power, in Lukes' sense, since it rested on keeping latent the tension between many individuals' health interests and the state's interests in protecting social and economic functioning.</AbstractText>
                <CopyrightInformation>© 2019 Foundation for the Sociology of Health &amp; Illness.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mulinari</LastName>
                    <ForeName>Shai</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8773-9796</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Sociology, Lund University, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vilhelmsson</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6635-8182</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Sociology, Lund University, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Social Medicine and Global Health, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2013-1268</GrantID>
                    <Agency>Swedish Research Council</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sociol Health Illn</MedlineTA>
            <NlmUniqueID>8205036</NlmUniqueID>
            <ISSNLinking>0141-9889</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Steven Lukes</Keyword>
            <Keyword MajorTopicYN="N">countervailing powers</Keyword>
            <Keyword MajorTopicYN="N">pandemic influenza</Keyword>
            <Keyword MajorTopicYN="N">pharmaceuticalisation</Keyword>
            <Keyword MajorTopicYN="N">power</Keyword>
            <Keyword MajorTopicYN="N">vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31602672</ArticleId>
            <ArticleId IdType="doi">10.1111/1467-9566.13006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31601264</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1297-9716</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>50</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Veterinary research</Title>
                <ISOAbbreviation>Vet. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Role of neuromedin B and its receptor in the innate immune responses against influenza A virus infection in vitro and in vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn>80</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13567-019-0695-2</ELocationID>
            <Abstract>
                <AbstractText>The peptide neuromedin B (NMB) and its receptor (NMBR) represent a system (NMB/NMBR) of neuromodulation. Here, it was demonstrated that the expression of NMBR in cells or murine lung tissues was clearly upregulated in response to H1N1/PR8 influenza A virus infection. Furthermore, the in vitro and in vivo activities of NMB/NMBR during PR8 infection were investigated. It was observed that A549 cells lacking endogenous NMBR were more susceptible to virus infection than control cells, as evidenced by the increased virus production in the cells. Interestingly, a significant decrease in IFN-α and increased IL-6 expression were observed in these cells. The role of this system in innate immunity against PR8 infection was probed by treating mice with NMB. The NMB-treated mice were less susceptible to virus challenge, as evidenced by increased survival, increased body weight, and decreased viral NP expression compared with the control animals. Additionally, the results showed that exogenous NMB not only enhanced IFN-α expression but also appeared to inhibit the expression of NP and IL-6 in PR8-infected cells and animals. As expected, opposing effects were observed in the NMBR antagonist-treated cells and mice, which further confirmed the effects of NMB. Together, these data suggest that NMB/NMBR may be an important component of the host defence against influenza A virus infection. Thus, these proteins may serve as promising candidates for the development of novel antiviral drugs.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Guihong</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0252-4380</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Key laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agricultural and Forestry University, Fujian, 350002, China. 877813797@qq.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Huipeng</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agricultural and Forestry University, Fujian, 350002, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Mengyao</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agricultural and Forestry University, Fujian, 350002, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cai</LastName>
                    <ForeName>Zifeng</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agricultural and Forestry University, Fujian, 350002, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Cuiqin</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agricultural and Forestry University, Fujian, 350002, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qi</LastName>
                    <ForeName>Baomin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agricultural and Forestry University, Fujian, 350002, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Ji-Long</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agricultural and Forestry University, Fujian, 350002, China. chenjl@im.ac.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>U1805231</GrantID>
                    <Agency>National Nature Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>31602046</GrantID>
                    <Agency>National Nature Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>31302050</GrantID>
                    <Agency>National Nature Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2014</GrantID>
                    <Agency>FAFU Program for Promising Academic Youngster</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>(2016YFD0500205)</GrantID>
                    <Agency>National Key Research and Development Program of China</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Vet Res</MedlineTA>
            <NlmUniqueID>9309551</NlmUniqueID>
            <ISSNLinking>0928-4249</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31601264</ArticleId>
            <ArticleId IdType="doi">10.1186/s13567-019-0695-2</ArticleId>
            <ArticleId IdType="pii">10.1186/s13567-019-0695-2</ArticleId>
            <ArticleId IdType="pmc">PMC6785861</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Stem Cells Transl Med. 2019 Mar;8(3):271-284</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30394698</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2013 Aug 1;73(15):4898-908</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23749639</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2013 Jun 1;381(9881):1916-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23623390</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16625539</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunol Today. 1991 Mar;12(3):A7-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1712594</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2015 Feb 25;175(2-4):232-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25554243</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2013 Jul 11;369(2):191-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23841736</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunol Cell Biol. 2007 Feb-Mar;85(2):85-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17213831</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Peptides. 1985;6 Suppl 3:245-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3841690</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genes Cells. 2001 Jul;6(7):631-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11473581</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Nutr. 2003 Feb;133(2):504-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12566491</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biol Reprod. 2012 May 17;86(5):154, 1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22262690</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2009 Jun;15(6):966-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19523305</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 Mar 13;10(3):e0119115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25768797</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Vaccine Immunol. 2010 May;17(5):728-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20219878</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2013 Jul 25;499(7459):500-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23823727</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2012 Feb 24;36(2):166-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22365663</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pharmacol Rep. 2017 Jun;69(3):438-447</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28315588</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Res. 2018 Oct 1;49(1):98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30285871</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Peptides. 2009 Feb;30(2):234-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18992779</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2014 Aug;88(15):8375-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24829357</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2005 Oct 1;366(9492):1175-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16198766</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18625765</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2001 Jul 20;286(1):197-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11448172</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Mol Cell Biol. 2001 May;2(5):378-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11331912</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2006 Oct;12(10):1203-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16964257</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Interferon Cytokine Res. 2007 Mar;27(3):181-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17348816</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2006 Dec;5(12):1015-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17139286</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Infect Dis. 2007 Jul 15;196(2):249-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17570112</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Prog Neurobiol. 2000 Oct;62(3):297-312</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10840151</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Clin North Am Small Anim Pract. 1985 Sep;15(5):919-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3000052</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Infect Dis. 2008 Dec;21(6):626-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18978531</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2005 Sep 29;353(13):1374-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16192482</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Neuroimmunol. 2006 Nov;180(1-2):88-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16930726</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2009 Mar 5;360(10):953-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19258250</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2014 Jan;10(1):e1003845</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24391501</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Risk Saf Med. 2011;23(4):201-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22156085</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31600542</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-1208</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>137</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Microbial pathogenesis</Title>
                <ISOAbbreviation>Microb. Pathog.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Amantadine resistance markers among low pathogenic avian influenza H9N2 viruses isolated from poultry in India, during 2009-2017.</ArticleTitle>
            <Pagination>
                <MedlinePgn>103779</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0882-4010(19)31493-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.micpath.2019.103779</ELocationID>
            <Abstract>
                <AbstractText>Antiviral susceptibility screening of avian influenza (AI) H9N2 viruses is crucial considering their role at the animal-human interface and potential to cause human infections. The Matrix 2 (M2) inhibitors (amantadine and rimantadine) have been used for prophylaxis and treatment of influenza A virus infections, however, resistance to these drugs has been widely reported. Information about amantadine susceptibility of H9N2 viruses from India is scanty. Matrix genes of 48H9N2 viruses isolated from India during 2009-2017 were sequenced and M2 trans-membrane region sequences were screened for mutations which are known to confer resistance to amantadine namely, L26F, V27A, A30 T/V, S31N and G34E. All the viruses isolated during the year 2009 were sensitive to amantadine. However, resistance started to appear since the year 2010 and all the viruses isolated from the year 2015 onwards showed presence of molecular markers conferring resistance to amantadine. Majority of the resistant viruses exhibited S31 N mutation. Four isolates showed presence of V27A + S31 N dual mutations. Comparison of the M2 sequences from other Asian countries showed different patterns of amantadine resistance wherein phylogenetic analysis of the M genes of the strains from Pakistan formed a separate cluster. In conclusion, the present study reports prevalence and gradual increase of amantadine resistance among AI H9N2 viruses in India, emphasizing the importance of the antiviral surveillance.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kode</LastName>
                    <ForeName>Sadhana S</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, 130/1, Sus Road, Pashan, Pune, 411021, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pawar</LastName>
                    <ForeName>Shailesh D</ForeName>
                    <Initials>SD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, 130/1, Sus Road, Pashan, Pune, 411021, India. Electronic address: shaileshpawarniv@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tare</LastName>
                    <ForeName>Deeksha S</ForeName>
                    <Initials>DS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, 130/1, Sus Road, Pashan, Pune, 411021, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keng</LastName>
                    <ForeName>Sachin S</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, 130/1, Sus Road, Pashan, Pune, 411021, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mullick</LastName>
                    <ForeName>Jayati</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Avian Influenza Group, Microbial Containment Complex, ICMR-National Institute of Virology, 130/1, Sus Road, Pashan, Pune, 411021, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Microb Pathog</MedlineTA>
            <NlmUniqueID>8606191</NlmUniqueID>
            <ISSNLinking>0882-4010</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Amantadine resistance</Keyword>
            <Keyword MajorTopicYN="N">Avian influenza</Keyword>
            <Keyword MajorTopicYN="N">H9N2</Keyword>
            <Keyword MajorTopicYN="N">India</Keyword>
            <Keyword MajorTopicYN="N">M2 mutations</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31600542</ArticleId>
            <ArticleId IdType="pii">S0882-4010(19)31493-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.micpath.2019.103779</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31600274</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Adaptation of H3N2 canine influenza virus to feline cell culture.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0223507</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0223507</ELocationID>
            <Abstract>
                <AbstractText>H3N2 canine influenza viruses are prevalent in Asian and North American countries. During circulation of the viruses in dogs, these viruses are occasionally transmitted to cats. If this canine virus causes an epidemic in cats too, sporadic infections may occur in humans because of the close contact between these companion animals and humans, possibly triggering an emergence of mutant viruses with a pandemic potential. In this study, we aimed to gain an insight into the mutations responsible for inter-species transmission of H3N2 virus from dogs to cats. We found that feline CRFK cell-adapted viruses acquired several mutations in multiple genome segments. Among them, HA1-K299R, HA2-T107I, NA-L35R, and M2-W41C mutations individually increased virus growth in CRFK cells. With a combination of these mutations, virus growth further increased not only in CRFK cells but also in other feline fcwf-4 cells. Both HA1-K299R and HA2-T107I mutations increased thermal resistance of the viruses. In addition, HA2-T107I increased the pH requirement for membrane fusion. These findings suggest that the mutations, especially the two HA mutations, identified in this study, might be responsible for adaptation of H3N2 canine influenza viruses in cats.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kamiki</LastName>
                    <ForeName>Haruhiko</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsugo</LastName>
                    <ForeName>Hiromichi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ishida</LastName>
                    <ForeName>Hiroho</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kobayashi-Kitamura</LastName>
                    <ForeName>Tomoya</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sekine</LastName>
                    <ForeName>Wataru</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Takenaka-Uema</LastName>
                    <ForeName>Akiko</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murakami</LastName>
                    <ForeName>Shin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Horimoto</LastName>
                    <ForeName>Taisuke</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9201-9424</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31600274</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0223507</ArticleId>
            <ArticleId IdType="pii">PONE-D-19-18114</ArticleId>
            <ArticleId IdType="pmc">PMC6786582</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2008 Jan 31;451(7178):591-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18235503</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochemistry. 1992 Oct 13;31(40):9609-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1327122</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bull World Health Organ. 1972;47(4):461-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4196340</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virol J. 2015 Apr 01;12:50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25889762</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2010 Dec;16(12):2019-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21122255</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virol Sin. 2015 Jun;30(3):221-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25953615</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2009 Jun 18;459(7249):931-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19525932</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2002 Oct 18;277(42):39880-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12183461</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2009 Apr;83(8):3568-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19193808</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2000 Jul;74(14):6538-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10864667</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2017 Dec;23(12):1950-1957</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28858604</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2012 Mar 23;155(2-4):409-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22033043</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2004 Oct 8;306(5694):241</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15345779</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Am Vet Med Assoc. 2016 May 1;248(9):1022-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27074610</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2006 Apr;12(4):681-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16704821</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MBio. 2018 Jun 5;9(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29871917</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2015 May;479-480:234-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25812763</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virus Genes. 2014 Feb;48(1):56-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24101341</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10430945</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2017 Jul 12;91(15):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28515300</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Genet Evol. 2013 Dec;20:471-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24161411</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2015 Nov 10;5:15928</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26552719</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>FASEB J. 2007 Apr;21(4):995-1002</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17218542</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Rec. 2012 Nov 10;171(19):477</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22952134</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2011 Oct;92(Pt 10):2350-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21715595</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Immun. 1981 Nov;34(2):354-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7309229</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2012 Mar;93(Pt 3):551-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22131311</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Infect Genet Evol. 2010 Dec;10(8):1286-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20732458</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2019 Aug 13;93(17):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31189708</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2015 Dec;21(12):2154-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26583707</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2006 Nov;12(11):1744-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17283627</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Emerg Infect Dis. 2008 May;14(5):741-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18439355</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2005 Oct 21;310(5747):482-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16186182</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Virol. 2001 Dec;146(12):2275-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11811679</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 Dec 30;90(6):2981-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26719265</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Influenza Other Respir Viruses. 2017 Jan;11(1):74-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27426214</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2012 Feb;86(3):1405-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22090129</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2008 Jan 20;370(2):403-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17936324</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microbiol Rev. 1992 Mar;56(1):152-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1579108</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>mSphere. 2018 Jan 3;3(1):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29299534</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bull World Health Organ. 1970;43(6):859-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5314017</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2005 Jun 3;280(22):21463-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15784624</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Microbiol. 2011 Dec;49(12):4101-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21956989</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Microbiol. 2013 Aug 30;165(3-4):281-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23618838</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biophys J. 1995 Oct;69(4):1363-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8534806</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 1985 Feb;40(2):431-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3967299</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vet Rec. 2014 Jan 25;174(4):96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24336761</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Zoonoses Public Health. 2011 Dec;58(8):573-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21824359</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31599544</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1828-1427</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>55</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Veterinaria italiana</Title>
                <ISOAbbreviation>Vet. Ital.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hemagglutinin consensus-based prophylactic approaches to overcome influenza virus diversity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>195-201</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.12834/VetIt.1944.10352.1</ELocationID>
            <Abstract>
                <AbstractText>Each year millions of people are infected by influenza viruses, and this causes a substantial economic and health burden on our society. Influenza epidemics and pandemics are attributable to the ongoing evolution of influenza viruses through antigenic drift and shift, respectively. One of the reasons for the continuous circulation of influenza viruses in the human population is the incomplete protection conferred by currently available seasonal influenza vaccines against possible arising drifted or shifted influenza strains. Recently, tremendous efforts have been focused on the development of a more effective broadly reactive or universal influenza vaccine. The main objective of underdevelopment vaccines is to protect the human population not only from currently circulating virus strains but also from possible future variants without the need for their continuous update. Different approaches have been developed to reach this goal and elicit an effective and cross-protective immune response. Among these, consensus-based prophylactic approaches to effectively prevent influenza infections are the major focus of this review.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sautto</LastName>
                    <ForeName>Giuseppe Andrea</ForeName>
                    <Initials>GA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ross</LastName>
                    <ForeName>Ted M</ForeName>
                    <Initials>TM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, University of Georgia, Athens, GA, USA. Email: tedross@uga.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>Vet Ital</MedlineTA>
            <NlmUniqueID>0201543</NlmUniqueID>
            <ISSNLinking>0505-401X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Computationally-optimized broadly reactive antigen (COBRA)</Keyword>
            <Keyword MajorTopicYN="N">Consensus sequence</Keyword>
            <Keyword MajorTopicYN="N">Influenza virus</Keyword>
            <Keyword MajorTopicYN="N">Universal influenza vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31599544</ArticleId>
            <ArticleId IdType="doi">10.12834/VetIt.1944.10352.1</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31598281</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2054-5703</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>6</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Royal Society open science</Title>
                <ISOAbbreviation>R Soc Open Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Label-free sensitive detection of influenza virus using PZT discs with a synthetic sialylglycopolymer receptor layer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>190255</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1098/rsos.190255</ELocationID>
            <Abstract>
                <AbstractText>We describe rapid, label-free detection of Influenza A viruses using the first radial mode of oscillations of lead zirconate titanate (PZT) piezoelectric discs with a 2 mm radius and 100 µm thickness fabricated from a piezoelectric membrane. The discs are modified with a synthetic sialylglycopolymer receptor layer, and the coated discs are inserted in a flowing virus suspension. Label-free detection of the virus is achieved by monitoring the disc radial mode resonance frequency shift. Piezo transducers with sialylglycopolymer sensor layers exhibited a long lifetime, a high sensitivity and the possibility of regeneration. We demonstrate positive, label-free detection of Influenza A viruses at concentrations below 10<sup>5</sup> virus particles per millilitre. We show that label-free, selective, sensitive detection of influenza viruses by home appliances is possible in principle.</AbstractText>
                <CopyrightInformation>© 2019 The Authors.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Erofeev</LastName>
                    <ForeName>Alexander S</ForeName>
                    <Initials>AS</Initials>
                    <Identifier Source="ORCID">0000-0002-6631-821X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Lomonosov Moscow State University, 1, Leninskie Gory, Moscow 119991, Russia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National University of Science and Technology 'MISIS', Leninskiy prospect 4, 119991 Moscow, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gorelkin</LastName>
                    <ForeName>Petr V</ForeName>
                    <Initials>PV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Nanotechnology LLC, Skolkovo, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kolesov</LastName>
                    <ForeName>Dmitry V</ForeName>
                    <Initials>DV</Initials>
                    <AffiliationInfo>
                        <Affiliation>FSBSI Institute of General Pathology and Pathophysiology, 8, Baltiyskaya st., Moscow 125315, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kiselev</LastName>
                    <ForeName>Gleb A</ForeName>
                    <Initials>GA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Advanced Technologies Center, 4-5-47, Stroiteley Street, Moscow 119311, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dubrovin</LastName>
                    <ForeName>Evgeniy V</ForeName>
                    <Initials>EV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lomonosov Moscow State University, 1, Leninskie Gory, Moscow 119991, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yaminsky</LastName>
                    <ForeName>Igor V</ForeName>
                    <Initials>IV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lomonosov Moscow State University, 1, Leninskie Gory, Moscow 119991, Russia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Advanced Technologies Center, 4-5-47, Stroiteley Street, Moscow 119311, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>Dryad</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>10.5061/dryad.6045tk0</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>R Soc Open Sci</MedlineTA>
            <NlmUniqueID>101647528</NlmUniqueID>
            <ISSNLinking>2054-5703</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">biosensor</Keyword>
            <Keyword MajorTopicYN="N">influenza</Keyword>
            <Keyword MajorTopicYN="N">microelectromechanical systems</Keyword>
            <Keyword MajorTopicYN="N">sialylglycopolymer</Keyword>
            <Keyword MajorTopicYN="N">virus detection</Keyword>
        </KeywordList>
        <CoiStatement>We have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31598281</ArticleId>
            <ArticleId IdType="doi">10.1098/rsos.190255</ArticleId>
            <ArticleId IdType="pii">rsos190255</ArticleId>
            <ArticleId IdType="pmc">PMC6774986</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Biosens Bioelectron. 2013 Apr 15;42:148-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23202345</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Glycoconj J. 2005 Feb;22(1-2):43-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15864434</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biosens Bioelectron. 2015 Mar 15;65:211-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25461160</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Glycoconj J. 1998 May;15(5):431-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9881745</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J R Soc Interface. 2009 Dec 6;6 Suppl 6:S783-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19773292</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomed Opt Express. 2017 Jul 07;8(8):3551-3558</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28856034</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Soc Belg Med Trop. 1972;52(1):9-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4334129</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Carbohydr Res. 1993 Jul 19;245(2):175-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8370021</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Theranostics. 2017 Apr 10;7(7):1835-1846</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28638471</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol Methods. 2009 Dec;162(1-2):14-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19628008</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biosens Bioelectron. 2014 Nov 15;61:357-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24912036</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2013 Mar;9(3):e1003205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23505369</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biosens Bioelectron. 2010 Nov 15;26(3):964-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20863681</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nanoscale Res Lett. 2015 Feb 18;10:69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25852365</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17383-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15583121</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2005 Apr 10;334(2):276-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15780877</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2003 Sep 1;313(2):473-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12954214</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nanotechnology. 2010 Feb 19;21(7):75501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20081290</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Chromatogr A. 2006 Jun 23;1118(2):281-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16712860</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biosens Bioelectron. 2009 Aug 15;24(12):3455-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19487115</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Analyst. 2015 Sep 7;140(17):6131-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26215598</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Analyst. 2010 Jul;135(7):1531-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20414486</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biosens Bioelectron. 2011 Jun 15;26(10):4146-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21536419</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Mol Life Sci. 2006 Jun;63(12):1331-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16596337</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 Nov 16;7(1):15707</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29146948</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anal Chim Acta. 2017 Apr 22;963:112-118</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28335964</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Future Virol. 2014 Jan;9(1):41-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25067941</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biosens Bioelectron. 2017 Jun 15;92:234-240</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28222368</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2017 Mar 28;12(3):e0174314</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28350811</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31598013</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0035-9254</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>68</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the Royal Statistical Society. Series C, Applied statistics</Title>
                <ISOAbbreviation>J R Stat Soc Ser C Appl Stat</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Improving the identification of antigenic sites in the H1N1 influenza virus through accounting for the experimental structure in a sparse hierarchical Bayesian model.</ArticleTitle>
            <Pagination>
                <MedlinePgn>859-885</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/rssc.12338</ELocationID>
            <Abstract>
                <AbstractText>Understanding how genetic changes allow emerging virus strains to escape the protection afforded by vaccination is vital for the maintenance of effective vaccines. We use structural and phylogenetic differences between pairs of virus strains to identify important antigenic sites on the surface of the influenza A(H1N1) virus through the prediction of haemagglutination inhibition (HI) titre: pairwise measures of the antigenic similarity of virus strains. We propose a sparse hierarchical Bayesian model that can deal with the pairwise structure and inherent experimental variability in the H1N1 data through the introduction of latent variables. The latent variables represent the underlying HI titre measurement of any given pair of virus strains and help to account for the fact that, for any HI titre measurement between the same pair of virus strains, the difference in the viral sequence remains the same. Through accurately representing the structure of the H1N1 data, the model can select virus sites which are antigenic, while its latent structure achieves the computational efficiency that is required to deal with large virus sequence data, as typically available for the influenza virus. In addition to the latent variable model, we also propose a new method, the block-integrated widely applicable information criterion biWAIC, for selecting between competing models. We show how this enables us to select the random effects effectively when used with the model proposed and we apply both methods to an A(H1N1) data set.</AbstractText>
                <CopyrightInformation>© 2019 The Authors Journal of the Royal Statistical Society: Series C (Applied Statistics) Published by John Wiley &amp; Sons Ltd on behalf of the Royal Statistical Society.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Davies</LastName>
                    <ForeName>Vinny</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Glasgow UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Harvey</LastName>
                    <ForeName>William T</ForeName>
                    <Initials>WT</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Glasgow UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reeve</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Glasgow UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Husmeier</LastName>
                    <ForeName>Dirk</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Glasgow UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J R Stat Soc Ser C Appl Stat</MedlineTA>
            <NlmUniqueID>101086541</NlmUniqueID>
            <ISSNLinking>0035-9254</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antigenic variability</Keyword>
            <Keyword MajorTopicYN="N">Bayesian hierarchical models</Keyword>
            <Keyword MajorTopicYN="N">Influenza virus</Keyword>
            <Keyword MajorTopicYN="N">Latent variable models</Keyword>
            <Keyword MajorTopicYN="N">Markov chain Monte Carlo sampling</Keyword>
            <Keyword MajorTopicYN="N">Mixed effects models</Keyword>
            <Keyword MajorTopicYN="N">Spike‐and‐slab prior</Keyword>
            <Keyword MajorTopicYN="N">Widely applicable information criterion</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31598013</ArticleId>
            <ArticleId IdType="doi">10.1111/rssc.12338</ArticleId>
            <ArticleId IdType="pii">RSSC12338</ArticleId>
            <ArticleId IdType="pmc">PMC6774336</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2016 Jul 22;11(7):e0159360</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27448206</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2006 Mar 15;22(6):739-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16368767</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Med. 1942 Jan 1;75(1):49-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19871167</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Stat Appl Genet Mol Biol. 2014 Oct;13(5):531-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25153608</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Virol. 2007 Dec;88(Pt 12):3209-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18024888</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2014 Mar 6;507(7490):57-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24572367</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2016 Apr 08;12(4):e1005526</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27057693</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Comput Biol. 2010 Dec 09;6(12):e1001027</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21151576</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2004 Mar 19;303(5665):1838-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14764886</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>IEEE Trans Pattern Anal Mach Intell. 1984 Jun;6(6):721-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22499653</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Annu Rev Biochem. 2000;69:531-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10966468</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 1982 Dec;31(2 Pt 1):417-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6186384</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2014 Aug 20;32(37):4713-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24582632</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31597930</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1935-3456</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Mucosal immunology</Title>
                <ISOAbbreviation>Mucosal Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Targeting the IL-22/IL-22BP axis enhances tight junctions and reduces inflammation during influenza infection.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41385-019-0206-9</ELocationID>
            <Abstract>
                <AbstractText>The seasonal burden of influenza coupled with the pandemic outbreaks of more pathogenic strains underscore a critical need to understand the pathophysiology of influenza injury in the lung. Interleukin-22 (IL-22) is a promising cytokine that is critical in protecting the lung during infection. This cytokine is strongly regulated by the soluble receptor IL-22-binding protein (IL-22BP), which is constitutively expressed in the lungs where it inhibits IL-22 activity. The IL-22/IL-22BP axis is thought to prevent chronic exposure of epithelial cells to IL-22. However, the importance of this axis is not understood during an infection such as influenza. Here we demonstrate through the use of IL-22BP-knockout mice (il-22ra2<sup>-/-</sup>) that a pro-IL-22 environment reduces pulmonary inflammation during H1N1 (PR8/34 H1N1) infection and protects the lung by promoting tight junction formation. We confirmed these results in normal human bronchial epithelial cells in vitro demonstrating improved membrane resistance and induction of the tight junction proteins Cldn4, Tjp1, and Tjp2. Importantly, we show that administering recombinant IL-22 in vivo reduces inflammation and fluid leak into the lung. Taken together, our results demonstrate the IL-22/IL-22BP axis is a potential targetable pathway for reducing influenza-induced pneumonia.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hebert</LastName>
                    <ForeName>K D</ForeName>
                    <Initials>KD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mclaughlin</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galeas-Pena</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Z</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eddens</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Richard King Mellon Foundation Institute for Pediatric Research, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 15224, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Govero</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pilewski</LastName>
                    <ForeName>J M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kolls</LastName>
                    <ForeName>J K</ForeName>
                    <Initials>JK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pociask</LastName>
                    <ForeName>D A</ForeName>
                    <Initials>DA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Critical Care and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA, USA. dpociask@tulane.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R35 HL139930</GrantID>
                    <Acronym>HL</Acronym>
                    <Agency>NHLBI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mucosal Immunol</MedlineTA>
            <NlmUniqueID>101299742</NlmUniqueID>
            <ISSNLinking>1933-0219</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>06</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31597930</ArticleId>
            <ArticleId IdType="doi">10.1038/s41385-019-0206-9</ArticleId>
            <ArticleId IdType="pii">10.1038/s41385-019-0206-9</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31597771</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Identification of key amino acids in the PB2 and M1 proteins of H7N9 influenza virus that affect its transmission in guinea pigs.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">JVI.01180-19</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01180-19</ELocationID>
            <Abstract>
                <AbstractText>Efficient human-to-human transmission is a prerequisite for a novel influenza virus to cause an influenza pandemic; however, the genetic determinants of influenza virus transmission are still not fully understood. In this study, we compared the respiratory droplet transmissibility of four H7N9 viruses that are genetic closely related and found that these viruses have dissimilar transmissibility in guinea pigs: A/Anhui/1/2013 (AH/1) transmitted efficiently, whereas the other three viruses did not transmit. The three non-transmissible viruses have one to eight amino acid differences compared with the AH/1 virus. To investigate which of these amino acids is important for transmission, we used reverse genetics to generate a series of reassortants and mutants in the AH/1 background and tested their transmissibility in guinea pigs. We found that the NA of the non-transmissible virus A/chicken/Shanghai/S1053/2013 had low enzymatic activity that impaired the transmission of AH/1 virus, and three amino acid mutations--V292I and K627E in PB2 and D156E in M1--independently abolished the transmission of the AH/1 virus. We further found that an NA reassortant and three single-amino-acid mutants replicated less efficiently than the AH/1 virus in A549 cells, and that the amino acid at position 156 of M1 affected the morphology of H7N9 viruses. Our study identifies key amino acids in PB2 and M1 that play important roles in H7N9 influenza virus transmission and provides new insights into the transmissibility of influenza virus.<b>Importance</b> Efficient transmission is a prerequisite for a novel influenza virus to cause an influenza pandemic; however, the genetic determinants of influenza virus transmission remain poorly understood. H7N9 influenza viruses, which emerged in 2013 in China, have caused over 1,560 human infection cases, showing clear pandemic potential. Previous studies have shown that the H7N9 viruses differ in their transmissibility in animal models. Here we found two amino acids in PB2 (292V and 627K) and one in M1 (156D) that are extremely important for H7N9 virus transmission. Of note, PB2 292V and M1 156D appear in most H7N9 viruses, and the PB2 627K mutation could easily occur when the H7N9 virus replicates in humans. Our study thus identifies new amino acids that are important for influenza virus transmission and suggests that just a few key amino acid changes can render the H7N9 virus transmissible in mammals.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Kong et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kong</LastName>
                    <ForeName>Huihui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Shujie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jingfei</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gu</LastName>
                    <ForeName>Chunyang</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zeng</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Jianzhong</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Deng</LastName>
                    <ForeName>Guohua</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guan</LastName>
                    <ForeName>Yuntao</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Hualan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, CAAS, People's Republic of China. chenhualan@caas.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31597771</ArticleId>
            <ArticleId IdType="pii">JVI.01180-19</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01180-19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31597765</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hemagglutinin-dependent tropism of H5N1 and H7N9 influenza viruses to human endothelial cells is determined by reduced stability of the HA which allows the virus to cope with inefficient endosomal acidification and constitutively expressed IFITM3.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">JVI.01223-19</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01223-19</ELocationID>
            <Abstract>
                <AbstractText>Previous studies revealed that certain avian influenza A viruses (IAVs), including zoonotic H5N1 and H7N9 IAVs, infect cultured human lung microvascular endothelial cells (HULEC) more efficiently than other IAVs and that tropism to HULEC is determined by viral hemagglutinin (HA). To characterize mechanisms of HA-mediated endotheliotropism, we used 2:6 recombinant IAVs harbouring HAs from distinctive avian and human viruses and found that efficient infection of HULEC correlated with low conformational stability of the HA. We next studied effects on viral infectivity of single-point amino acid substitutions in the HA of 2:6 recombinant virus A/Vietnam/1203/2004-PR8 (H5N1). Substitutions H8Q, H103Y, T315I and K58<sub>2</sub>I, which increased stability of the HA, markedly reduced viral infectivity for HULEC, whereas substitutions K189N and K218Q, which altered typical H5N1-virus-like receptor specificity and reduced binding avidity of the HA, led to only marginal reduction of infectivity. None of these substitutions affected virus infection in MDCK cells. We confirmed the previous observation of elevated basal expression of IFITM3 protein in HULEC and found that endosomal acidification is less efficient in HULEC than in MDCK cells. In accord with these findings, counteraction of IFITM3-mediated restriction by amphotericin B and reduction of endosomal pH by moderate acidification of the extracellular medium, enhanced infectivity of viruses with stable HA for HULEC without significant effect on infectivity for MDCK cells. Collectively, our results indicate that relatively high pH optimum of fusion of the HA of zoonotic H5N1 and H7N9 IAVs allows them to overcome antiviral effects of inefficient endosomal acidification and IFITM3 in human endothelial cells.<b>IMPORTANCE</b> Receptor specificity of the HA of IAVs is known to be a critical determinant of viral cell tropism. Here we show that fusion properties of the HA may also play a key role in the tropism. Thus, we demonstrate that IAVs having relatively low pH optimum of fusion, cannot efficiently infect human endothelial cells owing to their relatively high endosomal pH and increased expression of fusion-inhibiting IFITM3 protein. These restrictions can be overcome by IAVs with elevated pH of fusion, such as zoonotic H5N1 and H7N9. Our results illustrate that infectivity of IAVs depends on an interplay between HA conformational stability, endosomal acidification and IFITM3 expression in target cells and extracellular pH. Given significant variation of HA stability among animal, human and zoonotic IAVs, our findings prompt further studies on the fusion-dependent tropism of IAVs to different cell types in humans and its role in viral host range and pathogenicity.</AbstractText>
                <CopyrightInformation>Copyright © 2019 American Society for Microbiology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hensen</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8467-8537</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Virology, Philipps University, Marburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matrosovich</LastName>
                    <ForeName>Tatyana</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Virology, Philipps University, Marburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roth</LastName>
                    <ForeName>Katrin</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Tumor Biology and Immunology (ZTI), Core Facility Cellular Imaging, Philipps University, Marburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Klenk</LastName>
                    <ForeName>Hans-Dieter</ForeName>
                    <Initials>HD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Virology, Philipps University, Marburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matrosovich</LastName>
                    <ForeName>Mikhail</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1618-2083</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Virology, Philipps University, Marburg, Germany m.matrosovich@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31597765</ArticleId>
            <ArticleId IdType="pii">JVI.01223-19</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01223-19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31597759</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hemagglutinin cleavability, acid-stability and temperature dependence optimize influenza B virus for replication in human airways.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">JVI.01430-19</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01430-19</ELocationID>
            <Abstract>
                <AbstractText>Influenza A virus (IAV) and influenza B virus (IBV) cause yearly epidemics with significant morbidity and mortality. When zoonotic IAVs enter the human population, the viral hemagglutinin (HA) requires adaptation to achieve sustained virus transmission. In contrast, IBV has been circulating in humans, its only host, for a long period of time. Whether this entailed adaptation of IBV HA to the human airways is unknown. To address this question, we compared two seasonal IAV (A/H1N1 and A/H3N2) and two IBV viruses (B/Victoria and B/Yamagata lineage) with regard to host-dependent activity of HA as the mediator of membrane fusion during viral entry. We first investigated proteolytic activation of HA, by covering all type II transmembrane serine protease (TTSP) and kallikrein enzymes, many of which proved present in human respiratory epithelium. Compared to IAV, the IBV HA0 precursor is cleaved by a broader panel of TTSPs and activated with much higher efficiency. Accordingly, knockdown of a single protease, TMPRSS2, abrogated spread of IAV but not IBV in human respiratory epithelial cells. Second, the HA fusion pH proved similar for IBV and human-adapted IAVs (one exception being HA of 1918 IAV). Third, IBV HA exhibited higher expression at 33°C, a temperature required for membrane fusion by B/Victoria HA. This indicates pronounced adaptation of IBV HA to the mildly acidic pH and cooler temperature of human upper airways. These distinct and intrinsic features of IBV HA are compatible with extensive host-adaptation during prolonged circulation of this respiratory virus in the human population.<b>IMPORTANCE</b> Influenza epidemics are caused by influenza A (IAV) and influenza B (IBV) viruses. IBV causes substantial disease, however it is far less studied than IAV. While IAV originates from animal reservoirs, IBV circulates in humans only. Virus spread requires that the viral hemagglutinin (HA) is active and sufficiently stable in human airways. We here resolve how these mechanisms differ between IBV and IAV. Whereas human IAVs rely on one particular protease for HA activation, this is not the case for IBV. Superior activation of IBV by several proteases should enhance shedding of infectious particles. IBV HA exhibits acid-stability and a preference for 33°C, indicating pronounced adaptation to the human upper airways, where the pH is mildly acidic and a cooler temperature exists. These adaptive features are rationalized by the long existence of IBV in humans, and may have broader relevance for understanding the biology and evolution of respiratory viruses.</AbstractText>
                <CopyrightInformation>Copyright © 2019 American Society for Microbiology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Laporte</LastName>
                    <ForeName>Manon</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU Leuven-University of Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stevaert</LastName>
                    <ForeName>Annelies</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU Leuven-University of Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raeymaekers</LastName>
                    <ForeName>Valerie</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU Leuven-University of Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boogaerts</LastName>
                    <ForeName>Talitha</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU Leuven-University of Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nehlmeier</LastName>
                    <ForeName>Inga</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chiu</LastName>
                    <ForeName>Winston</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU Leuven-University of Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Benkheil</LastName>
                    <ForeName>Mohammed</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU Leuven-University of Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vanaudenaerde</LastName>
                    <ForeName>Bart</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU Leuven-University of Leuven, Department of Chronic Diseases, Metabolism and Ageing, Laboratory of Pneumology, University Hospital Leuven, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pöhlmann</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Naesens</LastName>
                    <ForeName>Lieve</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU Leuven-University of Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium lieve.naesens@kuleuven.be.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31597759</ArticleId>
            <ArticleId IdType="pii">JVI.01430-19</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01430-19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31596660</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2164-554X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human vaccines &amp; immunotherapeutics</Title>
                <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evaluating impact of school outreach vaccination programme in Hong Kong influenza season 2018 - 2019.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-4</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2019.1678357</ELocationID>
            <Abstract>
                <AbstractText>School-based vaccination, as a means to mitigate seasonal influenza outbreak, depends on attaining adequate coverage rate. We evaluated the potential of a fully subsidized school outreach vaccination (SOV) program to achieve epidemic prevention potential in Hong Kong. The purpose of this study was to evaluate the impact of SOV program 2018-2019 on influenza vaccination rates and influenza-like illness (ILI) in the primary school students and their household members during the influenza season. The vaccination rate was significantly higher in the schools offering SOV (intervention schools) (69.2% vs. 34.3%) than those not offering SOV (control schools) (<i>p</i> &lt; .0001). The ILI rate was significantly reduced from 14.1% among non-vaccinated to 7.7% among vaccinated students (<i>p</i> &lt; .0001). Influenza vaccine effectiveness against ILI was 45.3%. The vaccination rates of the household members were the same in both intervention and control schools except in the sub-group of preschool household members with the intervention significantly higher than the control group (43.8% vs. 32%, <i>p</i> &lt; .0001). SOV program significantly improved influenza vaccine coverage, and the vaccine reduced ILI incidence. Extension of SOV program to all primary schools as well as kindergartens in Hong Kong could achieve epidemic prevention potential and should be evaluated.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lau</LastName>
                    <ForeName>Yu Lung</ForeName>
                    <Initials>YL</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4780-0289</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wong</LastName>
                    <ForeName>Wilfred Hing Sang</ForeName>
                    <Initials>WHS</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8396-2368</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hattangdi-Haridas</LastName>
                    <ForeName>Sonal R</ForeName>
                    <Initials>SR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chow</LastName>
                    <ForeName>Chun Bong</ForeName>
                    <Initials>CB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Vaccin Immunother</MedlineTA>
            <NlmUniqueID>101572652</NlmUniqueID>
            <ISSNLinking>2164-5515</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Influenza-like illness</Keyword>
            <Keyword MajorTopicYN="N">school outreach vaccination program</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31596660</ArticleId>
            <ArticleId IdType="doi">10.1080/21645515.2019.1678357</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31595535</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1348-0421</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Microbiology and immunology</Title>
                <ISOAbbreviation>Microbiol. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Serological survey of influenza A virus infection in Japanese wild boars (Sus scrofa leucomystax).</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/1348-0421.12750</ELocationID>
            <Abstract>
                <AbstractText>We conducted a serological survey to detect antibodies against influenza A virus (IAV) in Japanese wild boars in Kagoshima prefecture, Japan, between 2014 and 2017. Sero-prevalence against a pandemic-like swine H1N1 (H1N1pdm) virus was identified in 27.1% of specimens, and 1.7% were positive for both swine H1N2 and H3N2 viruses, indicating that wild boars could play an important role in the dynamics of H1N1pdm viral dispersion in the wild. The high frequency of positive results for sera against the H1N1pdm virus suggests that cross-species IAV transmission between wild boars, livestock and humans is a threat to veterinary and public health. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fujimoto</LastName>
                    <ForeName>Yoshikazu</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2847-3291</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Transboundary Animal Diseases Research Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Joint Graduate School of Veterinary Medicine, Kagoshima University, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Inoue</LastName>
                    <ForeName>Hideya</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shiga Prefectural Institute of Public Health, Shiga, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ozawa</LastName>
                    <ForeName>Makoto</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7731-5321</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Transboundary Animal Diseases Research Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Joint Graduate School of Veterinary Medicine, Kagoshima University, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsuu</LastName>
                    <ForeName>Aya</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Transboundary Animal Diseases Research Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Joint Graduate School of Veterinary Medicine, Kagoshima University, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Australia</Country>
            <MedlineTA>Microbiol Immunol</MedlineTA>
            <NlmUniqueID>7703966</NlmUniqueID>
            <ISSNLinking>0385-5600</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Animal RNA Virus</Keyword>
            <Keyword MajorTopicYN="N">Epidemiology</Keyword>
            <Keyword MajorTopicYN="N">Influenza A virus</Keyword>
            <Keyword MajorTopicYN="N">Wild boar</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31595535</ArticleId>
            <ArticleId IdType="doi">10.1111/1348-0421.12750</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31594636</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2104</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>520</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochemical and biophysical research communications</Title>
                <ISOAbbreviation>Biochem. Biophys. Res. Commun.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Demethylation around the transcriptional start site of the IFN-β gene induces IFN-β production and protection against influenza virus infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>269-276</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0006-291X(19)31874-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2019.09.136</ELocationID>
            <Abstract>
                <AbstractText>Seasonal influenza is related to lifestyle-associated risk factors and it has been suggested that the epigenetic state of the individual plays an important role in the severity of infection. It is well known that epigenetics stringently regulate gene expression in each tissue and that aberrant epigenetic states can influence disease development. Despite some studies, limited information is available on changes in epigenetic states before and after influenza virus infection; in particular, it is unknown whether the epigenetic state at specific sites affects subsequent infection. Here, we analyzed CpG methylation states in clones derived from human primary small airway epithelial cells with the same genetic background but different viral replication rates. Our study revealed that demethylating CpGs downstream of the IFN-β transcription start site using a CRISPR/dCas9 system suppressed viral replication during subsequent influenza virus infection. Thus, our observations suggest that epigenome editing might provide adequate protection against the influenza virus.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nishioka</LastName>
                    <ForeName>Keisuke</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Electronic address: din85051@koto.kpu-m.ac.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Daidoji</LastName>
                    <ForeName>Tomo</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakaya</LastName>
                    <ForeName>Takaaki</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
            <NlmUniqueID>0372516</NlmUniqueID>
            <ISSNLinking>0006-291X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CpG methylation</Keyword>
            <Keyword MajorTopicYN="N">Epigenetics</Keyword>
            <Keyword MajorTopicYN="N">IFN-Beta</Keyword>
            <Keyword MajorTopicYN="N">Influenza virus</Keyword>
            <Keyword MajorTopicYN="N">Viral infection</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31594636</ArticleId>
            <ArticleId IdType="pii">S0006-291X(19)31874-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbrc.2019.09.136</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31594458</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-0254</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>26</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biomolecular structure &amp; dynamics</Title>
                <ISOAbbreviation>J. Biomol. Struct. Dyn.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Design of fluorinated sialic acid analog inhibitor to H5 hemagglutinin of H5N1 influenza virus through molecular dynamics simulation study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-10</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/07391102.2019.1677500</ELocationID>
            <Abstract>
                <AbstractText>Influenza epidemics and pandemics are caused by influenza A virus. The cell surface protein of hemagglutinin and neuraminidase is responsible for viral infection and release of progeny virus on the host cell membrane. Now 18 hemagglutinin and 11 neuraminidase subtypes are identified. The avian influenza virus of H5N1 is an emergent threat to public health issues. To control the influenza viral infection it is necessary to develop antiviral inhibitors and vaccination. In the present investigation we carried out 50 ns Molecular Dynamics simulation on H5 hemagglutinin of Influenza A virus H5N1 complexed with fluorinated sialic acid by substituting fluorine atoms at any two hydroxyls of sialic acid by considering combinatorial combination. The binding affinity between the protein-ligand complex system is investigated by calculating pair interaction energy and MM-PBSA binding free energy. All the complex structures are stabilized by hydrogen bonding interactions between the H5 protein and the ligand fluorinated sialic acid. It is concluded from all the analyses that the fluorinated complexes enhance the inhibiting potency against H5 hemagglutinin and the order of inhibiting potency is SIA-F9 ≫ SIA-F2 ≈ SIA-F7 ≈ SIA-F2F4 ≈ SIA-F2F9 ≈ SIA-F7F9 &gt; SIA-F7F8 ≈ SIA-F2F8 ≈ SIA-F8F9 &gt; SIA-F4 ≈ SIA-F4F7 ≈ SIA-F4F8 ≈ SIA-F8 ≈ SIA-F2F7 ≈ SIA &gt; SIA-F4F9. This study suggests that one can design the inhibitor by using the mono fluorinated models SIA-F9, SIA-F2 and SIA-F7 and difluorinated models SIA-F2F4, SIA-F2F9 and SIA-F7F9 to inhibit H5 of H5N1 to avoid Influenza A viral infection. Communicated by Ramaswamy H. Sarma.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jeyaram</LastName>
                    <ForeName>R A</ForeName>
                    <Initials>RA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Laboratory of Molecular Biophysics, Department of Physics, School of Advanced Sciences, Vellore Institute of Technology , Vellore , Tamil Nadu , India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Radha</LastName>
                    <ForeName>C Anu</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Laboratory of Molecular Biophysics, Department of Physics, School of Advanced Sciences, Vellore Institute of Technology , Vellore , Tamil Nadu , India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gromiha</LastName>
                    <ForeName>M Michael</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras , Chennai , Tamil Nadu , India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Veluraja</LastName>
                    <ForeName>K</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Laboratory of Molecular Biophysics, Department of Physics, School of Advanced Sciences, Vellore Institute of Technology , Vellore , Tamil Nadu , India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Biomol Struct Dyn</MedlineTA>
            <NlmUniqueID>8404176</NlmUniqueID>
            <ISSNLinking>0739-1102</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">H5N1</Keyword>
            <Keyword MajorTopicYN="N">MM-PBSA</Keyword>
            <Keyword MajorTopicYN="N">NAMD</Keyword>
            <Keyword MajorTopicYN="N">molecular dynamics</Keyword>
            <Keyword MajorTopicYN="N">sialic acid</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31594458</ArticleId>
            <ArticleId IdType="doi">10.1080/07391102.2019.1677500</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31592345</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2167-8359</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>7</Volume>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PeerJ</Title>
                <ISOAbbreviation>PeerJ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Tandem mass tag-based quantitative proteomic analysis of lycorine treatment in highly pathogenic avian influenza H5N1 virus infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e7697</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj.7697</ELocationID>
            <Abstract>
                <AbstractText>Highly pathogenic H5N1 influenza viruses (HPAIV) cause rapid systemic illness and death in susceptible animals, leading to a disease with high morbidity and mortality rates. Although vaccines and drugs are the best solution to prevent this threat, a more effective treatment for H5 strains of influenza has yet to be developed. Therefore, the development of therapeutics/drugs that combat H5N1 influenza virus infection is becoming increasingly important. Lycorine, the major component of Amaryllidaceae alkaloids, exhibits better protective effects against A/CK/GD/178/04 (H5N1) (GD178) viruses than the commercial neuraminidase (NA) inhibitor oseltamivir in our prior study. Lycorine demonstrates outstanding antiviral activity because of its inhibitory activity against the export of viral ribonucleoprotein complexes (vRNPs) from the nucleus. However, how lycorine affects the proteome of AIV infected cells is unknown. Therefore, we performed a comparative proteomic analysis to identify changes in protein expression in AIV-infected Madin-Darby Canine Kidney cells treated with lycorine. Three groups were designed: mock infection group (M), virus infection group (V), and virus infection and lycorine-treated after virus infection group (L). The multiplexed tandem mass tag (TMT) approach was employed to analyze protein level in this study. In total, 5,786 proteins were identified from the three groups of cells by using TMT proteomic analysis. In the V/M group, 1,101 proteins were identified, of which 340 differentially expressed proteins (DEPs) were determined during HPAIV infection; among the 1,059 proteins identified from the lycorine-treated group, 258 proteins presented significant change. Here, 71 proteins showed significant upregulation or downregulation of expression in the virus-infected/mock and virus-infected/lycorine-treated comparisons, and the proteins in each fraction were functionally classified further. Interestingly, lycorine treatment decreased the levels of the nuclear pore complex protein 93 (Nup93, E2RSV7), which is associated with nuclear-cytoplasmic transport. In addition, Western blot experiments confirmed that the expression of Nup93 was significantly downregulated in lycorine treatment but induced after viral infection. Our results may provide new insights into how lycorine may trap vRNPs in the nucleus and suggest new potential therapeutic targets for influenza virus.</AbstractText>
                <CopyrightInformation>©2019 Yang et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>College of Life Science and Technology, Jinan University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jia Hao</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Xiao Li</ForeName>
                    <Initials>XL</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Life Science and Technology, Jinan University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lao</LastName>
                    <ForeName>Guang Jie</ForeName>
                    <Initials>GJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Guan Ming</ForeName>
                    <Initials>GM</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yao Lan</ForeName>
                    <Initials>YL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Wen Cai</ForeName>
                    <Initials>WC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Laboratory Animal Science, Jinan University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PeerJ</MedlineTA>
            <NlmUniqueID>101603425</NlmUniqueID>
            <ISSNLinking>2167-8359</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Highly pathogenic avian influenza virus</Keyword>
            <Keyword MajorTopicYN="N">Lycorine</Keyword>
            <Keyword MajorTopicYN="N">Multiplex tandem mass tag</Keyword>
            <Keyword MajorTopicYN="N">Nuclear pore complex protein 93</Keyword>
            <Keyword MajorTopicYN="N">Nuclear-cytoplasmic transport</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare there are no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31592345</ArticleId>
            <ArticleId IdType="doi">10.7717/peerj.7697</ArticleId>
            <ArticleId IdType="pii">7697</ArticleId>
            <ArticleId IdType="pmc">PMC6778435</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2015 Dec 17;4:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26673895</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Proteome Res. 2014 Dec 5;13(12):6176-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25338131</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2017 Nov 16;8(1):1558</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29146960</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer Ther. 2017 Dec;16(12):2711-2723</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28974556</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2016 Oct 18;11(10):e0164115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27755556</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Med Chem. 2009 Oct 22;52(20):6244-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19788245</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25352553</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 1986 Jan 15;261(2):505-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3001065</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2017 Jun 30;66(25):668-676</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28662019</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2019 Feb 5;93(4):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30463961</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>AIDS. 2016 Sep 24;30(15):2289-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27427877</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proteomics. 2011 May;11(10):2019-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21500348</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Planta. 2016 Feb;243(2):531-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26526413</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Med Chem. 2017 Jul 28;135:70-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28433777</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer Ther. 2016 Jan;15(1):60-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26637366</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Chem Inf Model. 2016 Jan 25;56(1):82-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26703840</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cosmet Sci. 2008 Sep-Oct;59(5):419-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18841306</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Molecules. 2016 Oct 27;21(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27801807</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>EuPA Open Proteom. 2015 Mar 1;6:10-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25893165</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Bot. 2012 Mar;63(5):1809-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22200664</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Fitoterapia. 2012 Jan;83(1):81-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21968064</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2008 Mar;77(3):232-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18243348</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2014 Dec 1;24(23):5381-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25453792</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>ChemMedChem. 2014 Jul;9(7):1522-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24574246</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2005 Jul;67(1):18-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15885816</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Proteome Res. 2012 Nov 2;11(11):5396-405</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22985253</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1315-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23302696</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cells. 2015 Jul 28;4(3):277-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26226003</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Res Virol. 1989 Mar-Apr;140(2):115-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2547235</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chem Cent J. 2012 Sep 08;6(1):96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22958411</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2017 Nov 9;8(1):1396</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29123131</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virol J. 2011 Oct 27;8:483</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22029605</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Virology. 2009 Feb 5;384(1):242-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19062063</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14597658</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Pathog. 2017 Oct 12;13(10):e1006650</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29023600</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Rep. 2007 Feb;17(2):377-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17203177</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2015 Nov 23;60(2):913-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26596952</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem. 2010 Jul 1;18(13):4694-701</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20627737</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2016 Apr;15(4):232-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27032831</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Microbiol. 2018 Jul 24;9:1675</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30087672</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2017 Sep 27;91(20):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28747506</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Malar J. 2018 Jun 25;17(1):244</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29941026</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Phytochemistry. 2011 May;72(7):645-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21324496</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chem Pharm Bull (Tokyo). 2009 Jun;57(6):610-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19483344</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Cell. 2012 Feb;23(4):740-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22171326</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Vaccine. 2013 Nov 19;31(48):5693-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24113260</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Hematol Oncol. 2014 Dec 05;7:85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25476752</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Methods. 2009 May;6(5):359-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19377485</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):922-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23136954</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>MBio. 2017 Nov 7;8(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29114028</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Phytochemistry. 1995 Nov;40(4):1295-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7492374</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12218-E12227</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30538201</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mass Spectrom Rev. 2006 May-Jun;25(3):450-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16429408</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int Immunopharmacol. 2012 Jan;12(1):249-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22155741</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microb Pathog. 2018 Feb;115:138-145</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29253598</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Clin Cancer Res. 2018 Jul 17;37(1):157</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30016965</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2015 Jun 20;6(17):15348-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25915156</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Epigenetics Chromatin. 2016 Dec 3;9:54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27980680</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mini Rev Med Chem. 2010 Jan;10(1):41-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20105122</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomed Pharmacother. 2016 Dec;84:1645-1653</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27847203</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2014 Jan 15;5(1):11-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24429466</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioorg Med Chem Lett. 2018 Jan 1;28(1):40-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29162457</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Sci. 2017 Jul 18;18(7):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28718801</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Virol. 2015 Jun;89(11):6009-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25810542</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Microb Pathog. 2015 May;82:27-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25752867</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Med Chem. 2016 Sep 14;120:313-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27218860</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31591166</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5522</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Infection and immunity</Title>
                <ISOAbbreviation>Infect. Immun.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transcriptional and pathological host responses to co-infection with virulent or attenuated <i>Mycoplasma gallisepticum</i> and low pathogenic avian influenza A virus in chickens.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">IAI.00607-19</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/IAI.00607-19</ELocationID>
            <Abstract>
                <AbstractText>The avian pathogen <i>Mycoplasma gallisepticum</i>, the etiologic agent of chronic respiratory disease in chickens, exhibits enhanced pathogenesis in the presence of a co-pathogen such as low-pathogenic avian influenza virus (LPAIV). To further investigate the intricacies of this co-pathogenesis, chickens were mono- or co-infected with either virulent <i>M. gallisepticum</i> strain R<sub>low</sub>, or LPAIV H3N8 (A/duck/Ukraine/1963) and assessed for tracheal histopathology, pathogen load, and transcriptomic host response to infection using RNA-sequencing. Chickens co-infected with <i>M. gallisepticum</i> R<sub>low</sub> followed by LPAIV H3N8 exhibited significantly more severe tracheal lesions and mucosal thickening than chickens infected with LPAIV H3N8 alone and higher viral loads than chickens infected first with H3N8 and subsequently with <i>M. gallisepticum</i> R<sub>low</sub> Recovery of live <i>M. gallisepticum</i> was significantly higher in chickens infected first with LPAIV H3N8 followed by <i>M. gallisepticum</i> R<sub>low</sub> compared to chickens given a mock infection followed by <i>M. gallisepticum</i> R<sub>low</sub> The transcriptional response to mono- and co-infection with <i>M. gallisepticum</i> and LPAIV highlighted the involvement of differential expression of genes such as TLR15, TLR21, and MMP1. Pathway and gene ontology analysis of these differentially expressed genes suggests that co-infection with virulent <i>M. gallisepticum</i> and LPAIV induces a decrease in expression of genes relating to ciliary activity <i>in vivo</i> and alters multiple immune-related signaling cascades. These data aid in the understanding of the relationship between <i>M. gallisepticum</i> and LPAIV during co-pathogenesis in the natural host and may contribute to the further understanding of co-pathogen infections of humans and other animals.</AbstractText>
                <CopyrightInformation>Copyright © 2019 American Society for Microbiology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Canter</LastName>
                    <ForeName>J A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology and Veterinary Sciences and the Center of Excellence for Vaccine Research, University of Connecticut, Storrs, Connecticut, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tulman</LastName>
                    <ForeName>E R</ForeName>
                    <Initials>ER</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology and Veterinary Sciences and the Center of Excellence for Vaccine Research, University of Connecticut, Storrs, Connecticut, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beaudet</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology and Veterinary Sciences and the Center of Excellence for Vaccine Research, University of Connecticut, Storrs, Connecticut, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Allied Health Sciences, University of Connecticut, Storrs, Connecticut, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology and Veterinary Sciences and the Center of Excellence for Vaccine Research, University of Connecticut, Storrs, Connecticut, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>May</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences, University of New England College of Medicine, Biddeford, Maine, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Szczepanek</LastName>
                    <ForeName>S M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology and Veterinary Sciences and the Center of Excellence for Vaccine Research, University of Connecticut, Storrs, Connecticut, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Geary</LastName>
                    <ForeName>S J</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathobiology and Veterinary Sciences and the Center of Excellence for Vaccine Research, University of Connecticut, Storrs, Connecticut, USA steven.geary@uconn.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Infect Immun</MedlineTA>
            <NlmUniqueID>0246127</NlmUniqueID>
            <ISSNLinking>0019-9567</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31591166</ArticleId>
            <ArticleId IdType="pii">IAI.00607-19</ArticleId>
            <ArticleId IdType="doi">10.1128/IAI.00607-19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>




</PubmedArticleSet>